'Mycose'
(id=92497033 ; fe=Mycose ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=4085 creation date=2022-11-27 touchdate=2025-12-08 20:02:07.000) ≈ 2481 relations sortantes
- Mycose --
r_associated #0: 30 / 1 ->
maladie infectieuse fongique
n1=Mycose | n2=maladie infectieuse fongique | rel=r_associated | relid=0 | w=30
- Mycose --
r_associated #0: 28 / 0.933 ->
maladie d'origine mycosique
n1=Mycose | n2=maladie d'origine mycosique | rel=r_associated | relid=0 | w=28
- Mycose --
r_associated #0: 27 / 0.9 ->
infection fongique
n1=Mycose | n2=infection fongique | rel=r_associated | relid=0 | w=27
- Mycose --
r_associated #0: 26 / 0.867 ->
en:fungal infection
n1=Mycose | n2=en:fungal infection | rel=r_associated | relid=0 | w=26
- Mycose --
r_associated #0: 24 / 0.8 ->
maladie mycotique
n1=Mycose | n2=maladie mycotique | rel=r_associated | relid=0 | w=24
- Mycose --
r_associated #0: 23 / 0.767 ->
champignon
n1=Mycose | n2=champignon | rel=r_associated | relid=0 | w=23
- Mycose --
r_associated #0: 22 / 0.733 ->
champignon
(mycose)
n1=Mycose | n2=champignon (mycose) | rel=r_associated | relid=0 | w=22
- Mycose --
r_associated #0: 22 / 0.733 ->
en:fungus disease
n1=Mycose | n2=en:fungus disease | rel=r_associated | relid=0 | w=22
- Mycose --
r_associated #0: 22 / 0.733 ->
en:fungus infection
n1=Mycose | n2=en:fungus infection | rel=r_associated | relid=0 | w=22
- Mycose --
r_associated #0: 21 / 0.7 ->
en:mycosis
n1=Mycose | n2=en:mycosis | rel=r_associated | relid=0 | w=21
- Mycose --
r_associated #0: 21 / 0.7 ->
infection mycosique
n1=Mycose | n2=infection mycosique | rel=r_associated | relid=0 | w=21
- Mycose --
r_associated #0: 21 / 0.7 ->
mycosis
n1=Mycose | n2=mycosis | rel=r_associated | relid=0 | w=21
- Mycose --
r_associated #0: 20 / 0.667 ->
Mycose buccale
n1=Mycose | n2=Mycose buccale | rel=r_associated | relid=0 | w=20
- Mycose --
r_associated #0: 20 / 0.667 ->
Mycose des ongles
n1=Mycose | n2=Mycose des ongles | rel=r_associated | relid=0 | w=20
- Mycose --
r_associated #0: 20 / 0.667 ->
Mycose invasive
n1=Mycose | n2=Mycose invasive | rel=r_associated | relid=0 | w=20
- Mycose --
r_associated #0: 20 / 0.667 ->
Mycose systémique
n1=Mycose | n2=Mycose systémique | rel=r_associated | relid=0 | w=20
- Mycose --
r_associated #0: 20 / 0.667 ->
Mycose vaginale
n1=Mycose | n2=Mycose vaginale | rel=r_associated | relid=0 | w=20
- Mycose --
r_associated #0: 20 / 0.667 ->
piment
n1=Mycose | n2=piment | rel=r_associated | relid=0 | w=20
- Mycose --
r_associated #0: 20 / 0.667 ->
Plante
n1=Mycose | n2=Plante | rel=r_associated | relid=0 | w=20
- Mycose --
r_associated #0: 18 / 0.6 ->
infection
n1=Mycose | n2=infection | rel=r_associated | relid=0 | w=18
- Mycose --
r_associated #0: 18 / 0.6 ->
peau
n1=Mycose | n2=peau | rel=r_associated | relid=0 | w=18
- Mycose --
r_associated #0: 17 / 0.567 ->
candidose
n1=Mycose | n2=candidose | rel=r_associated | relid=0 | w=17
- Mycose --
r_associated #0: 17 / 0.567 ->
inflammation
n1=Mycose | n2=inflammation | rel=r_associated | relid=0 | w=17
- Mycose --
r_associated #0: 17 / 0.567 ->
mycologie
n1=Mycose | n2=mycologie | rel=r_associated | relid=0 | w=17
- Mycose --
r_associated #0: 17 / 0.567 ->
pathologie
n1=Mycose | n2=pathologie | rel=r_associated | relid=0 | w=17
- Mycose --
r_associated #0: 17 / 0.567 ->
pied d'athlète
n1=Mycose | n2=pied d'athlète | rel=r_associated | relid=0 | w=17
- Mycose --
r_associated #0: 16 / 0.533 ->
mycose cutanée
n1=Mycose | n2=mycose cutanée | rel=r_associated | relid=0 | w=16
- Mycose --
r_associated #0: 15 / - ->
_SW
n1=Mycose | n2=_SW | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
actinomycose
n1=Mycose | n2=actinomycose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
affection cutanée
n1=Mycose | n2=affection cutanée | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
affection dermatologique
n1=Mycose | n2=affection dermatologique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
antimycosique
n1=Mycose | n2=antimycosique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
aspergillose
n1=Mycose | n2=aspergillose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
aspergillose bronchopulmonaire
n1=Mycose | n2=aspergillose bronchopulmonaire | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
bactériémie
n1=Mycose | n2=bactériémie | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
bactériémie non précisée
n1=Mycose | n2=bactériémie non précisée | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
bactériémies
n1=Mycose | n2=bactériémies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
biologie
n1=Mycose | n2=biologie | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
blastomycose
n1=Mycose | n2=blastomycose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
candida albicans
n1=Mycose | n2=candida albicans | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
champignons microscopiques
n1=Mycose | n2=champignons microscopiques | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
cryptococcose
n1=Mycose | n2=cryptococcose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
dermatophytie
n1=Mycose | n2=dermatophytie | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
dermatophytose
n1=Mycose | n2=dermatophytose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
dermatose
n1=Mycose | n2=dermatose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
dishydrose
n1=Mycose | n2=dishydrose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
e-400 mycoses termes généraux
n1=Mycose | n2=e-400 mycoses termes généraux | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:{21 (prednisolone 5 mg oral tablet) } pack
n1=Mycose | n2=en:{21 (prednisolone 5 mg oral tablet) } pack | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:{21 (prednisone 10 mg oral tablet) } pack
n1=Mycose | n2=en:{21 (prednisone 10 mg oral tablet) } pack | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:{21 (prednisone 5 mg oral tablet) } pack
n1=Mycose | n2=en:{21 (prednisone 5 mg oral tablet) } pack | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:{48 (prednisone 10 mg oral tablet) } pack
n1=Mycose | n2=en:{48 (prednisone 10 mg oral tablet) } pack | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:{48 (prednisone 5 mg oral tablet) } pack
n1=Mycose | n2=en:{48 (prednisone 5 mg oral tablet) } pack | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:120 actuat triamcinolone acetonide 0.055 mg/actuat nasal inhaler
n1=Mycose | n2=en:120 actuat triamcinolone acetonide 0.055 mg/actuat nasal inhaler | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:240 actuat triamcinolone acetonide 0.075 mg/actuat metered dose inhaler
n1=Mycose | n2=en:240 actuat triamcinolone acetonide 0.075 mg/actuat metered dose inhaler | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:240 actuat triamcinolone acetonide 0.1 mg/actuat metered dose inhaler
n1=Mycose | n2=en:240 actuat triamcinolone acetonide 0.1 mg/actuat metered dose inhaler | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:60 actuat triamcinolone acetonide 0.055 mg/actuat nasal inhaler
n1=Mycose | n2=en:60 actuat triamcinolone acetonide 0.055 mg/actuat nasal inhaler | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abdominal infection
n1=Mycose | n2=en:abdominal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abnormal b cell function
n1=Mycose | n2=en:abnormal b cell function | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abnormal delayed hypersensitivity skin test
n1=Mycose | n2=en:abnormal delayed hypersensitivity skin test | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abnormal immunoglobulin level
n1=Mycose | n2=en:abnormal immunoglobulin level | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abnormal laboratory test result
n1=Mycose | n2=en:abnormal laboratory test result | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abnormal lymphocytic accumulation in non-lymphoid tissue
n1=Mycose | n2=en:abnormal lymphocytic accumulation in non-lymphoid tissue | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abnormal ratios of cd4+ helper t cells
n1=Mycose | n2=en:abnormal ratios of cd4+ helper t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abnormality of b cell physiology
n1=Mycose | n2=en:abnormality of b cell physiology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abnormality of humoral immunity
n1=Mycose | n2=en:abnormality of humoral immunity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abnormality of t cells
n1=Mycose | n2=en:abnormality of t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abnormally large monocytes with vacuoles
n1=Mycose | n2=en:abnormally large monocytes with vacuoles | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abrasion and/or friction burn with infection
n1=Mycose | n2=en:abrasion and/or friction burn with infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abscess
n1=Mycose | n2=en:abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abscess formation in any organ
n1=Mycose | n2=en:abscess formation in any organ | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abscess fungal
n1=Mycose | n2=en:abscess fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abscesses are 'cold,' lacking erythema, heat, and swelling
n1=Mycose | n2=en:abscesses are 'cold,' lacking erythema, heat, and swelling | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absence of acetylcholine receptor (achr) autoantibodies
n1=Mycose | n2=en:absence of acetylcholine receptor (achr) autoantibodies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absence of anti-thyroid antibodies
n1=Mycose | n2=en:absence of anti-thyroid antibodies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absence of auto-antibodies to intrinsic factor or parietal cells
n1=Mycose | n2=en:absence of auto-antibodies to intrinsic factor or parietal cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absence of bactericidal oxidative 'respiratory burst' in phagocytes
n1=Mycose | n2=en:absence of bactericidal oxidative 'respiratory burst' in phagocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absence of cd3+ t cells (1 family)
n1=Mycose | n2=en:absence of cd3+ t cells (1 family) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absence of humoral and cellular immune response to foreign antigens
n1=Mycose | n2=en:absence of humoral and cellular immune response to foreign antigens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absence of lymph node germinal center
n1=Mycose | n2=en:absence of lymph node germinal center | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absence of lymph nodes (in 1 patient)
n1=Mycose | n2=en:absence of lymph nodes (in 1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absence of pancreatic autoantibodies
n1=Mycose | n2=en:absence of pancreatic autoantibodies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absence of pus formation at site of infection
n1=Mycose | n2=en:absence of pus formation at site of infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent antibody production
n1=Mycose | n2=en:absent antibody production | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent b lymphocytes in all organs
n1=Mycose | n2=en:absent b lymphocytes in all organs | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent cd8+ t cells
n1=Mycose | n2=en:absent cd8+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent cellular immunity
n1=Mycose | n2=en:absent cellular immunity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent delayed hypersensitivity skin test
n1=Mycose | n2=en:absent delayed hypersensitivity skin test | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent humoral immunity
n1=Mycose | n2=en:absent humoral immunity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent microvilli on the surface of peripheral blood lymphocytes
n1=Mycose | n2=en:absent microvilli on the surface of peripheral blood lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent mitogenic response
n1=Mycose | n2=en:absent mitogenic response | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent mitogenic response to staphylococcus aureus cowan antigen (sac)
n1=Mycose | n2=en:absent mitogenic response to staphylococcus aureus cowan antigen (sac) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent natural killer cell cytotoxicity
n1=Mycose | n2=en:absent natural killer cell cytotoxicity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent or reduced cd3+ cells
n1=Mycose | n2=en:absent or reduced cd3+ cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent or severely reduced numbers of b cells
n1=Mycose | n2=en:absent or severely reduced numbers of b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent or small dysplastic thymus
n1=Mycose | n2=en:absent or small dysplastic thymus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent peripheral blood b cells
n1=Mycose | n2=en:absent peripheral blood b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent peripheral blood t cells
n1=Mycose | n2=en:absent peripheral blood t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent plasma cells in all organs
n1=Mycose | n2=en:absent plasma cells in all organs | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent sialyl-lewis x ligand (slex) expression
n1=Mycose | n2=en:absent sialyl-lewis x ligand (slex) expression | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent specific antibody response
n1=Mycose | n2=en:absent specific antibody response | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent t cells
n1=Mycose | n2=en:absent t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent t lymphocytes
n1=Mycose | n2=en:absent t lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absent thymus
n1=Mycose | n2=en:absent thymus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:absolute lymphocyte count decreased
n1=Mycose | n2=en:absolute lymphocyte count decreased | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:abundant cd4+ t cells
n1=Mycose | n2=en:abundant cd4+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acanthosis nigricans
n1=Mycose | n2=en:acanthosis nigricans | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:accidental injury
n1=Mycose | n2=en:accidental injury | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acetylcholine receptor (achr) autoantibodies are found in a subset of patients
n1=Mycose | n2=en:acetylcholine receptor (achr) autoantibodies are found in a subset of patients | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acne
n1=Mycose | n2=en:acne | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acneform
n1=Mycose | n2=en:acneform | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acneiform dermatitis
n1=Mycose | n2=en:acneiform dermatitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acquired immunodeficiency syndrome
n1=Mycose | n2=en:acquired immunodeficiency syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acral erythema
n1=Mycose | n2=en:acral erythema | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:activated hla dr+ t cells in peripheral blood
n1=Mycose | n2=en:activated hla dr+ t cells in peripheral blood | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:activated mononuclear phagocytes
n1=Mycose | n2=en:activated mononuclear phagocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:activated t-helper cells
n1=Mycose | n2=en:activated t-helper cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:activation of the alternative complement pathway and depletion of complement components
n1=Mycose | n2=en:activation of the alternative complement pathway and depletion of complement components | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:activation of the complement system
n1=Mycose | n2=en:activation of the complement system | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acute bronchitis
n1=Mycose | n2=en:acute bronchitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acute contagious conjunctivitis
n1=Mycose | n2=en:acute contagious conjunctivitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acute infectious disease
n1=Mycose | n2=en:acute infectious disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acute nasopharyngitis
n1=Mycose | n2=en:acute nasopharyngitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acute pulmonary blastomycosis
n1=Mycose | n2=en:acute pulmonary blastomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:acute skin disorder
n1=Mycose | n2=en:acute skin disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:adenoma
n1=Mycose | n2=en:adenoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:adenovirus infection
n1=Mycose | n2=en:adenovirus infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:adverse cutaneous reaction to diagnostic procedure
n1=Mycose | n2=en:adverse cutaneous reaction to diagnostic procedure | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:adverse event associated with death
n1=Mycose | n2=en:adverse event associated with death | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:african histoplasmosis
n1=Mycose | n2=en:african histoplasmosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:agammaglobulinemia
n1=Mycose | n2=en:agammaglobulinemia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:age, sex or race-related dermatoses
n1=Mycose | n2=en:age, sex or race-related dermatoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:allergic reaction
n1=Mycose | n2=en:allergic reaction | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:allergic to dogs
n1=Mycose | n2=en:allergic to dogs | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:allergy to eggs
n1=Mycose | n2=en:allergy to eggs | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:allescheria infections
n1=Mycose | n2=en:allescheria infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:allescheriosis
n1=Mycose | n2=en:allescheriosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:alopecia
n1=Mycose | n2=en:alopecia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:alopecia febrilis
n1=Mycose | n2=en:alopecia febrilis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:alopecia follicularis
n1=Mycose | n2=en:alopecia follicularis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:alopecia localis
n1=Mycose | n2=en:alopecia localis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:alopecia neurotica
n1=Mycose | n2=en:alopecia neurotica | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:alopecia senilis
n1=Mycose | n2=en:alopecia senilis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:alopecia totalis
n1=Mycose | n2=en:alopecia totalis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:alpha/beta, cd4-/cd8- t cells are minimally or not increased
n1=Mycose | n2=en:alpha/beta, cd4-/cd8- t cells are minimally or not increased | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:altered hormone level (nos)
n1=Mycose | n2=en:altered hormone level (nos) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:altered neurotransmitter level (nos)
n1=Mycose | n2=en:altered neurotransmitter level (nos) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:altered t-cell regulation
n1=Mycose | n2=en:altered t-cell regulation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:alternaria infection
n1=Mycose | n2=en:alternaria infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:amyloidosis, primary cutaneous
n1=Mycose | n2=en:amyloidosis, primary cutaneous | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:anal fungal infection
n1=Mycose | n2=en:anal fungal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:anatomic structures
n1=Mycose | n2=en:anatomic structures | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ancillary infectious topics
n1=Mycose | n2=en:ancillary infectious topics | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:androgenetic alopecia
n1=Mycose | n2=en:androgenetic alopecia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:aneurysm, infected
n1=Mycose | n2=en:aneurysm, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:angioedema
n1=Mycose | n2=en:angioedema | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:anhidrosis
n1=Mycose | n2=en:anhidrosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:animal diseases and your health
n1=Mycose | n2=en:animal diseases and your health | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:animal-induced dermatosis
n1=Mycose | n2=en:animal-induced dermatosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:annular erythema
n1=Mycose | n2=en:annular erythema | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:anthrax
n1=Mycose | n2=en:anthrax | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:antibiotic
n1=Mycose | n2=en:antibiotic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:antibiotic resistance
n1=Mycose | n2=en:antibiotic resistance | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:antibody
n1=Mycose | n2=en:antibody | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:antibody-dependent cellular cytotoxicity of nk cells is unaffected
n1=Mycose | n2=en:antibody-dependent cellular cytotoxicity of nk cells is unaffected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:antifungal agent
n1=Mycose | n2=en:antifungal agent | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:antigen
n1=Mycose | n2=en:antigen | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:antigenically defective c8 detected
n1=Mycose | n2=en:antigenically defective c8 detected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:antigens, fungal
n1=Mycose | n2=en:antigens, fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:antinuclear antibody present (in some patients)
n1=Mycose | n2=en:antinuclear antibody present (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:antinuclear antibody present, speckled pattern
n1=Mycose | n2=en:antinuclear antibody present, speckled pattern | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:antinuclear autoantibodies (in some)
n1=Mycose | n2=en:antinuclear autoantibodies (in some) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:aplasia cutis congenita
n1=Mycose | n2=en:aplasia cutis congenita | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:approximately 60% of patients have anti-gad65 antibodies
n1=Mycose | n2=en:approximately 60% of patients have anti-gad65 antibodies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:armed macrophage
n1=Mycose | n2=en:armed macrophage | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arrest of b cell development at very early stage
n1=Mycose | n2=en:arrest of b cell development at very early stage | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arsenical keratosis of the palms and/or soles
n1=Mycose | n2=en:arsenical keratosis of the palms and/or soles | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:artefactual skin disease inflicted by others
n1=Mycose | n2=en:artefactual skin disease inflicted by others | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arteriovenous shunt infection
n1=Mycose | n2=en:arteriovenous shunt infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arthritis
n1=Mycose | n2=en:arthritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arthropathy associated with a mycosis
n1=Mycose | n2=en:arthropathy associated with a mycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arthropathy associated with mycoses, of multiple sites
n1=Mycose | n2=en:arthropathy associated with mycoses, of multiple sites | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arthropathy associated with mycoses, of the ankle and/or foot
n1=Mycose | n2=en:arthropathy associated with mycoses, of the ankle and/or foot | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arthropathy associated with mycoses, of the hand
n1=Mycose | n2=en:arthropathy associated with mycoses, of the hand | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arthropathy associated with mycoses, of the pelvic region and thigh
n1=Mycose | n2=en:arthropathy associated with mycoses, of the pelvic region and thigh | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arthropathy associated with mycoses, of the shoulder region
n1=Mycose | n2=en:arthropathy associated with mycoses, of the shoulder region | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arthropod-borne infectious disease
n1=Mycose | n2=en:arthropod-borne infectious disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arthropod-borne viral fevers and viral haemorrhagic fevers
n1=Mycose | n2=en:arthropod-borne viral fevers and viral haemorrhagic fevers | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:arthropod-borne viral infection
n1=Mycose | n2=en:arthropod-borne viral infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ascariasis
n1=Mycose | n2=en:ascariasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:aspects of mortality statistics
n1=Mycose | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:aspects of radionuclide imaging
n1=Mycose | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:aspergillosis
n1=Mycose | n2=en:aspergillosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:aspergillus infections
n1=Mycose | n2=en:aspergillus infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:aspiration pneumonitis
n1=Mycose | n2=en:aspiration pneumonitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:associated with autoantibodies to gad65 (anti-glutamic acid decarboxylase gad2, 138275) in serum and/or cerebrospinal fluid
n1=Mycose | n2=en:associated with autoantibodies to gad65 (anti-glutamic acid decarboxylase gad2, 138275) in serum and/or cerebrospinal fluid | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:associated with autoimmune disorders (e.g., diabetes mellitus, thyroiditis, pernicious anemia, vitiligo)
n1=Mycose | n2=en:associated with autoimmune disorders (e.g., diabetes mellitus, thyroiditis, pernicious anemia, vitiligo) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:associated with autoimmune disorders (systemic lupus erythematosus 152700 and hashimoto thyroiditis 140300)
n1=Mycose | n2=en:associated with autoimmune disorders (systemic lupus erythematosus 152700 and hashimoto thyroiditis 140300) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:associated with serum autoantibodies to glra1 (glycine receptor alpha-1 subunit 138491, reported in 1 patient)
n1=Mycose | n2=en:associated with serum autoantibodies to glra1 (glycine receptor alpha-1 subunit 138491, reported in 1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:association with autoimmune diseases
n1=Mycose | n2=en:association with autoimmune diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:asthenia
n1=Mycose | n2=en:asthenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:asthma
n1=Mycose | n2=en:asthma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:atopic disorders (eczema, food allergy, asthma)
n1=Mycose | n2=en:atopic disorders (eczema, food allergy, asthma) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:atrophoderma maculatum
n1=Mycose | n2=en:atrophoderma maculatum | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoantibodies (anti-nuclear, anti-dsdna, anti-cardiolipin)
n1=Mycose | n2=en:autoantibodies (anti-nuclear, anti-dsdna, anti-cardiolipin) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoantibodies (in some patients)
n1=Mycose | n2=en:autoantibodies (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoantibodies, transient
n1=Mycose | n2=en:autoantibodies, transient | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoantibody
n1=Mycose | n2=en:autoantibody | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoimmune disease
n1=Mycose | n2=en:autoimmune disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoimmune disease (in some patients)
n1=Mycose | n2=en:autoimmune disease (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoimmune disease resembling systemic lupus erythematosis (sle, 152700) (in about 26%)
n1=Mycose | n2=en:autoimmune disease resembling systemic lupus erythematosis (sle, 152700) (in about 26%) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoimmune disorders (i.e., itp, juvenile rheumatoid arthritis (jra), hypothyroidism, crohn disease)
n1=Mycose | n2=en:autoimmune disorders (i.e., itp, juvenile rheumatoid arthritis (jra), hypothyroidism, crohn disease) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoimmune disorders (in some patients)
n1=Mycose | n2=en:autoimmune disorders (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoimmune features (in some patients)
n1=Mycose | n2=en:autoimmune features (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoimmune neutropenia (less common)
n1=Mycose | n2=en:autoimmune neutropenia (less common) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoimmune skin disease
n1=Mycose | n2=en:autoimmune skin disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoimmunity to pancreatic beta cells (rare)
n1=Mycose | n2=en:autoimmunity to pancreatic beta cells (rare) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoinflammation, systemic
n1=Mycose | n2=en:autoinflammation, systemic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:autoinflammatory disorders
n1=Mycose | n2=en:autoinflammatory disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:b and t cell defects (reported in 2 sibs)
n1=Mycose | n2=en:b and t cell defects (reported in 2 sibs) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:b cells lack surface cd19 and cd81 expression
n1=Mycose | n2=en:b cells lack surface cd19 and cd81 expression | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:b cells lack surface cd19 expression
n1=Mycose | n2=en:b cells lack surface cd19 expression | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:b cells lack surface cd20 expression
n1=Mycose | n2=en:b cells lack surface cd20 expression | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:b-cell lymphocytosis
n1=Mycose | n2=en:b-cell lymphocytosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:b-cell lymphopenia
n1=Mycose | n2=en:b-cell lymphopenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bacteremia
n1=Mycose | n2=en:bacteremia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bacterial and viral infectious agents (b95-b97)
n1=Mycose | n2=en:bacterial and viral infectious agents (b95-b97) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bacterial conjunctivitis
n1=Mycose | n2=en:bacterial conjunctivitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bacterial infection
n1=Mycose | n2=en:bacterial infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bacterial infections
n1=Mycose | n2=en:bacterial infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bacterial infections and mycoses
n1=Mycose | n2=en:bacterial infections and mycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bacterial resistance
n1=Mycose | n2=en:bacterial resistance | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bacterial, viral and other infectious agents
n1=Mycose | n2=en:bacterial, viral and other infectious agents | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:balanitis
n1=Mycose | n2=en:balanitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:behcet syndrome
n1=Mycose | n2=en:behcet syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:benign non-infected urachal cyst
n1=Mycose | n2=en:benign non-infected urachal cyst | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:benign primary hypergammaglobulinemic purpura
n1=Mycose | n2=en:benign primary hypergammaglobulinemic purpura | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone
n1=Mycose | n2=en:betamethasone | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.00025 mg/mg topical gel
n1=Mycose | n2=en:betamethasone 0.00025 mg/mg topical gel | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.0005 mg/mg augmented topical gel
n1=Mycose | n2=en:betamethasone 0.0005 mg/mg augmented topical gel | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.0005 mg/mg augmented topical ointment
n1=Mycose | n2=en:betamethasone 0.0005 mg/mg augmented topical ointment | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.0005 mg/mg topical ointment
n1=Mycose | n2=en:betamethasone 0.0005 mg/mg topical ointment | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.025% cream
n1=Mycose | n2=en:betamethasone 0.025% cream | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.025% ointment
n1=Mycose | n2=en:betamethasone 0.025% ointment | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.1 mg/ml topical cream
n1=Mycose | n2=en:betamethasone 0.1 mg/ml topical cream | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.1% lotion
n1=Mycose | n2=en:betamethasone 0.1% lotion | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.1% ointment
n1=Mycose | n2=en:betamethasone 0.1% ointment | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.25 mg/ml topical lotion
n1=Mycose | n2=en:betamethasone 0.25 mg/ml topical lotion | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.5 mg/ml augmented topical cream
n1=Mycose | n2=en:betamethasone 0.5 mg/ml augmented topical cream | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.5 mg/ml augmented topical lotion
n1=Mycose | n2=en:betamethasone 0.5 mg/ml augmented topical lotion | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.5 mg/ml topical cream
n1=Mycose | n2=en:betamethasone 0.5 mg/ml topical cream | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.5 mg/ml topical lotion
n1=Mycose | n2=en:betamethasone 0.5 mg/ml topical lotion | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 0.6mg/5ml syrup
n1=Mycose | n2=en:betamethasone 0.6mg/5ml syrup | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 1 mg/ml topical cream
n1=Mycose | n2=en:betamethasone 1 mg/ml topical cream | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 1 mg/ml topical spray
n1=Mycose | n2=en:betamethasone 1 mg/ml topical spray | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 3 mg/ml / betamethasone acetate 3 mg/ml injectable suspension
n1=Mycose | n2=en:betamethasone 3 mg/ml / betamethasone acetate 3 mg/ml injectable suspension | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 3 mg/ml injectable solution
n1=Mycose | n2=en:betamethasone 3 mg/ml injectable solution | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 4 mg/ml injectable solution
n1=Mycose | n2=en:betamethasone 4 mg/ml injectable solution | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone 600micrograms tablet
n1=Mycose | n2=en:betamethasone 600micrograms tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone acetate
n1=Mycose | n2=en:betamethasone acetate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone benzoate
n1=Mycose | n2=en:betamethasone benzoate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone dipropionate
n1=Mycose | n2=en:betamethasone dipropionate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone sodium phosphate
n1=Mycose | n2=en:betamethasone sodium phosphate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone valerate
n1=Mycose | n2=en:betamethasone valerate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone valerate 0.12% aerosol
n1=Mycose | n2=en:betamethasone valerate 0.12% aerosol | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:betamethasone valerate pwdr
n1=Mycose | n2=en:betamethasone valerate pwdr | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bilateral suppurative otitis media
n1=Mycose | n2=en:bilateral suppurative otitis media | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:biliary tract infection fungal
n1=Mycose | n2=en:biliary tract infection fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:biopsy shows lipid-laden macrophages
n1=Mycose | n2=en:biopsy shows lipid-laden macrophages | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:birthmark
n1=Mycose | n2=en:birthmark | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:black piedra
n1=Mycose | n2=en:black piedra | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:blastomycosis
n1=Mycose | n2=en:blastomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:block at the pro-b to pre-b stage of differentiation
n1=Mycose | n2=en:block at the pro-b to pre-b stage of differentiation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:block of b-cell differentiation
n1=Mycose | n2=en:block of b-cell differentiation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:body odor
n1=Mycose | n2=en:body odor | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bone diseases, infectious
n1=Mycose | n2=en:bone diseases, infectious | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bone infection
n1=Mycose | n2=en:bone infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bone marrow shows lymphoid hyperplasia
n1=Mycose | n2=en:bone marrow shows lymphoid hyperplasia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:borrelia burgdorferi infection
n1=Mycose | n2=en:borrelia burgdorferi infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:botulinum toxin type a
n1=Mycose | n2=en:botulinum toxin type a | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:botulism
n1=Mycose | n2=en:botulism | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:breakthrough infection
n1=Mycose | n2=en:breakthrough infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:breast disorder
n1=Mycose | n2=en:breast disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:breast symptom of change in nipple
n1=Mycose | n2=en:breast symptom of change in nipple | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bromhidrosis
n1=Mycose | n2=en:bromhidrosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bronchiectasis
n1=Mycose | n2=en:bronchiectasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bronchiolitis
n1=Mycose | n2=en:bronchiolitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bronchitis
n1=Mycose | n2=en:bronchitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bronchitis fungal
n1=Mycose | n2=en:bronchitis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:bruise
n1=Mycose | n2=en:bruise | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:burkholderia cepacia infection
n1=Mycose | n2=en:burkholderia cepacia infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:burn
n1=Mycose | n2=en:burn | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:c1q deficiency
n1=Mycose | n2=en:c1q deficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:c1q molecule present, but dysfunctional
n1=Mycose | n2=en:c1q molecule present, but dysfunctional | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:c2 deficiency
n1=Mycose | n2=en:c2 deficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:c8 deficiency
n1=Mycose | n2=en:c8 deficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cachectic alopecia
n1=Mycose | n2=en:cachectic alopecia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cachexia
n1=Mycose | n2=en:cachexia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:campylobacter infection
n1=Mycose | n2=en:campylobacter infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cancer immunology
n1=Mycose | n2=en:cancer immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:candida enteritis
n1=Mycose | n2=en:candida enteritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:candida esophagitis
n1=Mycose | n2=en:candida esophagitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:candidal balanitis
n1=Mycose | n2=en:candidal balanitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:candidal cheilitis
n1=Mycose | n2=en:candidal cheilitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:candidal cystitis and urethritis
n1=Mycose | n2=en:candidal cystitis and urethritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:candidal otitis externa
n1=Mycose | n2=en:candidal otitis externa | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:candidiasis
n1=Mycose | n2=en:candidiasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:candidiasis of lung
n1=Mycose | n2=en:candidiasis of lung | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:candidiasis of other sites
n1=Mycose | n2=en:candidiasis of other sites | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:candidiasis of skin and nails
n1=Mycose | n2=en:candidiasis of skin and nails | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:candidiasis, vulvovaginal
n1=Mycose | n2=en:candidiasis, vulvovaginal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:carcinoma
n1=Mycose | n2=en:carcinoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:carcinosarcoma of skin
n1=Mycose | n2=en:carcinosarcoma of skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cardiovascular infections
n1=Mycose | n2=en:cardiovascular infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cat-scratch disease
n1=Mycose | n2=en:cat-scratch disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:catheter-related infection
n1=Mycose | n2=en:catheter-related infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cd4/cd8 ratio decreased
n1=Mycose | n2=en:cd4/cd8 ratio decreased | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cd4+ t-cell lymphopenia
n1=Mycose | n2=en:cd4+ t-cell lymphopenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cells show impaired immunologic responses to immune stimulation
n1=Mycose | n2=en:cells show impaired immunologic responses to immune stimulation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cellular immunodeficiency
n1=Mycose | n2=en:cellular immunodeficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cellular immunology
n1=Mycose | n2=en:cellular immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cellulitis
n1=Mycose | n2=en:cellulitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:central nervous system fungal infections
n1=Mycose | n2=en:central nervous system fungal infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:central nervous system infectious disorder
n1=Mycose | n2=en:central nervous system infectious disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:central nervous system viral diseases
n1=Mycose | n2=en:central nervous system viral diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cerebral sporotrichosis
n1=Mycose | n2=en:cerebral sporotrichosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:certain infectious and parasitic diseases
n1=Mycose | n2=en:certain infectious and parasitic diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:certain zoonotic bacterial diseases
n1=Mycose | n2=en:certain zoonotic bacterial diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chagas disease
n1=Mycose | n2=en:chagas disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chancriform syndrome
n1=Mycose | n2=en:chancriform syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chemically induced
n1=Mycose | n2=en:chemically induced | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chicken pox
n1=Mycose | n2=en:chicken pox | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:childhood immunization
n1=Mycose | n2=en:childhood immunization | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:childhood-onset systemic lupus erythematosus
n1=Mycose | n2=en:childhood-onset systemic lupus erythematosus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chills
n1=Mycose | n2=en:chills | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chlamydia infection
n1=Mycose | n2=en:chlamydia infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chlamydial infection
n1=Mycose | n2=en:chlamydial infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cholera
n1=Mycose | n2=en:cholera | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chromhidrosis
n1=Mycose | n2=en:chromhidrosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chromoblastomycosis
n1=Mycose | n2=en:chromoblastomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chromomycosis and phaeomycotic abscess
n1=Mycose | n2=en:chromomycosis and phaeomycotic abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chromomycosis and pheomycotic abscess
n1=Mycose | n2=en:chromomycosis and pheomycotic abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chromosome disorder
n1=Mycose | n2=en:chromosome disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chronic bronchitis
n1=Mycose | n2=en:chronic bronchitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chronic disease of skin
n1=Mycose | n2=en:chronic disease of skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chronic fatigue syndrome
n1=Mycose | n2=en:chronic fatigue syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chronic human papillomavirus (hpv) infection
n1=Mycose | n2=en:chronic human papillomavirus (hpv) infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chronic infection
n1=Mycose | n2=en:chronic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chronic infectious disease
n1=Mycose | n2=en:chronic infectious disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chronic mucocutaneous candidiasis
n1=Mycose | n2=en:chronic mucocutaneous candidiasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chronic noninfectious lymphadenopathy
n1=Mycose | n2=en:chronic noninfectious lymphadenopathy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chronic pulmonary blastomycosis
n1=Mycose | n2=en:chronic pulmonary blastomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:chronic viral infections (1 patient)
n1=Mycose | n2=en:chronic viral infections (1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:circulating immune complexes
n1=Mycose | n2=en:circulating immune complexes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:circulating t and b cells are naive
n1=Mycose | n2=en:circulating t and b cells are naive | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cladosporidia infections
n1=Mycose | n2=en:cladosporidia infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:clinical immunology
n1=Mycose | n2=en:clinical immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:clinical infection
n1=Mycose | n2=en:clinical infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:clostridium difficile colitis
n1=Mycose | n2=en:clostridium difficile colitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:coccidioides infections
n1=Mycose | n2=en:coccidioides infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:coccidioidomycosis
n1=Mycose | n2=en:coccidioidomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:coinfection
n1=Mycose | n2=en:coinfection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cold sore
n1=Mycose | n2=en:cold sore | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:collagen and elastic tissue disorders affecting skin
n1=Mycose | n2=en:collagen and elastic tissue disorders affecting skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:combined humoral and cellular immunodeficiency
n1=Mycose | n2=en:combined humoral and cellular immunodeficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:combined immunodeficiency (reported in 1 patient)
n1=Mycose | n2=en:combined immunodeficiency (reported in 1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:combined variable immunodeficiency involving b and t cells
n1=Mycose | n2=en:combined variable immunodeficiency involving b and t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:communicable disease by infectious agent
n1=Mycose | n2=en:communicable disease by infectious agent | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:communicable disease by vector
n1=Mycose | n2=en:communicable disease by vector | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:communicable diseases, emerging
n1=Mycose | n2=en:communicable diseases, emerging | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:community-acquired infections
n1=Mycose | n2=en:community-acquired infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:complement component consumption
n1=Mycose | n2=en:complement component consumption | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:complete inevitable miscarriage complicated by genital tract and pelvic infection
n1=Mycose | n2=en:complete inevitable miscarriage complicated by genital tract and pelvic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:complete legal termination of pregnancy with genital tract or pelvic infection
n1=Mycose | n2=en:complete legal termination of pregnancy with genital tract or pelvic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:complicated infection
n1=Mycose | n2=en:complicated infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:complication aspects
n1=Mycose | n2=en:complication aspects | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:condyloma acuminatum
n1=Mycose | n2=en:condyloma acuminatum | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:confluent bruising
n1=Mycose | n2=en:confluent bruising | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:congenital abnormality
n1=Mycose | n2=en:congenital abnormality | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:congenital generalized alopecia
n1=Mycose | n2=en:congenital generalized alopecia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:congenital hypoplasia of thymus
n1=Mycose | n2=en:congenital hypoplasia of thymus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:congenital infectious disease
n1=Mycose | n2=en:congenital infectious disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:congenital mesh qualifier
n1=Mycose | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:congenital skin disorder
n1=Mycose | n2=en:congenital skin disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:congenital/hereditary hypermelanotic disorder
n1=Mycose | n2=en:congenital/hereditary hypermelanotic disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:continuous activation of the alternative complement pathway
n1=Mycose | n2=en:continuous activation of the alternative complement pathway | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:corns and callus
n1=Mycose | n2=en:corns and callus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cosmetic
n1=Mycose | n2=en:cosmetic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cow's milk protein sensitivity
n1=Mycose | n2=en:cow's milk protein sensitivity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cross infection
n1=Mycose | n2=en:cross infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cryoglobulinemic purpura
n1=Mycose | n2=en:cryoglobulinemic purpura | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cryptococcal infections
n1=Mycose | n2=en:cryptococcal infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cryptococcal pneumonia
n1=Mycose | n2=en:cryptococcal pneumonia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cryptococcosis
n1=Mycose | n2=en:cryptococcosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cryptosporidiosis
n1=Mycose | n2=en:cryptosporidiosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ctrp terminology
n1=Mycose | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous anergy
n1=Mycose | n2=en:cutaneous anergy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous blastomycosis
n1=Mycose | n2=en:cutaneous blastomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous candidiasis
n1=Mycose | n2=en:cutaneous candidiasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous cd30+ lymphoproliferative disorder
n1=Mycose | n2=en:cutaneous cd30+ lymphoproliferative disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous chromomycosis
n1=Mycose | n2=en:cutaneous chromomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous coccidioidomycosis
n1=Mycose | n2=en:cutaneous coccidioidomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous cryptococcosis
n1=Mycose | n2=en:cutaneous cryptococcosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous endometriosis
n1=Mycose | n2=en:cutaneous endometriosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous fibrohistiocytic neoplasm
n1=Mycose | n2=en:cutaneous fibrohistiocytic neoplasm | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous fistula
n1=Mycose | n2=en:cutaneous fistula | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous hypersensitivity
n1=Mycose | n2=en:cutaneous hypersensitivity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous leishmaniasis
n1=Mycose | n2=en:cutaneous leishmaniasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous lupus erythematosus
n1=Mycose | n2=en:cutaneous lupus erythematosus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous lymphoproliferative disorder
n1=Mycose | n2=en:cutaneous lymphoproliferative disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous mucormycosis
n1=Mycose | n2=en:cutaneous mucormycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous precancerous condition
n1=Mycose | n2=en:cutaneous precancerous condition | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous pseudolymphoma
n1=Mycose | n2=en:cutaneous pseudolymphoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous reaction to injected foreign material
n1=Mycose | n2=en:cutaneous reaction to injected foreign material | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous rhinosporidiosis
n1=Mycose | n2=en:cutaneous rhinosporidiosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous sporotrichosis
n1=Mycose | n2=en:cutaneous sporotrichosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous synovial metaplasia
n1=Mycose | n2=en:cutaneous synovial metaplasia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous toxoplasmosis
n1=Mycose | n2=en:cutaneous toxoplasmosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutaneous tuberculous gumma
n1=Mycose | n2=en:cutaneous tuberculous gumma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cutis laxa
n1=Mycose | n2=en:cutis laxa | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cyst
n1=Mycose | n2=en:cyst | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cysticercosis
n1=Mycose | n2=en:cysticercosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cytokine defects
n1=Mycose | n2=en:cytokine defects | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cytomegaloviral infection
n1=Mycose | n2=en:cytomegaloviral infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:cytomegalovirus infection of skin
n1=Mycose | n2=en:cytomegalovirus infection of skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:de barsy syndrome
n1=Mycose | n2=en:de barsy syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased b cell survival and tolerance
n1=Mycose | n2=en:decreased b cell survival and tolerance | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased b cells
n1=Mycose | n2=en:decreased b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd19+ b cells
n1=Mycose | n2=en:decreased cd19+ b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd27+ b cells
n1=Mycose | n2=en:decreased cd27+ b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd3 complex
n1=Mycose | n2=en:decreased cd3 complex | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd3 expression on t cells
n1=Mycose | n2=en:decreased cd3 expression on t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd3(-)cd16/15(+) natural killer cells
n1=Mycose | n2=en:decreased cd3(-)cd16/15(+) natural killer cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd3+ cells subset
n1=Mycose | n2=en:decreased cd3+ cells subset | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd4+ and cd3+/cd4+ lymphocytes
n1=Mycose | n2=en:decreased cd4+ and cd3+/cd4+ lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd4+ cells subset
n1=Mycose | n2=en:decreased cd4+ cells subset | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd4+ t cells
n1=Mycose | n2=en:decreased cd4+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd4+cd45ra+ t cells
n1=Mycose | n2=en:decreased cd4+cd45ra+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd8+ cells subset
n1=Mycose | n2=en:decreased cd8+ cells subset | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cd8+ t cells
n1=Mycose | n2=en:decreased cd8+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cellular caspase-8 levels
n1=Mycose | n2=en:decreased cellular caspase-8 levels | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased circulating b cells
n1=Mycose | n2=en:decreased circulating b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased circulating b cells (total cd19+)
n1=Mycose | n2=en:decreased circulating b cells (total cd19+) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased circulating cd4+ t cells
n1=Mycose | n2=en:decreased circulating cd4+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased circulating class-switched memory b cells (cd19+cd27+igd-)
n1=Mycose | n2=en:decreased circulating class-switched memory b cells (cd19+cd27+igd-) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased circulating naive t cells (1 family)
n1=Mycose | n2=en:decreased circulating naive t cells (1 family) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased circulating nk cells
n1=Mycose | n2=en:decreased circulating nk cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased circulation t cells
n1=Mycose | n2=en:decreased circulation t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cytotoxic activity of cd8+ t cells
n1=Mycose | n2=en:decreased cytotoxic activity of cd8+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased cytotoxic t cell activity
n1=Mycose | n2=en:decreased cytotoxic t cell activity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased differentiated b cells
n1=Mycose | n2=en:decreased differentiated b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased drug level
n1=Mycose | n2=en:decreased drug level | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased effector t cells
n1=Mycose | n2=en:decreased effector t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased iga, plasma and secretory
n1=Mycose | n2=en:decreased iga, plasma and secretory | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased igm and igg2
n1=Mycose | n2=en:decreased igm and igg2 | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased immunoglobulin
n1=Mycose | n2=en:decreased immunoglobulin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased immunoglobulin g (igg)
n1=Mycose | n2=en:decreased immunoglobulin g (igg) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased immunoglobulins, progressive
n1=Mycose | n2=en:decreased immunoglobulins, progressive | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased invariant nk t cells
n1=Mycose | n2=en:decreased invariant nk t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased itk protein in lymphoid tissue
n1=Mycose | n2=en:decreased itk protein in lymphoid tissue | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased levels of naive t cells
n1=Mycose | n2=en:decreased levels of naive t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased lymphatic tissue (tonsil, thymus, mesenteric nodes, peyer patches)
n1=Mycose | n2=en:decreased lymphatic tissue (tonsil, thymus, mesenteric nodes, peyer patches) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased memory b cells
n1=Mycose | n2=en:decreased memory b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased memory b cells (in some patients)
n1=Mycose | n2=en:decreased memory b cells (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased memory b cells, progressive
n1=Mycose | n2=en:decreased memory b cells, progressive | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased memory t cells
n1=Mycose | n2=en:decreased memory t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased naive cd4+ and cd8+ t cells
n1=Mycose | n2=en:decreased naive cd4+ and cd8+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased natural killer cells
n1=Mycose | n2=en:decreased natural killer cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased natural killer t cells
n1=Mycose | n2=en:decreased natural killer t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased neutrophil and monocyte migration and chemotaxis
n1=Mycose | n2=en:decreased neutrophil and monocyte migration and chemotaxis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased nk cells, particularly nk cell precursors
n1=Mycose | n2=en:decreased nk cells, particularly nk cell precursors | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased nk levels (in some patients)
n1=Mycose | n2=en:decreased nk levels (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased number of cd4+ t cells
n1=Mycose | n2=en:decreased number of cd4+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased number of cd8+ t cells
n1=Mycose | n2=en:decreased number of cd8+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased number of tcr alpha/beta+ t cells
n1=Mycose | n2=en:decreased number of tcr alpha/beta+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased numbers of b cells
n1=Mycose | n2=en:decreased numbers of b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased numbers of circulating nk cells (less than 5%)
n1=Mycose | n2=en:decreased numbers of circulating nk cells (less than 5%) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased numbers of long-term memory cd8+ t cells
n1=Mycose | n2=en:decreased numbers of long-term memory cd8+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased numbers of mature b cells
n1=Mycose | n2=en:decreased numbers of mature b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased numbers of naive cd4+ and cd8+ t cells
n1=Mycose | n2=en:decreased numbers of naive cd4+ and cd8+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased numbers of natural killer cells (nk)
n1=Mycose | n2=en:decreased numbers of natural killer cells (nk) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased numbers of nk cells
n1=Mycose | n2=en:decreased numbers of nk cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased numbers of t cells
n1=Mycose | n2=en:decreased numbers of t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased numbers of thymus emigrant cells
n1=Mycose | n2=en:decreased numbers of thymus emigrant cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased or absent pre-b cells
n1=Mycose | n2=en:decreased or absent pre-b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased or normal numbers of nk cells
n1=Mycose | n2=en:decreased or normal numbers of nk cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased percentage of igd- igm- cd27+ class-switched memory b cells
n1=Mycose | n2=en:decreased percentage of igd- igm- cd27+ class-switched memory b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased percentage of igd+ igm+ cd27+ memory b cells
n1=Mycose | n2=en:decreased percentage of igd+ igm+ cd27+ memory b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased regulatory t cells
n1=Mycose | n2=en:decreased regulatory t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased serum complement c3
n1=Mycose | n2=en:decreased serum complement c3 | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased serum complement c3 (120700)
n1=Mycose | n2=en:decreased serum complement c3 (120700) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased serum complement factor b (cfb, 138470)
n1=Mycose | n2=en:decreased serum complement factor b (cfb, 138470) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased serum complement factor h (cfh, 134370)
n1=Mycose | n2=en:decreased serum complement factor h (cfh, 134370) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased serum complement factor i
n1=Mycose | n2=en:decreased serum complement factor i | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased serum iga
n1=Mycose | n2=en:decreased serum iga | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased serum igg and igm
n1=Mycose | n2=en:decreased serum igg and igm | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased serum igm
n1=Mycose | n2=en:decreased serum igm | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased specific antibodies
n1=Mycose | n2=en:decreased specific antibodies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased t cell activation
n1=Mycose | n2=en:decreased t cell activation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased t cell production of cytokines
n1=Mycose | n2=en:decreased t cell production of cytokines | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased t cell proliferation
n1=Mycose | n2=en:decreased t cell proliferation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased t cell response to mitogens
n1=Mycose | n2=en:decreased t cell response to mitogens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased t cell-dependent antibody production
n1=Mycose | n2=en:decreased t cell-dependent antibody production | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased t cells
n1=Mycose | n2=en:decreased t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased t-cell proliferative response to mitogens
n1=Mycose | n2=en:decreased t-cell proliferative response to mitogens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased t-cell proliferative responses in vitro
n1=Mycose | n2=en:decreased t-cell proliferative responses in vitro | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:decreased tolerance
n1=Mycose | n2=en:decreased tolerance | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:deep seated dermatophytosis
n1=Mycose | n2=en:deep seated dermatophytosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defect in b-cell differentiation
n1=Mycose | n2=en:defect in b-cell differentiation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defect in v(d)j recombination process
n1=Mycose | n2=en:defect in v(d)j recombination process | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective antibody production
n1=Mycose | n2=en:defective antibody production | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective antibody production against polysaccharide-based vaccines
n1=Mycose | n2=en:defective antibody production against polysaccharide-based vaccines | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective antibody production, particularly t-cell-independent
n1=Mycose | n2=en:defective antibody production, particularly t-cell-independent | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective antibody response
n1=Mycose | n2=en:defective antibody response | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective antigen-specific skin response
n1=Mycose | n2=en:defective antigen-specific skin response | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective b cell activation
n1=Mycose | n2=en:defective b cell activation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective b cell class-switching
n1=Mycose | n2=en:defective b cell class-switching | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective b cell differentiation
n1=Mycose | n2=en:defective b cell differentiation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective cd8+ t cell function
n1=Mycose | n2=en:defective cd8+ t cell function | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective cd95-induced apoptosis of peripheral blood lymphocytes
n1=Mycose | n2=en:defective cd95-induced apoptosis of peripheral blood lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective complement regulation
n1=Mycose | n2=en:defective complement regulation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective generation of somatic hypermutations (shm)
n1=Mycose | n2=en:defective generation of somatic hypermutations (shm) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective humoral response
n1=Mycose | n2=en:defective humoral response | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective il21r-related signaling
n1=Mycose | n2=en:defective il21r-related signaling | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective intracellular signaling in lymphocytes
n1=Mycose | n2=en:defective intracellular signaling in lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective lymphocyte apoptosis
n1=Mycose | n2=en:defective lymphocyte apoptosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective macrophage function
n1=Mycose | n2=en:defective macrophage function | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective natural killer cell (nk) activation
n1=Mycose | n2=en:defective natural killer cell (nk) activation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective neutrophil adhesion to endothelial cells
n1=Mycose | n2=en:defective neutrophil adhesion to endothelial cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective neutrophil function
n1=Mycose | n2=en:defective neutrophil function | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective nk function in spontaneous cellular cytotoxicity
n1=Mycose | n2=en:defective nk function in spontaneous cellular cytotoxicity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective production of nfkb1-dependent cytokines by white blood cells
n1=Mycose | n2=en:defective production of nfkb1-dependent cytokines by white blood cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective response of b and t cells to activation
n1=Mycose | n2=en:defective response of b and t cells to activation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:defective t cell function
n1=Mycose | n2=en:defective t cell function | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:deficient nk-cell mediated spontaneous and antibody-mediated cytotoxicity
n1=Mycose | n2=en:deficient nk-cell mediated spontaneous and antibody-mediated cytotoxicity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:degenerative skin disorder
n1=Mycose | n2=en:degenerative skin disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:delayed wound healing with normal immune system
n1=Mycose | n2=en:delayed wound healing with normal immune system | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dendritic cell cytopenia
n1=Mycose | n2=en:dendritic cell cytopenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dengue fever
n1=Mycose | n2=en:dengue fever | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:denuded skin
n1=Mycose | n2=en:denuded skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:depleted cd4+ t cells
n1=Mycose | n2=en:depleted cd4+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:depletion of components of the alternative complement pathway
n1=Mycose | n2=en:depletion of components of the alternative complement pathway | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermal sinus
n1=Mycose | n2=en:dermal sinus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatitis
n1=Mycose | n2=en:dermatitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatomycoses
n1=Mycose | n2=en:dermatomycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatomyositis
n1=Mycose | n2=en:dermatomyositis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatomyositis (in 1 patient)
n1=Mycose | n2=en:dermatomyositis (in 1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatophytic lymphadenitis (in some patients)
n1=Mycose | n2=en:dermatophytic lymphadenitis (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatophytosis
n1=Mycose | n2=en:dermatophytosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatoses, general and nec
n1=Mycose | n2=en:dermatoses, general and nec | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatosis due to algae
n1=Mycose | n2=en:dermatosis due to algae | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatosis of infancy
n1=Mycose | n2=en:dermatosis of infancy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatosis of suspected viral etiology
n1=Mycose | n2=en:dermatosis of suspected viral etiology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatosis resulting from intravascular thrombosis
n1=Mycose | n2=en:dermatosis resulting from intravascular thrombosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatosis resulting from vascular insufficiency
n1=Mycose | n2=en:dermatosis resulting from vascular insufficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatosis secondary to peripheral nerve disorder
n1=Mycose | n2=en:dermatosis secondary to peripheral nerve disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dermatosis steroid-induced
n1=Mycose | n2=en:dermatosis steroid-induced | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:developmental arrest of b cells at the pre-b to pro-b cell transition stage
n1=Mycose | n2=en:developmental arrest of b cells at the pre-b to pro-b cell transition stage | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:developmental immunology
n1=Mycose | n2=en:developmental immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:device-related infection
n1=Mycose | n2=en:device-related infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:diabetic dermopathy
n1=Mycose | n2=en:diabetic dermopathy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:diagnosis aspect
n1=Mycose | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:diffuse alopecia
n1=Mycose | n2=en:diffuse alopecia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:diffuse fetal skin edema
n1=Mycose | n2=en:diffuse fetal skin edema | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:diffuse inflammatory erythema
n1=Mycose | n2=en:diffuse inflammatory erythema | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:digestive system infection
n1=Mycose | n2=en:digestive system infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:diminished proliferative response of t cells to allogenic cells, mitogens, and antigens
n1=Mycose | n2=en:diminished proliferative response of t cells to allogenic cells, mitogens, and antigens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:diphtheria
n1=Mycose | n2=en:diphtheria | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:direct contact transmission infection
n1=Mycose | n2=en:direct contact transmission infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:discoid lupus erythematosus
n1=Mycose | n2=en:discoid lupus erythematosus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disease of mucous membrane
n1=Mycose | n2=en:disease of mucous membrane | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disease of possible viral origin
n1=Mycose | n2=en:disease of possible viral origin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disease of skin and appendages
n1=Mycose | n2=en:disease of skin and appendages | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disease transmission qualifier
n1=Mycose | n2=en:disease transmission qualifier | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder due to abnormality of dermal elastin
n1=Mycose | n2=en:disorder due to abnormality of dermal elastin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder of keratinization
n1=Mycose | n2=en:disorder of keratinization | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder of lymphatics affecting the skin
n1=Mycose | n2=en:disorder of lymphatics affecting the skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder of scalp
n1=Mycose | n2=en:disorder of scalp | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder of skin co-occurrent with human immunodeficiency virus infection
n1=Mycose | n2=en:disorder of skin co-occurrent with human immunodeficiency virus infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder of skin color
n1=Mycose | n2=en:disorder of skin color | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder of skin due to tattoo ink
n1=Mycose | n2=en:disorder of skin due to tattoo ink | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder of skin of head
n1=Mycose | n2=en:disorder of skin of head | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder of skin of lower limb
n1=Mycose | n2=en:disorder of skin of lower limb | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder of skin of neck
n1=Mycose | n2=en:disorder of skin of neck | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder of skin of trunk
n1=Mycose | n2=en:disorder of skin of trunk | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorder of skin of upper limb
n1=Mycose | n2=en:disorder of skin of upper limb | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorders of skin induced by physical agents
n1=Mycose | n2=en:disorders of skin induced by physical agents | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disorders, general, functional and nec
n1=Mycose | n2=en:disorders, general, functional and nec | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disseminated aspergillosis
n1=Mycose | n2=en:disseminated aspergillosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disseminated blastomycosis
n1=Mycose | n2=en:disseminated blastomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disseminated candidiasis
n1=Mycose | n2=en:disseminated candidiasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disseminated coccidioidomycosis
n1=Mycose | n2=en:disseminated coccidioidomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disseminated cryptococcosis
n1=Mycose | n2=en:disseminated cryptococcosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disseminated infection with dimorphic fungi (coccidioides and histoplasma)
n1=Mycose | n2=en:disseminated infection with dimorphic fungi (coccidioides and histoplasma) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disseminated mucormycosis
n1=Mycose | n2=en:disseminated mucormycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disseminated paracoccidioidomycosis
n1=Mycose | n2=en:disseminated paracoccidioidomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disseminated sporotrichosis
n1=Mycose | n2=en:disseminated sporotrichosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:disturbance of hair cycle
n1=Mycose | n2=en:disturbance of hair cycle | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:drug action increased
n1=Mycose | n2=en:drug action increased | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:drug interaction
n1=Mycose | n2=en:drug interaction | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:drug skin rash
n1=Mycose | n2=en:drug skin rash | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dust-borne infectious disease
n1=Mycose | n2=en:dust-borne infectious disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dysfunction - skin disorders
n1=Mycose | n2=en:dysfunction - skin disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dysfunctional alternative complement pathway
n1=Mycose | n2=en:dysfunctional alternative complement pathway | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dysfunctional nk cells
n1=Mycose | n2=en:dysfunctional nk cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:dysgammaglobulinemia
n1=Mycose | n2=en:dysgammaglobulinemia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ear infection
n1=Mycose | n2=en:ear infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ebola hemorrhagic fever
n1=Mycose | n2=en:ebola hemorrhagic fever | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ectopic thymus
n1=Mycose | n2=en:ectopic thymus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ectromelia
n1=Mycose | n2=en:ectromelia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:eczema
n1=Mycose | n2=en:eczema | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:eczemetous abnormalities
n1=Mycose | n2=en:eczemetous abnormalities | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:edema, generalized
n1=Mycose | n2=en:edema, generalized | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:elastoidosis, nodular
n1=Mycose | n2=en:elastoidosis, nodular | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:electron microscopy: skin
n1=Mycose | n2=en:electron microscopy: skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:elevated iga (equal to or greater than 2.6g/l)
n1=Mycose | n2=en:elevated iga (equal to or greater than 2.6g/l) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:elevated igd
n1=Mycose | n2=en:elevated igd | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:elevated immunoglobulins, particularly ige
n1=Mycose | n2=en:elevated immunoglobulins, particularly ige | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:elevated levels of serum ige
n1=Mycose | n2=en:elevated levels of serum ige | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:elevated polyclonal igd (equal to or greater than 100 iu/ml)
n1=Mycose | n2=en:elevated polyclonal igd (equal to or greater than 100 iu/ml) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:embryologic
n1=Mycose | n2=en:embryologic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:emphysematous cholecystitis
n1=Mycose | n2=en:emphysematous cholecystitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:encephalitis
n1=Mycose | n2=en:encephalitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:endogenous infection
n1=Mycose | n2=en:endogenous infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:endophthalmitides, infectious
n1=Mycose | n2=en:endophthalmitides, infectious | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:enterobiasis
n1=Mycose | n2=en:enterobiasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:enterocolitis fungal
n1=Mycose | n2=en:enterocolitis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:enteroviral encephalomyelitis
n1=Mycose | n2=en:enteroviral encephalomyelitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:enterovirus infections
n1=Mycose | n2=en:enterovirus infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:environmental illness
n1=Mycose | n2=en:environmental illness | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:enzymology
n1=Mycose | n2=en:enzymology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:epidemiologic
n1=Mycose | n2=en:epidemiologic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:epiploic appendagitis
n1=Mycose | n2=en:epiploic appendagitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:epithelioid hemangioma
n1=Mycose | n2=en:epithelioid hemangioma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythema
n1=Mycose | n2=en:erythema | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythema dyschromicum perstans
n1=Mycose | n2=en:erythema dyschromicum perstans | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythema fugax
n1=Mycose | n2=en:erythema fugax | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythema infectiosum
n1=Mycose | n2=en:erythema infectiosum | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythema papulatum
n1=Mycose | n2=en:erythema papulatum | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythema scarlatiniforme
n1=Mycose | n2=en:erythema scarlatiniforme | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythema simplex
n1=Mycose | n2=en:erythema simplex | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythema tuberculatum
n1=Mycose | n2=en:erythema tuberculatum | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythema urticatum
n1=Mycose | n2=en:erythema urticatum | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythema vesiculosum
n1=Mycose | n2=en:erythema vesiculosum | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythromelalgia
n1=Mycose | n2=en:erythromelalgia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:erythrophagocytosis in late phase
n1=Mycose | n2=en:erythrophagocytosis in late phase | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:escherichia coli infection
n1=Mycose | n2=en:escherichia coli infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ethnologic
n1=Mycose | n2=en:ethnologic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:etiology aspects
n1=Mycose | n2=en:etiology aspects | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:eumycetoma
n1=Mycose | n2=en:eumycetoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:evidence of ebv infection
n1=Mycose | n2=en:evidence of ebv infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:exaggerated cellular immune processes
n1=Mycose | n2=en:exaggerated cellular immune processes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:exposure as collected domain
n1=Mycose | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:exserohilum infections
n1=Mycose | n2=en:exserohilum infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:extrahepatic reticuloendothelial system spared
n1=Mycose | n2=en:extrahepatic reticuloendothelial system spared | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:extrapulmonary histoplasmosis
n1=Mycose | n2=en:extrapulmonary histoplasmosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:eye infection
n1=Mycose | n2=en:eye infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:facial dermatoses
n1=Mycose | n2=en:facial dermatoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:factitial panniculitis
n1=Mycose | n2=en:factitial panniculitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:failed attempted termination of pregnancy with genital tract or pelvic infection
n1=Mycose | n2=en:failed attempted termination of pregnancy with genital tract or pelvic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fertility immunology
n1=Mycose | n2=en:fertility immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fetal disorder
n1=Mycose | n2=en:fetal disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fever
n1=Mycose | n2=en:fever | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fever chills
n1=Mycose | n2=en:fever chills | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:few mature neutrophils in the bone marrow
n1=Mycose | n2=en:few mature neutrophils in the bone marrow | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fixed eruption
n1=Mycose | n2=en:fixed eruption | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fludrocortisone
n1=Mycose | n2=en:fludrocortisone | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fludrocortisone acetate
n1=Mycose | n2=en:fludrocortisone acetate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fludrocortisone acetate 100micrograms tablet
n1=Mycose | n2=en:fludrocortisone acetate 100micrograms tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:focal infection
n1=Mycose | n2=en:focal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fomite transmitted infectious disease
n1=Mycose | n2=en:fomite transmitted infectious disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:food allergies (in some patients)
n1=Mycose | n2=en:food allergies (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:food allergy
n1=Mycose | n2=en:food allergy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:foot diseases
n1=Mycose | n2=en:foot diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:foot infections leading to amputation
n1=Mycose | n2=en:foot infections leading to amputation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:foot ulcer
n1=Mycose | n2=en:foot ulcer | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fracture blister
n1=Mycose | n2=en:fracture blister | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:frequent bacterial, fungal and viral infections
n1=Mycose | n2=en:frequent bacterial, fungal and viral infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:frequent bacterial, viral, and opportunistic infections
n1=Mycose | n2=en:frequent bacterial, viral, and opportunistic infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:frequent bacterial, viral, protozoan, and fungal infections
n1=Mycose | n2=en:frequent bacterial, viral, protozoan, and fungal infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:frequent fungal, viral, and opportunistic infections
n1=Mycose | n2=en:frequent fungal, viral, and opportunistic infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:frequent illnesses
n1=Mycose | n2=en:frequent illnesses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:frequent infections in childhood
n1=Mycose | n2=en:frequent infections in childhood | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:frequent infections t-lymphocyte dysfunction, rare
n1=Mycose | n2=en:frequent infections t-lymphocyte dysfunction, rare | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fulminant infectious mononucleosis
n1=Mycose | n2=en:fulminant infectious mononucleosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal abscess central nervous system
n1=Mycose | n2=en:fungal abscess central nervous system | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal cystitis
n1=Mycose | n2=en:fungal cystitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal ear infection
n1=Mycose | n2=en:fungal ear infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal encephalitis
n1=Mycose | n2=en:fungal encephalitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal endophthalmitis
n1=Mycose | n2=en:fungal endophthalmitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal esophagitis
n1=Mycose | n2=en:fungal esophagitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal eye infections
n1=Mycose | n2=en:fungal eye infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal gastritis
n1=Mycose | n2=en:fungal gastritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal gastrointestinal infection
n1=Mycose | n2=en:fungal gastrointestinal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal infection of brain
n1=Mycose | n2=en:fungal infection of brain | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal infection of lung
n1=Mycose | n2=en:fungal infection of lung | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal infections nec
n1=Mycose | n2=en:fungal infections nec | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal keratitis
n1=Mycose | n2=en:fungal keratitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal labyrinthitis
n1=Mycose | n2=en:fungal labyrinthitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal lower respiratory tract infections
n1=Mycose | n2=en:fungal lower respiratory tract infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal paronychia
n1=Mycose | n2=en:fungal paronychia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal pericarditis
n1=Mycose | n2=en:fungal pericarditis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal peritonitis
n1=Mycose | n2=en:fungal peritonitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal pharyngitis
n1=Mycose | n2=en:fungal pharyngitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal pneumonia
n1=Mycose | n2=en:fungal pneumonia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal retinitis
n1=Mycose | n2=en:fungal retinitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal rhinitis
n1=Mycose | n2=en:fungal rhinitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal sinusitis
n1=Mycose | n2=en:fungal sinusitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungal tracheitis
n1=Mycose | n2=en:fungal tracheitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungemia
n1=Mycose | n2=en:fungemia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:funguria
n1=Mycose | n2=en:funguria | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungus
n1=Mycose | n2=en:fungus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fungus in medical device environment
n1=Mycose | n2=en:fungus in medical device environment | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fusariosis
n1=Mycose | n2=en:fusariosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:fusarium
n1=Mycose | n2=en:fusarium | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:gangrene
n1=Mycose | n2=en:gangrene | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:gastroenteritis
n1=Mycose | n2=en:gastroenteritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:gastrointestinal candidiasis
n1=Mycose | n2=en:gastrointestinal candidiasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:gastrointestinal mucormycosis
n1=Mycose | n2=en:gastrointestinal mucormycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:generalized enlarged lymph nodes
n1=Mycose | n2=en:generalized enlarged lymph nodes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:generalized lymphohistiocytic infiltrates in late phase
n1=Mycose | n2=en:generalized lymphohistiocytic infiltrates in late phase | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:genetic aspects
n1=Mycose | n2=en:genetic aspects | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:genital herpes
n1=Mycose | n2=en:genital herpes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:genital infection fungal
n1=Mycose | n2=en:genital infection fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:geotrichosis
n1=Mycose | n2=en:geotrichosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:germs and hygiene
n1=Mycose | n2=en:germs and hygiene | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:giant germinal centers in lymph nodes
n1=Mycose | n2=en:giant germinal centers in lymph nodes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:giardia infections
n1=Mycose | n2=en:giardia infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:gonorrhea
n1=Mycose | n2=en:gonorrhea | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:graft infection
n1=Mycose | n2=en:graft infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:graft versus host disease in skin
n1=Mycose | n2=en:graft versus host disease in skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:granulocyte dysfunction (1 patient)
n1=Mycose | n2=en:granulocyte dysfunction (1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:granuloma
n1=Mycose | n2=en:granuloma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:granuloma formation
n1=Mycose | n2=en:granuloma formation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:granuloma inguinale
n1=Mycose | n2=en:granuloma inguinale | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:granulomas can appear on skin, tongue, lungs, or other tissues
n1=Mycose | n2=en:granulomas can appear on skin, tongue, lungs, or other tissues | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:granulomas, non-infectious
n1=Mycose | n2=en:granulomas, non-infectious | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:granulomatous infection
n1=Mycose | n2=en:granulomatous infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:granulomatous rosacea
n1=Mycose | n2=en:granulomatous rosacea | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:grover's disease
n1=Mycose | n2=en:grover's disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:h1n1 influenza
n1=Mycose | n2=en:h1n1 influenza | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hair
n1=Mycose | n2=en:hair | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hair and hair follicle diseases
n1=Mycose | n2=en:hair and hair follicle diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hair disorder
n1=Mycose | n2=en:hair disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hair follicle disorder
n1=Mycose | n2=en:hair follicle disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hakuri
n1=Mycose | n2=en:hakuri | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:halitosis
n1=Mycose | n2=en:halitosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hamartoma of integument
n1=Mycose | n2=en:hamartoma of integument | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hand dermatoses
n1=Mycose | n2=en:hand dermatoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hangover from any alcohol or other drugs substance
n1=Mycose | n2=en:hangover from any alcohol or other drugs substance | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hantavirus infection
n1=Mycose | n2=en:hantavirus infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hashimoto thyroiditis
n1=Mycose | n2=en:hashimoto thyroiditis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:heat stroke
n1=Mycose | n2=en:heat stroke | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:helicobacter pylori infection
n1=Mycose | n2=en:helicobacter pylori infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:helminthiasis
n1=Mycose | n2=en:helminthiasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:helminthic disorders
n1=Mycose | n2=en:helminthic disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hematohidrosis
n1=Mycose | n2=en:hematohidrosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hemophagocytic syndrome (hs) characterized by acute onset of uncontrolled t-lymphocyte and macrophage activation
n1=Mycose | n2=en:hemophagocytic syndrome (hs) characterized by acute onset of uncontrolled t-lymphocyte and macrophage activation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hemophagocytosis (in some patients)
n1=Mycose | n2=en:hemophagocytosis (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hemophagocytosis in bone marrow and lymph nodes
n1=Mycose | n2=en:hemophagocytosis in bone marrow and lymph nodes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hemophagocytosis in bone marrow, lymph nodes, spleen, liver, and central nervous system
n1=Mycose | n2=en:hemophagocytosis in bone marrow, lymph nodes, spleen, liver, and central nervous system | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hemophilus infection
n1=Mycose | n2=en:hemophilus infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hemorrhage of skin in neonate
n1=Mycose | n2=en:hemorrhage of skin in neonate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hemorrhagic otitis externa
n1=Mycose | n2=en:hemorrhagic otitis externa | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hemorrhagic varicella pneumonitis
n1=Mycose | n2=en:hemorrhagic varicella pneumonitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hepatic infection
n1=Mycose | n2=en:hepatic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hepatic infection fungal
n1=Mycose | n2=en:hepatic infection fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hepatitis
n1=Mycose | n2=en:hepatitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hepatitis a infection
n1=Mycose | n2=en:hepatitis a infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hepatitis b infection
n1=Mycose | n2=en:hepatitis b infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hepatitis c virus
n1=Mycose | n2=en:hepatitis c virus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hereditary disorder of the integument
n1=Mycose | n2=en:hereditary disorder of the integument | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hernia
n1=Mycose | n2=en:hernia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:herpes simplex infections
n1=Mycose | n2=en:herpes simplex infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:herpes simplex otitis externa
n1=Mycose | n2=en:herpes simplex otitis externa | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:herpes simplex virus infection, mucocutaneous
n1=Mycose | n2=en:herpes simplex virus infection, mucocutaneous | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:herpes zoster
n1=Mycose | n2=en:herpes zoster | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:herpes zoster oticus
n1=Mycose | n2=en:herpes zoster oticus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:herpesviridae infections
n1=Mycose | n2=en:herpesviridae infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:herpetic iridocyclitis
n1=Mycose | n2=en:herpetic iridocyclitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hidradenitis suppurativa
n1=Mycose | n2=en:hidradenitis suppurativa | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:histology shows large regions of necrosis in lymph nodes, thymus, bone marrow, and spleen
n1=Mycose | n2=en:histology shows large regions of necrosis in lymph nodes, thymus, bone marrow, and spleen | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:histoplasmosis
n1=Mycose | n2=en:histoplasmosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:histoplasmosis, unspecified without mention of manifestation
n1=Mycose | n2=en:histoplasmosis, unspecified without mention of manifestation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:historical aspects qualifier
n1=Mycose | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hiv infection
n1=Mycose | n2=en:hiv infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hiv positivity
n1=Mycose | n2=en:hiv positivity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hiv/aids
n1=Mycose | n2=en:hiv/aids | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hiv/aids and infections
n1=Mycose | n2=en:hiv/aids and infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hla antigens cw6, b13, b17 associated with psoriasis
n1=Mycose | n2=en:hla antigens cw6, b13, b17 associated with psoriasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:human head louse
n1=Mycose | n2=en:human head louse | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:human herpes virus 6 infection of skin
n1=Mycose | n2=en:human herpes virus 6 infection of skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:human herpes virus 7 infection of skin
n1=Mycose | n2=en:human herpes virus 7 infection of skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:human papillomavirus
n1=Mycose | n2=en:human papillomavirus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:humoral defect (in some)
n1=Mycose | n2=en:humoral defect (in some) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:humoral deficiency (likely result of t-cell abnormalities)
n1=Mycose | n2=en:humoral deficiency (likely result of t-cell abnormalities) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hyper iga (in some patients)
n1=Mycose | n2=en:hyper iga (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypereosinophilia
n1=Mycose | n2=en:hypereosinophilia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypergammaglobulinemia
n1=Mycose | n2=en:hypergammaglobulinemia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypergammaglobulinemia (in some patients)
n1=Mycose | n2=en:hypergammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hyperglobulinemia
n1=Mycose | n2=en:hyperglobulinemia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hyperglobulinemia, polyclonal (in some patients)
n1=Mycose | n2=en:hyperglobulinemia, polyclonal (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hyperinflammatory disorder
n1=Mycose | n2=en:hyperinflammatory disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hyperinflammatory state
n1=Mycose | n2=en:hyperinflammatory state | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hyperinflammatory state (in some patients)
n1=Mycose | n2=en:hyperinflammatory state (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hyperkeratosis of pinta
n1=Mycose | n2=en:hyperkeratosis of pinta | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hyperplasia of tonsils
n1=Mycose | n2=en:hyperplasia of tonsils | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hyperproliferation of effector t cells
n1=Mycose | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypersensitivity
n1=Mycose | n2=en:hypersensitivity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypertrichosis
n1=Mycose | n2=en:hypertrichosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypertrophic disorder of skin, unspecified
n1=Mycose | n2=en:hypertrophic disorder of skin, unspecified | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypertrophy
n1=Mycose | n2=en:hypertrophy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypocomplementemia (in some patients)
n1=Mycose | n2=en:hypocomplementemia (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypogammaglobulinemia
n1=Mycose | n2=en:hypogammaglobulinemia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypogammaglobulinemia (1 patient)
n1=Mycose | n2=en:hypogammaglobulinemia (1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypogammaglobulinemia (in some patients)
n1=Mycose | n2=en:hypogammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypogammaglobulinemia, profound
n1=Mycose | n2=en:hypogammaglobulinemia, profound | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypoglobulinemia result
n1=Mycose | n2=en:hypoglobulinemia result | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypohidrosis
n1=Mycose | n2=en:hypohidrosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypoimmunoglobulinemia
n1=Mycose | n2=en:hypoimmunoglobulinemia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypoplastic thymus which often lacks hassal corpuscles
n1=Mycose | n2=en:hypoplastic thymus which often lacks hassal corpuscles | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypothermia adverse event
n1=Mycose | n2=en:hypothermia adverse event | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:hypotrichosis
n1=Mycose | n2=en:hypotrichosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:idiopathic hirsutism
n1=Mycose | n2=en:idiopathic hirsutism | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:igg, decreased
n1=Mycose | n2=en:igg, decreased | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:igm deficiency
n1=Mycose | n2=en:igm deficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:igm immunodeficiency (in some patients)
n1=Mycose | n2=en:igm immunodeficiency (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:il6 continuously elevated (in some patients)
n1=Mycose | n2=en:il6 continuously elevated (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ill-defined infectious disease
n1=Mycose | n2=en:ill-defined infectious disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immune defect due to a t cell deficit
n1=Mycose | n2=en:immune defect due to a t cell deficit | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immune dysregulation
n1=Mycose | n2=en:immune dysregulation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immune response process
n1=Mycose | n2=en:immune response process | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immune system disorder
n1=Mycose | n2=en:immune system disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunity
n1=Mycose | n2=en:immunity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunization
n1=Mycose | n2=en:immunization | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunizations and screening for infectious disease
n1=Mycose | n2=en:immunizations and screening for infectious disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunodeficiency (in some patients)
n1=Mycose | n2=en:immunodeficiency (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunodeficiency syndrome
n1=Mycose | n2=en:immunodeficiency syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunodeficiency, primarily affecting b cell line
n1=Mycose | n2=en:immunodeficiency, primarily affecting b cell line | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunodeficiency, severe combined (in some patients)
n1=Mycose | n2=en:immunodeficiency, severe combined (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunogenetics
n1=Mycose | n2=en:immunogenetics | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunoglobulin a decreased
n1=Mycose | n2=en:immunoglobulin a decreased | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunoglobulin a deficiency (disorder)
n1=Mycose | n2=en:immunoglobulin a deficiency (disorder) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunoglobulin deficiency (iga, igg, igm)
n1=Mycose | n2=en:immunoglobulin deficiency (iga, igg, igm) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunohematology
n1=Mycose | n2=en:immunohematology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunologic evaluation unremarkable
n1=Mycose | n2=en:immunologic evaluation unremarkable | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunology
n1=Mycose | n2=en:immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunology aspects
n1=Mycose | n2=en:immunology aspects | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunology, other
n1=Mycose | n2=en:immunology, other | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunophenotyping
n1=Mycose | n2=en:immunophenotyping | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunoregulation
n1=Mycose | n2=en:immunoregulation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunosuppression-related infectious disease
n1=Mycose | n2=en:immunosuppression-related infectious disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:immunotoxicity
n1=Mycose | n2=en:immunotoxicity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired b cell class-switching
n1=Mycose | n2=en:impaired b cell class-switching | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired b cell memory cells
n1=Mycose | n2=en:impaired b cell memory cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired b-cell differentiation
n1=Mycose | n2=en:impaired b-cell differentiation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired cellular and humoral immunity
n1=Mycose | n2=en:impaired cellular and humoral immunity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired ig class switch recombination
n1=Mycose | n2=en:impaired ig class switch recombination | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired immune responses
n1=Mycose | n2=en:impaired immune responses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired lymphocyte apoptosis
n1=Mycose | n2=en:impaired lymphocyte apoptosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired lymphocyte proliferation response to malignancy
n1=Mycose | n2=en:impaired lymphocyte proliferation response to malignancy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired seroconversion of immunoglobulins in response to vaccination
n1=Mycose | n2=en:impaired seroconversion of immunoglobulins in response to vaccination | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired signaling through the t-cell receptor
n1=Mycose | n2=en:impaired signaling through the t-cell receptor | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired skin integrity
n1=Mycose | n2=en:impaired skin integrity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired survival of mature t cells
n1=Mycose | n2=en:impaired survival of mature t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired t cell activation
n1=Mycose | n2=en:impaired t cell activation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired t cell function
n1=Mycose | n2=en:impaired t cell function | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired t cell immunity
n1=Mycose | n2=en:impaired t cell immunity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired t cell proliferation and activation
n1=Mycose | n2=en:impaired t cell proliferation and activation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired t cell proliferative response
n1=Mycose | n2=en:impaired t cell proliferative response | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impaired t-cell proliferation to certain stimuli
n1=Mycose | n2=en:impaired t-cell proliferation to certain stimuli | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:impetigo
n1=Mycose | n2=en:impetigo | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:in blood
n1=Mycose | n2=en:in blood | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:in cerebrospinal fluid
n1=Mycose | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:in urine
n1=Mycose | n2=en:in urine | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:inability to mount antibody response to antigen
n1=Mycose | n2=en:inability to mount antibody response to antigen | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:inability to reject allogenic cells
n1=Mycose | n2=en:inability to reject allogenic cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:inadvertent inoculation with vaccinia virus following contact with smallpox vaccination site
n1=Mycose | n2=en:inadvertent inoculation with vaccinia virus following contact with smallpox vaccination site | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increase in b cell number
n1=Mycose | n2=en:increase in b cell number | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increase in b cells (in some patients)
n1=Mycose | n2=en:increase in b cells (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increase in cd8+ t cells (in some patients)
n1=Mycose | n2=en:increase in cd8+ t cells (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increase in certain cytokines (il4, il5, il13, il17) upon stimulation
n1=Mycose | n2=en:increase in certain cytokines (il4, il5, il13, il17) upon stimulation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased activated cd8+ t cells
n1=Mycose | n2=en:increased activated cd8+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased alpha-interferon activity
n1=Mycose | n2=en:increased alpha-interferon activity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased cd21+ (low) b cells
n1=Mycose | n2=en:increased cd21+ (low) b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased circulating transitional b cells (cd19+cd38+igm+)
n1=Mycose | n2=en:increased circulating transitional b cells (cd19+cd38+igm+) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased drug level
n1=Mycose | n2=en:increased drug level | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased effector cd8+ t cells
n1=Mycose | n2=en:increased effector cd8+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased frequency of bacterial, viral, and fungal infections
n1=Mycose | n2=en:increased frequency of bacterial, viral, and fungal infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased ig
n1=Mycose | n2=en:increased ig | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased iga level
n1=Mycose | n2=en:increased iga level | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased ige impaired nk cell activity
n1=Mycose | n2=en:increased ige impaired nk cell activity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased ige level
n1=Mycose | n2=en:increased ige level | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased igm (1 patient)
n1=Mycose | n2=en:increased igm (1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased igm level
n1=Mycose | n2=en:increased igm level | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased il6, episodic
n1=Mycose | n2=en:increased il6, episodic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased immunoglobulin
n1=Mycose | n2=en:increased immunoglobulin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased levels of t cells bearing gamma/delta antigen receptor
n1=Mycose | n2=en:increased levels of t cells bearing gamma/delta antigen receptor | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased number of cd4-/cd8- t cells expressing alpha/beta t-cell receptors
n1=Mycose | n2=en:increased number of cd4-/cd8- t cells expressing alpha/beta t-cell receptors | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased number of cd4(-)cd8(-)tcr-alpha-beta(+) t cells
n1=Mycose | n2=en:increased number of cd4(-)cd8(-)tcr-alpha-beta(+) t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased number of circulating lymphocytes
n1=Mycose | n2=en:increased number of circulating lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased number of peripheral cd3+ t cells
n1=Mycose | n2=en:increased number of peripheral cd3+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased percentage of naive b cells
n1=Mycose | n2=en:increased percentage of naive b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased percentage of naive igd+ igm+ cd27- b cells
n1=Mycose | n2=en:increased percentage of naive igd+ igm+ cd27- b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased percentage of naive t cells
n1=Mycose | n2=en:increased percentage of naive t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased proportion of cd19+ b cells
n1=Mycose | n2=en:increased proportion of cd19+ b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased proportion of hla dr+ and cd57+ t cells
n1=Mycose | n2=en:increased proportion of hla dr+ and cd57+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased serum ige
n1=Mycose | n2=en:increased serum ige | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased serum ige (1 patient)
n1=Mycose | n2=en:increased serum ige (1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased serum ige, iga, igg
n1=Mycose | n2=en:increased serum ige, iga, igg | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased serum igm (in some patients)
n1=Mycose | n2=en:increased serum igm (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased susceptibility to bacterial infections
n1=Mycose | n2=en:increased susceptibility to bacterial infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased susceptibility to certain bacterial infections, especially neisseria meningitidis
n1=Mycose | n2=en:increased susceptibility to certain bacterial infections, especially neisseria meningitidis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased susceptibility to ebv infection
n1=Mycose | n2=en:increased susceptibility to ebv infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased susceptibility to haemophilus influenzae infections
n1=Mycose | n2=en:increased susceptibility to haemophilus influenzae infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased susceptibility to infections
n1=Mycose | n2=en:increased susceptibility to infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased susceptibility to infections (bacterial, fungal, and viral)
n1=Mycose | n2=en:increased susceptibility to infections (bacterial, fungal, and viral) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased susceptibility to mycobacteria, bacteria, fungi, and viruses
n1=Mycose | n2=en:increased susceptibility to mycobacteria, bacteria, fungi, and viruses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased susceptibility to neisseria infections
n1=Mycose | n2=en:increased susceptibility to neisseria infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased susceptibility to pneumocystis and cytomegalovirus infections
n1=Mycose | n2=en:increased susceptibility to pneumocystis and cytomegalovirus infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased susceptibility to severe and frequent infections with staphylococcus aureus
n1=Mycose | n2=en:increased susceptibility to severe and frequent infections with staphylococcus aureus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased susceptibility to streptococcus pneumoniae infections
n1=Mycose | n2=en:increased susceptibility to streptococcus pneumoniae infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased t cell activation
n1=Mycose | n2=en:increased t cell activation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased tolerance
n1=Mycose | n2=en:increased tolerance | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased total number of cd19+ b cells
n1=Mycose | n2=en:increased total number of cd19+ b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:increased transitional b cells
n1=Mycose | n2=en:increased transitional b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:indeterminate leprosy
n1=Mycose | n2=en:indeterminate leprosy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:indirect contact transmission infection
n1=Mycose | n2=en:indirect contact transmission infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infected discoid eczema
n1=Mycose | n2=en:infected discoid eczema | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infected lymphocele
n1=Mycose | n2=en:infected lymphocele | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection
n1=Mycose | n2=en:infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection - non-suppurative
n1=Mycose | n2=en:infection - non-suppurative | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection aggravated
n1=Mycose | n2=en:infection aggravated | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection associated with artificial insemination
n1=Mycose | n2=en:infection associated with artificial insemination | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection associated with device
n1=Mycose | n2=en:infection associated with device | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection by histoplasma capsulatum
n1=Mycose | n2=en:infection by histoplasma capsulatum | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection by myobia musculi
n1=Mycose | n2=en:infection by myobia musculi | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection by oomycetes
n1=Mycose | n2=en:infection by oomycetes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection by site
n1=Mycose | n2=en:infection by site | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection due to chordate
n1=Mycose | n2=en:infection due to chordate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection due to resistant organism
n1=Mycose | n2=en:infection due to resistant organism | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection in patient who abuses drugs
n1=Mycose | n2=en:infection in patient who abuses drugs | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection in patient with spinal cord injury
n1=Mycose | n2=en:infection in patient with spinal cord injury | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection in the elderly
n1=Mycose | n2=en:infection in the elderly | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection induced
n1=Mycose | n2=en:infection induced | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection of cervical spine
n1=Mycose | n2=en:infection of cervical spine | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection of larynx
n1=Mycose | n2=en:infection of larynx | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection of uncertain etiology
n1=Mycose | n2=en:infection of uncertain etiology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection of wound hematoma
n1=Mycose | n2=en:infection of wound hematoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection precipitated
n1=Mycose | n2=en:infection precipitated | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infection pyogenic
n1=Mycose | n2=en:infection pyogenic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infections - pathogen unspecified
n1=Mycose | n2=en:infections - pathogen unspecified | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infections specific to perinatal period
n1=Mycose | n2=en:infections specific to perinatal period | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious and parasitic conditions in the mother classifiable elsewhere, but complicating pregnancy, childbirth, or the puerperium
n1=Mycose | n2=en:infectious and parasitic conditions in the mother classifiable elsewhere, but complicating pregnancy, childbirth, or the puerperium | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious arthritis of temporomandibular joint
n1=Mycose | n2=en:infectious arthritis of temporomandibular joint | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious bovine keratoconjunctivitis
n1=Mycose | n2=en:infectious bovine keratoconjunctivitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious disease associated with acquired immune deficiency syndrome
n1=Mycose | n2=en:infectious disease associated with acquired immune deficiency syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious disease due to plant
n1=Mycose | n2=en:infectious disease due to plant | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious disease immunology
n1=Mycose | n2=en:infectious disease immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious disease in mother complicating pregnancy, childbirth and/or puerperium
n1=Mycose | n2=en:infectious disease in mother complicating pregnancy, childbirth and/or puerperium | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious disease prevention / control
n1=Mycose | n2=en:infectious disease prevention / control | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious disorder
n1=Mycose | n2=en:infectious disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious disorder by site
n1=Mycose | n2=en:infectious disorder by site | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious disorder of the fetus
n1=Mycose | n2=en:infectious disorder of the fetus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious endarteritis of arterial duct
n1=Mycose | n2=en:infectious endarteritis of arterial duct | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious granuloma
n1=Mycose | n2=en:infectious granuloma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious lymphocytosis
n1=Mycose | n2=en:infectious lymphocytosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious mononucleosis
n1=Mycose | n2=en:infectious mononucleosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious myositis
n1=Mycose | n2=en:infectious myositis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious process
n1=Mycose | n2=en:infectious process | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious secondary iritis
n1=Mycose | n2=en:infectious secondary iritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious sequelae of disorders
n1=Mycose | n2=en:infectious sequelae of disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious sialoadenitis of major salivary gland
n1=Mycose | n2=en:infectious sialoadenitis of major salivary gland | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infectious synovitis
n1=Mycose | n2=en:infectious synovitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infective arthritis
n1=Mycose | n2=en:infective arthritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infective discitis
n1=Mycose | n2=en:infective discitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infective eczematoid dermatitis
n1=Mycose | n2=en:infective eczematoid dermatitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infective endarteritis at site of aortic coarctation
n1=Mycose | n2=en:infective endarteritis at site of aortic coarctation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infective food poisoning
n1=Mycose | n2=en:infective food poisoning | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infective paralysis of accommodation
n1=Mycose | n2=en:infective paralysis of accommodation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:infective stricture of esophagus
n1=Mycose | n2=en:infective stricture of esophagus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:inflammatory dermatosis
n1=Mycose | n2=en:inflammatory dermatosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:influenza
n1=Mycose | n2=en:influenza | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:influenza in birds
n1=Mycose | n2=en:influenza in birds | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site abscess
n1=Mycose | n2=en:injection site abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site atrophy
n1=Mycose | n2=en:injection site atrophy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site cyst
n1=Mycose | n2=en:injection site cyst | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site edema
n1=Mycose | n2=en:injection site edema | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site fibrosis
n1=Mycose | n2=en:injection site fibrosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site granuloma
n1=Mycose | n2=en:injection site granuloma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site hemorrhage
n1=Mycose | n2=en:injection site hemorrhage | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site hypersensitivity
n1=Mycose | n2=en:injection site hypersensitivity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site inflammation
n1=Mycose | n2=en:injection site inflammation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site mass
n1=Mycose | n2=en:injection site mass | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site necrosis
n1=Mycose | n2=en:injection site necrosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site pain
n1=Mycose | n2=en:injection site pain | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:injection site reaction
n1=Mycose | n2=en:injection site reaction | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:insect bites and stings
n1=Mycose | n2=en:insect bites and stings | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:intentional drug overdose
n1=Mycose | n2=en:intentional drug overdose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:intentional trauma
n1=Mycose | n2=en:intentional trauma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:interference laboratory test
n1=Mycose | n2=en:interference laboratory test | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:interstitial pneumonia
n1=Mycose | n2=en:interstitial pneumonia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:intertrigo of abdominal skin fold
n1=Mycose | n2=en:intertrigo of abdominal skin fold | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:intestinal infectious disease (disorder)
n1=Mycose | n2=en:intestinal infectious disease (disorder) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:intracranial pyogenic abscess
n1=Mycose | n2=en:intracranial pyogenic abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:intraepidermal pustular dermatitis
n1=Mycose | n2=en:intraepidermal pustular dermatitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:intraspinal pyogenic abscess
n1=Mycose | n2=en:intraspinal pyogenic abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:intrinsic b cell defect
n1=Mycose | n2=en:intrinsic b cell defect | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:invasive pulmonary aspergillosis
n1=Mycose | n2=en:invasive pulmonary aspergillosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:isolated absence of cd8+ t cells
n1=Mycose | n2=en:isolated absence of cd8+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:itching purpura
n1=Mycose | n2=en:itching purpura | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:joint tuberculosis
n1=Mycose | n2=en:joint tuberculosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:juvenile xanthogranuloma
n1=Mycose | n2=en:juvenile xanthogranuloma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:kaposi sarcoma
n1=Mycose | n2=en:kaposi sarcoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:kappa-chain deficiency
n1=Mycose | n2=en:kappa-chain deficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:kawasaki disease
n1=Mycose | n2=en:kawasaki disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:keloid
n1=Mycose | n2=en:keloid | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:keratoacanthoma
n1=Mycose | n2=en:keratoacanthoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:keratoconjunctivitis due to adenovirus
n1=Mycose | n2=en:keratoconjunctivitis due to adenovirus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:keratoconjunctivitis due to molluscum contagiosum
n1=Mycose | n2=en:keratoconjunctivitis due to molluscum contagiosum | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:keratoderma
n1=Mycose | n2=en:keratoderma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:keratosis
n1=Mycose | n2=en:keratosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:keratosis lichenoides chronica
n1=Mycose | n2=en:keratosis lichenoides chronica | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:kerion celsi
n1=Mycose | n2=en:kerion celsi | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:klebsiella infections
n1=Mycose | n2=en:klebsiella infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:laboratory accident/infection
n1=Mycose | n2=en:laboratory accident/infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:laboratory infection
n1=Mycose | n2=en:laboratory infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lack of acquired antibodies
n1=Mycose | n2=en:lack of acquired antibodies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lack of autoantibodies
n1=Mycose | n2=en:lack of autoantibodies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lack of cd27 expression on lymphocytes
n1=Mycose | n2=en:lack of cd27 expression on lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lack of circulating dendritic cells
n1=Mycose | n2=en:lack of circulating dendritic cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lack of circulating monocytes
n1=Mycose | n2=en:lack of circulating monocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lack of drug action
n1=Mycose | n2=en:lack of drug action | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lack of peripheral cd3+ t cells
n1=Mycose | n2=en:lack of peripheral cd3+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lack of thymus on ultrasound
n1=Mycose | n2=en:lack of thymus on ultrasound | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:laryngitis fungal
n1=Mycose | n2=en:laryngitis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:late effect of injuries to skin and/or subcutaneous tissues
n1=Mycose | n2=en:late effect of injuries to skin and/or subcutaneous tissues | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:late effects of other and unspecified infectious and parasitic diseases
n1=Mycose | n2=en:late effects of other and unspecified infectious and parasitic diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:latent infection
n1=Mycose | n2=en:latent infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:latent infection appearance of
n1=Mycose | n2=en:latent infection appearance of | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:leg dermatoses
n1=Mycose | n2=en:leg dermatoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:legionella pneumonia
n1=Mycose | n2=en:legionella pneumonia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:leishmaniasis
n1=Mycose | n2=en:leishmaniasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lepromatous skin complications
n1=Mycose | n2=en:lepromatous skin complications | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:leprosy, lepromatous
n1=Mycose | n2=en:leprosy, lepromatous | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:leukocyte adhesion deficiency, type iii
n1=Mycose | n2=en:leukocyte adhesion deficiency, type iii | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:leukocytosis
n1=Mycose | n2=en:leukocytosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:leukopenia
n1=Mycose | n2=en:leukopenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lice
n1=Mycose | n2=en:lice | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lichen planus
n1=Mycose | n2=en:lichen planus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lipomatosis
n1=Mycose | n2=en:lipomatosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lipomatosis, multiple symmetrical
n1=Mycose | n2=en:lipomatosis, multiple symmetrical | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:listeriosis
n1=Mycose | n2=en:listeriosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:liver abscess due to portal pyemia
n1=Mycose | n2=en:liver abscess due to portal pyemia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lobomycosis
n1=Mycose | n2=en:lobomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:localized scleroderma
n1=Mycose | n2=en:localized scleroderma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:localized skin lesion
n1=Mycose | n2=en:localized skin lesion | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:loss of or marked reduction of v(d)j recombination activity
n1=Mycose | n2=en:loss of or marked reduction of v(d)j recombination activity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low birth weight
n1=Mycose | n2=en:low birth weight | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low igg
n1=Mycose | n2=en:low igg | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low igg and iga
n1=Mycose | n2=en:low igg and iga | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low igg in adolescence (2 of 4 affected individuals)
n1=Mycose | n2=en:low igg in adolescence (2 of 4 affected individuals) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low igg with antibody deficiency
n1=Mycose | n2=en:low igg with antibody deficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low levels of antibodies to s. pneumoniae, h. influenzae type b
n1=Mycose | n2=en:low levels of antibodies to s. pneumoniae, h. influenzae type b | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low levels of memory b cells
n1=Mycose | n2=en:low levels of memory b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low memory b cells
n1=Mycose | n2=en:low memory b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low naive t cells
n1=Mycose | n2=en:low naive t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low nk cells
n1=Mycose | n2=en:low nk cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low or normal serum immunoglobulins
n1=Mycose | n2=en:low or normal serum immunoglobulins | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low specific antibody titers (e.g., tetanus, polio virus, mumps, rubella)
n1=Mycose | n2=en:low specific antibody titers (e.g., tetanus, polio virus, mumps, rubella) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low t-cell function
n1=Mycose | n2=en:low t-cell function | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low to normal immunoglobulin levels
n1=Mycose | n2=en:low to normal immunoglobulin levels | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low-absent igg, iga
n1=Mycose | n2=en:low-absent igg, iga | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low-normal iga levels
n1=Mycose | n2=en:low-normal iga levels | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:low-to-absent igg, iga, ige
n1=Mycose | n2=en:low-to-absent igg, iga, ige | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ludwig's angina
n1=Mycose | n2=en:ludwig's angina | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lung diseases, fungal
n1=Mycose | n2=en:lung diseases, fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lupus-like syndrome (in some patients)
n1=Mycose | n2=en:lupus-like syndrome (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymph node architecture severely altered: lack of follicles, depletion of lymphocytes, and increased proportion of interdigitating reticular cells and eosinophils
n1=Mycose | n2=en:lymph node architecture severely altered: lack of follicles, depletion of lymphocytes, and increased proportion of interdigitating reticular cells and eosinophils | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymph node hyperplasia
n1=Mycose | n2=en:lymph node hyperplasia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymph nodes are small and poorly developed
n1=Mycose | n2=en:lymph nodes are small and poorly developed | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymph nodes show florid reactive follicular hyperplasia and marked paracortical expansion with immunoblasts and plasma cells
n1=Mycose | n2=en:lymph nodes show florid reactive follicular hyperplasia and marked paracortical expansion with immunoblasts and plasma cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymph nodes show reactive follicular hyperplasia and non-caseating granulomas
n1=Mycose | n2=en:lymph nodes show reactive follicular hyperplasia and non-caseating granulomas | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphadenitis
n1=Mycose | n2=en:lymphadenitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphadenitis fungal
n1=Mycose | n2=en:lymphadenitis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphadenitis subsequent to bcg vaccination (in 1 patient)
n1=Mycose | n2=en:lymphadenitis subsequent to bcg vaccination (in 1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphadenopathy (cervical, inguinal, axillary)
n1=Mycose | n2=en:lymphadenopathy (cervical, inguinal, axillary) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphadenopathy (in some patients)
n1=Mycose | n2=en:lymphadenopathy (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphadenopathy in late phase
n1=Mycose | n2=en:lymphadenopathy in late phase | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphadenopathy may occur
n1=Mycose | n2=en:lymphadenopathy may occur | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphadenopathy subsequent to bcg vaccination
n1=Mycose | n2=en:lymphadenopathy subsequent to bcg vaccination | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphadenopathy, generalized (in some patients)
n1=Mycose | n2=en:lymphadenopathy, generalized (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphangitis
n1=Mycose | n2=en:lymphangitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphocutaneous sporotrichosis
n1=Mycose | n2=en:lymphocutaneous sporotrichosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphocyte count normal
n1=Mycose | n2=en:lymphocyte count normal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphogranuloma venereum
n1=Mycose | n2=en:lymphogranuloma venereum | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphohistiocytic infiltration and hemophagocytosis in multiple organs
n1=Mycose | n2=en:lymphohistiocytic infiltration and hemophagocytosis in multiple organs | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphohistiocytosis
n1=Mycose | n2=en:lymphohistiocytosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphoid depletion
n1=Mycose | n2=en:lymphoid depletion | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphoid hyperplasia
n1=Mycose | n2=en:lymphoid hyperplasia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphoid hypoplasia
n1=Mycose | n2=en:lymphoid hypoplasia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphopenia
n1=Mycose | n2=en:lymphopenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphopenia (1 family)
n1=Mycose | n2=en:lymphopenia (1 family) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphopenia, progressive
n1=Mycose | n2=en:lymphopenia, progressive | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphoproliferation
n1=Mycose | n2=en:lymphoproliferation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:lymphostatic verrucoses
n1=Mycose | n2=en:lymphostatic verrucoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:malaise
n1=Mycose | n2=en:malaise | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:malaria
n1=Mycose | n2=en:malaria | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:malignant hyperthermia syndrome
n1=Mycose | n2=en:malignant hyperthermia syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:malignant skin neoplasm
n1=Mycose | n2=en:malignant skin neoplasm | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:marked depletion of lymphoid tissues
n1=Mycose | n2=en:marked depletion of lymphoid tissues | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:marked reduction in cd4+/cd8+ ratio (in some patients)
n1=Mycose | n2=en:marked reduction in cd4+/cd8+ ratio (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:markedly depressed t lymphocyte proportion
n1=Mycose | n2=en:markedly depressed t lymphocyte proportion | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:markedly elevated ige levels
n1=Mycose | n2=en:markedly elevated ige levels | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:markedly reduced cd3+ proportion
n1=Mycose | n2=en:markedly reduced cd3+ proportion | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:markedly reduced neutrophil motility
n1=Mycose | n2=en:markedly reduced neutrophil motility | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:markedly reduced numbers of natural killer cells
n1=Mycose | n2=en:markedly reduced numbers of natural killer cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:markedly reduced t cell function
n1=Mycose | n2=en:markedly reduced t cell function | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:masked infection
n1=Mycose | n2=en:masked infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:massive osteolyses
n1=Mycose | n2=en:massive osteolyses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mastitis fungal
n1=Mycose | n2=en:mastitis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mastocytosis
n1=Mycose | n2=en:mastocytosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:maturational arrest of granulocytes at the promyelocyte/myelocyte stage seen on bone marrow biopsy
n1=Mycose | n2=en:maturational arrest of granulocytes at the promyelocyte/myelocyte stage seen on bone marrow biopsy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:measles
n1=Mycose | n2=en:measles | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:medication error
n1=Mycose | n2=en:medication error | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:medicine
n1=Mycose | n2=en:medicine | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:melanocytic nevus
n1=Mycose | n2=en:melanocytic nevus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:melanoma
n1=Mycose | n2=en:melanoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:meningitis
n1=Mycose | n2=en:meningitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:meningitis, fungal
n1=Mycose | n2=en:meningitis, fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:meningococcal infections
n1=Mycose | n2=en:meningococcal infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mesenteric adenitis due to pasteurella multocida
n1=Mycose | n2=en:mesenteric adenitis due to pasteurella multocida | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:metabolic and nutritional disorders affecting skin
n1=Mycose | n2=en:metabolic and nutritional disorders affecting skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:metabolic aspects
n1=Mycose | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:methicillin-resistant staphylococcus aureus infection
n1=Mycose | n2=en:methicillin-resistant staphylococcus aureus infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:michelin tire baby syndrome
n1=Mycose | n2=en:michelin tire baby syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:microbiological
n1=Mycose | n2=en:microbiological | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:microorganism immunology
n1=Mycose | n2=en:microorganism immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:microsporidiosis
n1=Mycose | n2=en:microsporidiosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:microsporosis nigra
n1=Mycose | n2=en:microsporosis nigra | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mild to moderately reduced t cell count
n1=Mycose | n2=en:mild to moderately reduced t cell count | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mildly decreased or normal t-cell proliferative responses
n1=Mycose | n2=en:mildly decreased or normal t-cell proliferative responses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mildly decreased proliferative responses of t cells
n1=Mycose | n2=en:mildly decreased proliferative responses of t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:miliaria
n1=Mycose | n2=en:miliaria | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mitosporic ascomycota
n1=Mycose | n2=en:mitosporic ascomycota | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:moderate-low complement c3
n1=Mycose | n2=en:moderate-low complement c3 | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:moderately depressed antibody response to polysaccharide antigens
n1=Mycose | n2=en:moderately depressed antibody response to polysaccharide antigens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:moderately elevated ige
n1=Mycose | n2=en:moderately elevated ige | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mold
n1=Mycose | n2=en:mold | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:molecular immunology
n1=Mycose | n2=en:molecular immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:monilial prostatitis
n1=Mycose | n2=en:monilial prostatitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:moniliasis axillary
n1=Mycose | n2=en:moniliasis axillary | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:monkeypox
n1=Mycose | n2=en:monkeypox | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:monocytes show impaired motility
n1=Mycose | n2=en:monocytes show impaired motility | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:monocytopenia
n1=Mycose | n2=en:monocytopenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:monocytosis
n1=Mycose | n2=en:monocytosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:morgellons disease
n1=Mycose | n2=en:morgellons disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mucocutaneous candidiasis
n1=Mycose | n2=en:mucocutaneous candidiasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mucocutaneous cryptococcosis
n1=Mycose | n2=en:mucocutaneous cryptococcosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mucopurulent vaginitis
n1=Mycose | n2=en:mucopurulent vaginitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mucopyocele
n1=Mycose | n2=en:mucopyocele | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mucormycosis
n1=Mycose | n2=en:mucormycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:multiple congenital anomalies
n1=Mycose | n2=en:multiple congenital anomalies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mumps
n1=Mycose | n2=en:mumps | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mycetoma
n1=Mycose | n2=en:mycetoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mycobacterial infection
n1=Mycose | n2=en:mycobacterial infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mycobacterial infectious disorders
n1=Mycose | n2=en:mycobacterial infectious disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mycobacterium tuberculosis infection reactivated
n1=Mycose | n2=en:mycobacterium tuberculosis infection reactivated | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mycoplasmal infectious disorders
n1=Mycose | n2=en:mycoplasmal infectious disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mycoses
n1=Mycose | n2=en:mycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mycotic corneal ulcer
n1=Mycose | n2=en:mycotic corneal ulcer | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mycotic endocarditis
n1=Mycose | n2=en:mycotic endocarditis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mycotic infection screening
n1=Mycose | n2=en:mycotic infection screening | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mycotic miscarriage
n1=Mycose | n2=en:mycotic miscarriage | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:mycotoxicosis
n1=Mycose | n2=en:mycotoxicosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:myelitis due to herpes simplex
n1=Mycose | n2=en:myelitis due to herpes simplex | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:myeloid proliferation
n1=Mycose | n2=en:myeloid proliferation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:myocarditis due to influenza virus
n1=Mycose | n2=en:myocarditis due to influenza virus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:myocarditis mycotic
n1=Mycose | n2=en:myocarditis mycotic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:nail
n1=Mycose | n2=en:nail | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:nail diseases
n1=Mycose | n2=en:nail diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:natural killer cells, reduced numbers and cytotoxicity
n1=Mycose | n2=en:natural killer cells, reduced numbers and cytotoxicity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:natural killer t cell count decreased
n1=Mycose | n2=en:natural killer t cell count decreased | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:necrobiotic disorders
n1=Mycose | n2=en:necrobiotic disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:necrolytic migratory erythema
n1=Mycose | n2=en:necrolytic migratory erythema | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:necrotic process
n1=Mycose | n2=en:necrotic process | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:necrotising fasciitis fungal
n1=Mycose | n2=en:necrotising fasciitis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:necrotizing ulcerative gingivitis
n1=Mycose | n2=en:necrotizing ulcerative gingivitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neonatal infectious disorder
n1=Mycose | n2=en:neonatal infectious disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neonatal infective mastitis
n1=Mycose | n2=en:neonatal infective mastitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neonatal sepsis
n1=Mycose | n2=en:neonatal sepsis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neoplasm
n1=Mycose | n2=en:neoplasm | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neoplasm of integumentary system
n1=Mycose | n2=en:neoplasm of integumentary system | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neoplasm/cancer immunology
n1=Mycose | n2=en:neoplasm/cancer immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:nephrogenic fibrosing dermopathy
n1=Mycose | n2=en:nephrogenic fibrosing dermopathy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:nervous system infectious disorder
n1=Mycose | n2=en:nervous system infectious disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neuroimmunology
n1=Mycose | n2=en:neuroimmunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neuroimmunomodulation
n1=Mycose | n2=en:neuroimmunomodulation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neuroleptic malignant syndrome
n1=Mycose | n2=en:neuroleptic malignant syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neutropenia
n1=Mycose | n2=en:neutropenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neutropenia (in some patients)
n1=Mycose | n2=en:neutropenia (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neutrophilic eccrine hidradenitis
n1=Mycose | n2=en:neutrophilic eccrine hidradenitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neutrophils show defective intracellular nadph oxidase production
n1=Mycose | n2=en:neutrophils show defective intracellular nadph oxidase production | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:neutrophils show disorganized lysosomal compartments on ultrastructural analysis
n1=Mycose | n2=en:neutrophils show disorganized lysosomal compartments on ultrastructural analysis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:nevus of ito
n1=Mycose | n2=en:nevus of ito | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:nk cells showed unusual surface cd16 antibody reactions
n1=Mycose | n2=en:nk cells showed unusual surface cd16 antibody reactions | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no antibodies to intrinsic factor
n1=Mycose | n2=en:no antibodies to intrinsic factor | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no concurrent allergies
n1=Mycose | n2=en:no concurrent allergies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no concurrent parasitic infection
n1=Mycose | n2=en:no concurrent parasitic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no evidence of common prenatal infections
n1=Mycose | n2=en:no evidence of common prenatal infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no evidence of immunodeficiency
n1=Mycose | n2=en:no evidence of immunodeficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no evidence of intrauterine or perinatal infection
n1=Mycose | n2=en:no evidence of intrauterine or perinatal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no evidence of prenatal infection
n1=Mycose | n2=en:no evidence of prenatal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no immune defects reported
n1=Mycose | n2=en:no immune defects reported | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no immunodeficiency
n1=Mycose | n2=en:no immunodeficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no immunologic abnormalities
n1=Mycose | n2=en:no immunologic abnormalities | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no response to pneumococcal vaccination
n1=Mycose | n2=en:no response to pneumococcal vaccination | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:no severe viral infections
n1=Mycose | n2=en:no severe viral infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:non-caseating granulomas (bone marrow and lymph nodes)
n1=Mycose | n2=en:non-caseating granulomas (bone marrow and lymph nodes) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:non-gonococcal urethritis
n1=Mycose | n2=en:non-gonococcal urethritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:non-malignant mixed lymphohistiocytic infiltration of the reticuloendothelial system
n1=Mycose | n2=en:non-malignant mixed lymphohistiocytic infiltration of the reticuloendothelial system | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:non-neoplastic skin disorder
n1=Mycose | n2=en:non-neoplastic skin disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:non-scarring alopecia
n1=Mycose | n2=en:non-scarring alopecia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:non-specific cutaneous reaction in hodgkin's disease
n1=Mycose | n2=en:non-specific cutaneous reaction in hodgkin's disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:non-union of ankle joint with infection
n1=Mycose | n2=en:non-union of ankle joint with infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:non-union of joint of foot with infection
n1=Mycose | n2=en:non-union of joint of foot with infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal activity of natural killer cells
n1=Mycose | n2=en:normal activity of natural killer cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal b cell function
n1=Mycose | n2=en:normal b cell function | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal b cells
n1=Mycose | n2=en:normal b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal b-cell (cd19+) count
n1=Mycose | n2=en:normal b-cell (cd19+) count | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal b-cell count
n1=Mycose | n2=en:normal b-cell count | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal cell mediated immunity
n1=Mycose | n2=en:normal cell mediated immunity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal igg, iga, igm, ige levels
n1=Mycose | n2=en:normal igg, iga, igm, ige levels | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal levels of igm, iga, and igg
n1=Mycose | n2=en:normal levels of igm, iga, and igg | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal lymphocyte response to pokeweed mitogen and conconavalin a
n1=Mycose | n2=en:normal lymphocyte response to pokeweed mitogen and conconavalin a | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal nk cells
n1=Mycose | n2=en:normal nk cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal number of b cells
n1=Mycose | n2=en:normal number of b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal number of circulating lymphocytes
n1=Mycose | n2=en:normal number of circulating lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal number of natural killer cells
n1=Mycose | n2=en:normal number of natural killer cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal number of t cells
n1=Mycose | n2=en:normal number of t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal numbers and function of t cells
n1=Mycose | n2=en:normal numbers and function of t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal numbers of absolute b cells
n1=Mycose | n2=en:normal numbers of absolute b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal numbers of b cells
n1=Mycose | n2=en:normal numbers of b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal numbers of cd19+ b-lymphocytes
n1=Mycose | n2=en:normal numbers of cd19+ b-lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal numbers of cd56+ natural killer cells
n1=Mycose | n2=en:normal numbers of cd56+ natural killer cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal numbers of circulating t cells
n1=Mycose | n2=en:normal numbers of circulating t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal numbers of lymphocytes
n1=Mycose | n2=en:normal numbers of lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal numbers of lymphocytes and nk cells
n1=Mycose | n2=en:normal numbers of lymphocytes and nk cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal numbers of t and b cells
n1=Mycose | n2=en:normal numbers of t and b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal or decreased numbers of circulating b cells
n1=Mycose | n2=en:normal or decreased numbers of circulating b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal or elevated lymphocytes
n1=Mycose | n2=en:normal or elevated lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal or elevated number of peripheral blood b cells
n1=Mycose | n2=en:normal or elevated number of peripheral blood b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal or elevated numbers of functional natural killer cells (nk)
n1=Mycose | n2=en:normal or elevated numbers of functional natural killer cells (nk) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal or increased igm
n1=Mycose | n2=en:normal or increased igm | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal or increased numbers of b cells
n1=Mycose | n2=en:normal or increased numbers of b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal or increased numbers of transitional b cells
n1=Mycose | n2=en:normal or increased numbers of transitional b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal or reduced numbers of b cells
n1=Mycose | n2=en:normal or reduced numbers of b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal response to bacterial antigens
n1=Mycose | n2=en:normal response to bacterial antigens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal serum immunoglobulin levels
n1=Mycose | n2=en:normal serum immunoglobulin levels | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal t cells
n1=Mycose | n2=en:normal t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal t-cell numbers
n1=Mycose | n2=en:normal t-cell numbers | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal thymus
n1=Mycose | n2=en:normal thymus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal titers to t cell-dependent vaccines
n1=Mycose | n2=en:normal titers to t cell-dependent vaccines | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal to elevated igg
n1=Mycose | n2=en:normal to elevated igg | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:normal-elevated igm
n1=Mycose | n2=en:normal-elevated igm | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:norovirus infections
n1=Mycose | n2=en:norovirus infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:nosocomial infection
n1=Mycose | n2=en:nosocomial infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:nursing therapy
n1=Mycose | n2=en:nursing therapy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:nut hypersensitivity
n1=Mycose | n2=en:nut hypersensitivity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:nutritional management
n1=Mycose | n2=en:nutritional management | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:obstetric breast infections
n1=Mycose | n2=en:obstetric breast infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:odontogenic infection of jaw
n1=Mycose | n2=en:odontogenic infection of jaw | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:often an infecting organism cannot be identified
n1=Mycose | n2=en:often an infecting organism cannot be identified | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:onychomycosis
n1=Mycose | n2=en:onychomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:opportunistic infection
n1=Mycose | n2=en:opportunistic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:opportunistic infections (cmv, pneumocystis, candida)
n1=Mycose | n2=en:opportunistic infections (cmv, pneumocystis, candida) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:opportunistic infections include nocardia asteroides and mycobacterium avium complex
n1=Mycose | n2=en:opportunistic infections include nocardia asteroides and mycobacterium avium complex | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:opportunistic mycosis
n1=Mycose | n2=en:opportunistic mycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:oral candidiasis
n1=Mycose | n2=en:oral candidiasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:oral fungal infection
n1=Mycose | n2=en:oral fungal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:oropharyngitis fungal
n1=Mycose | n2=en:oropharyngitis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:osseous cryptococcosis
n1=Mycose | n2=en:osseous cryptococcosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:osteomyelitis
n1=Mycose | n2=en:osteomyelitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:osteomyelitis fungal
n1=Mycose | n2=en:osteomyelitis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other and unspecified infectious and parasitic diseases
n1=Mycose | n2=en:other and unspecified infectious and parasitic diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other and unspecified mycoses
n1=Mycose | n2=en:other and unspecified mycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other and unspecified superficial injury of other, multiple, and unspecified sites, infected
n1=Mycose | n2=en:other and unspecified superficial injury of other, multiple, and unspecified sites, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other bacterial diseases
n1=Mycose | n2=en:other bacterial diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other dermatophytoses
n1=Mycose | n2=en:other dermatophytoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other dermatoses
n1=Mycose | n2=en:other dermatoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other diseases caused by chlamydiae
n1=Mycose | n2=en:other diseases caused by chlamydiae | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other diseases due to viruses and chlamydiae
n1=Mycose | n2=en:other diseases due to viruses and chlamydiae | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other disorders of the skin and subcutaneous tissue
n1=Mycose | n2=en:other disorders of the skin and subcutaneous tissue | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other forms of aspergillosis
n1=Mycose | n2=en:other forms of aspergillosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other forms of blastomycosis
n1=Mycose | n2=en:other forms of blastomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other forms of chromomycosis
n1=Mycose | n2=en:other forms of chromomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other forms of coccidioidomycosis
n1=Mycose | n2=en:other forms of coccidioidomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other forms of cryptococcosis
n1=Mycose | n2=en:other forms of cryptococcosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other forms of paracoccidioidomycosis
n1=Mycose | n2=en:other forms of paracoccidioidomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other forms of sporotrichosis
n1=Mycose | n2=en:other forms of sporotrichosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other human herpesvirus
n1=Mycose | n2=en:other human herpesvirus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other infection due to medical care, nec in mdr
n1=Mycose | n2=en:other infection due to medical care, nec in mdr | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other infections; including parasitic
n1=Mycose | n2=en:other infections; including parasitic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other infectious diseases
n1=Mycose | n2=en:other infectious diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium
n1=Mycose | n2=en:other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other mycoses
n1=Mycose | n2=en:other mycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other mycoses, not elsewhere classified
n1=Mycose | n2=en:other mycoses, not elsewhere classified | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other pulmonary aspergillosis
n1=Mycose | n2=en:other pulmonary aspergillosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other skin disorders
n1=Mycose | n2=en:other skin disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other spec infect and parasit diseases of mother, comp preg, c/birth, or the puerp, unspec as to eoc
n1=Mycose | n2=en:other spec infect and parasit diseases of mother, comp preg, c/birth, or the puerp, unspec as to eoc | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other specified conditions of integument specific to fetus and newborn
n1=Mycose | n2=en:other specified conditions of integument specific to fetus and newborn | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other specified dermatoses
n1=Mycose | n2=en:other specified dermatoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other specified disorders of skin
n1=Mycose | n2=en:other specified disorders of skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other specified infectious and parasitic diseases
n1=Mycose | n2=en:other specified infectious and parasitic diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other specified infectious and parasitic diseases of mother, antepartum condition or complication
n1=Mycose | n2=en:other specified infectious and parasitic diseases of mother, antepartum condition or complication | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other specified infectious and parasitic diseases of mother, complicating pregnancy, childbirth, or
n1=Mycose | n2=en:other specified infectious and parasitic diseases of mother, complicating pregnancy, childbirth, or | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other specified infectious and parasitic diseases of mother, delivered, with mention of postpartum complication
n1=Mycose | n2=en:other specified infectious and parasitic diseases of mother, delivered, with mention of postpartum complication | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other specified infectious and parasitic diseases of mother, delivered, with or without mention of antepartum condition
n1=Mycose | n2=en:other specified infectious and parasitic diseases of mother, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other specified infectious and parasitic diseases of mother, postpartum condition or complication
n1=Mycose | n2=en:other specified infectious and parasitic diseases of mother, postpartum condition or complication | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other specified mycoses
n1=Mycose | n2=en:other specified mycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other specified superficial mycoses
n1=Mycose | n2=en:other specified superficial mycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other spirochaetal diseases
n1=Mycose | n2=en:other spirochaetal diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other superficial mycoses
n1=Mycose | n2=en:other superficial mycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other symptoms involving skin and integumentary tissues
n1=Mycose | n2=en:other symptoms involving skin and integumentary tissues | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other urogenital candidiasis
n1=Mycose | n2=en:other urogenital candidiasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other viral diseases
n1=Mycose | n2=en:other viral diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:other zygomycoses
n1=Mycose | n2=en:other zygomycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:otitis externa
n1=Mycose | n2=en:otitis externa | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:otitis media
n1=Mycose | n2=en:otitis media | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:otitis media fungal
n1=Mycose | n2=en:otitis media fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:otogenic intracranial abscess
n1=Mycose | n2=en:otogenic intracranial abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:otomycosis
n1=Mycose | n2=en:otomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:overdose
n1=Mycose | n2=en:overdose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:overdose accidental
n1=Mycose | n2=en:overdose accidental | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:overgrowth fungal
n1=Mycose | n2=en:overgrowth fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:overproduction by t lymphocytes and macrophages of cytokines, particularly interferon gamma and tumor necrosis factor alpha
n1=Mycose | n2=en:overproduction by t lymphocytes and macrophages of cytokines, particularly interferon gamma and tumor necrosis factor alpha | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pain
n1=Mycose | n2=en:pain | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pancreatitis fungal
n1=Mycose | n2=en:pancreatitis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:panniculitis
n1=Mycose | n2=en:panniculitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:papillomavirus infections
n1=Mycose | n2=en:papillomavirus infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:papular purpuric gloves and socks syndrome
n1=Mycose | n2=en:papular purpuric gloves and socks syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:papulonodular disease of skin
n1=Mycose | n2=en:papulonodular disease of skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:paracoccidioidomycosis
n1=Mycose | n2=en:paracoccidioidomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:parasitic diseases
n1=Mycose | n2=en:parasitic diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:parasitic infection
n1=Mycose | n2=en:parasitic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:parasitology
n1=Mycose | n2=en:parasitology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:partial t-cell lymphopenia
n1=Mycose | n2=en:partial t-cell lymphopenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:partially defective antibody production
n1=Mycose | n2=en:partially defective antibody production | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pathological aspects
n1=Mycose | n2=en:pathological aspects | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:patient problem codes fda cdrh
n1=Mycose | n2=en:patient problem codes fda cdrh | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pattern bruising
n1=Mycose | n2=en:pattern bruising | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:paucity of lymphoid tissue
n1=Mycose | n2=en:paucity of lymphoid tissue | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pediatric infectious disease terminology
n1=Mycose | n2=en:pediatric infectious disease terminology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pediatric infectious disorder
n1=Mycose | n2=en:pediatric infectious disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pediatric terminology
n1=Mycose | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pediculosis, acariasis and other infestations
n1=Mycose | n2=en:pediculosis, acariasis and other infestations | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pelvic infection
n1=Mycose | n2=en:pelvic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pelvic inflammatory disease
n1=Mycose | n2=en:pelvic inflammatory disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pemphigus
n1=Mycose | n2=en:pemphigus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:penicillium infection
n1=Mycose | n2=en:penicillium infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:penicillosis
n1=Mycose | n2=en:penicillosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:perinatal cutaneous hemorrhage
n1=Mycose | n2=en:perinatal cutaneous hemorrhage | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:perinatal disorder
n1=Mycose | n2=en:perinatal disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:periodontal abscess
n1=Mycose | n2=en:periodontal abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:peripheral lymphopenia
n1=Mycose | n2=en:peripheral lymphopenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:perirectal abscess
n1=Mycose | n2=en:perirectal abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:peristomal skin complication
n1=Mycose | n2=en:peristomal skin complication | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:peroneal alopecia
n1=Mycose | n2=en:peroneal alopecia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:persistent acantholytic dermatosis of fawcett and miller
n1=Mycose | n2=en:persistent acantholytic dermatosis of fawcett and miller | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:persistent infection
n1=Mycose | n2=en:persistent infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:petrous apicitis
n1=Mycose | n2=en:petrous apicitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:phaeohyphomycosis
n1=Mycose | n2=en:phaeohyphomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:phaeohyphomycosis of skin
n1=Mycose | n2=en:phaeohyphomycosis of skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pharmacotherapeutic
n1=Mycose | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pheohyphomycotic brain abscess
n1=Mycose | n2=en:pheohyphomycotic brain abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:photosensitive dermatitis
n1=Mycose | n2=en:photosensitive dermatitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:photosensitivity disorders
n1=Mycose | n2=en:photosensitivity disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:physiopathological
n1=Mycose | n2=en:physiopathological | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:piedra
n1=Mycose | n2=en:piedra | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:piedra, white
n1=Mycose | n2=en:piedra, white | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:piercing and tattoos
n1=Mycose | n2=en:piercing and tattoos | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pigment changes
n1=Mycose | n2=en:pigment changes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pigmented purpuric eruption
n1=Mycose | n2=en:pigmented purpuric eruption | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pili annulati
n1=Mycose | n2=en:pili annulati | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pilonidal disease
n1=Mycose | n2=en:pilonidal disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pilonidal sinus with abscess
n1=Mycose | n2=en:pilonidal sinus with abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:plague
n1=Mycose | n2=en:plague | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pneumococcal infections
n1=Mycose | n2=en:pneumococcal infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pneumocystis infections
n1=Mycose | n2=en:pneumocystis infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pneumocystis pneumonia
n1=Mycose | n2=en:pneumocystis pneumonia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pneumonia
n1=Mycose | n2=en:pneumonia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:poikiloderma, hereditary sclerosing
n1=Mycose | n2=en:poikiloderma, hereditary sclerosing | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:poison ivy, oak and sumac
n1=Mycose | n2=en:poison ivy, oak and sumac | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:polio and post-polio syndrome
n1=Mycose | n2=en:polio and post-polio syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:poliomyelitis and other non-arthropod-borne viral diseases and prion diseases of central nervous system
n1=Mycose | n2=en:poliomyelitis and other non-arthropod-borne viral diseases and prion diseases of central nervous system | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:polyclonal b-cell lymphocytosis
n1=Mycose | n2=en:polyclonal b-cell lymphocytosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:polymorphic b cell lymphoproliferation
n1=Mycose | n2=en:polymorphic b cell lymphoproliferation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:polymorphonuclear leukocytosis, episodic
n1=Mycose | n2=en:polymorphonuclear leukocytosis, episodic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:polymyalgia rheumatica
n1=Mycose | n2=en:polymyalgia rheumatica | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:polysaccharide antibody response defect
n1=Mycose | n2=en:polysaccharide antibody response defect | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:poor adhesion related functions, such as adhesion to endothelial cells, chemotaxis, and antibody-dependent cellular cytotoxicity
n1=Mycose | n2=en:poor adhesion related functions, such as adhesion to endothelial cells, chemotaxis, and antibody-dependent cellular cytotoxicity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:poor antibody response
n1=Mycose | n2=en:poor antibody response | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:poor differentiation and proliferation of b and t cells
n1=Mycose | n2=en:poor differentiation and proliferation of b and t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:poor production of certain cytokines (il-12, gamma-interferon, il-10, il-6, tnf-alpha) after stimulation
n1=Mycose | n2=en:poor production of certain cytokines (il-12, gamma-interferon, il-10, il-6, tnf-alpha) after stimulation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:poor proliferative response of t lymphocytes to specific antigens
n1=Mycose | n2=en:poor proliferative response of t lymphocytes to specific antigens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:poor t-cell mitogen response
n1=Mycose | n2=en:poor t-cell mitogen response | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:porphyria
n1=Mycose | n2=en:porphyria | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:porphyria cutanea tarda
n1=Mycose | n2=en:porphyria cutanea tarda | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:positive anti-nucleus antibodies
n1=Mycose | n2=en:positive anti-nucleus antibodies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:positive antinuclear autoantibodies
n1=Mycose | n2=en:positive antinuclear autoantibodies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:post vaccination syndrome
n1=Mycose | n2=en:post vaccination syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:post-vaccination varicella (in 1 patient)
n1=Mycose | n2=en:post-vaccination varicella (in 1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:postprocedural intra-abdominal sepsis
n1=Mycose | n2=en:postprocedural intra-abdominal sepsis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:precipitated by infection (influenza a, influenza b, mycoplasma, hhv6)
n1=Mycose | n2=en:precipitated by infection (influenza a, influenza b, mycoplasma, hhv6) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone
n1=Mycose | n2=en:prednisolone | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 1.2 mg/ml ophthalmic suspension
n1=Mycose | n2=en:prednisolone 1.2 mg/ml ophthalmic suspension | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 100 mg/ml injectable suspension
n1=Mycose | n2=en:prednisolone 100 mg/ml injectable suspension | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 10mg orally disintegrating tablet
n1=Mycose | n2=en:prednisolone 10mg orally disintegrating tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 10mg/5ml oral solution
n1=Mycose | n2=en:prednisolone 10mg/5ml oral solution | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 15mg orally disintegrating tablet
n1=Mycose | n2=en:prednisolone 15mg orally disintegrating tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 15mg/5ml syrup
n1=Mycose | n2=en:prednisolone 15mg/5ml syrup | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 2.5 mg/ml ophthalmic suspension
n1=Mycose | n2=en:prednisolone 2.5 mg/ml ophthalmic suspension | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 20 mg/ml injectable suspension
n1=Mycose | n2=en:prednisolone 20 mg/ml injectable suspension | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 30mg orally disintegrating tablet
n1=Mycose | n2=en:prednisolone 30mg orally disintegrating tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 4 mg/ml oral solution
n1=Mycose | n2=en:prednisolone 4 mg/ml oral solution | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 40 mg/ml injectable solution
n1=Mycose | n2=en:prednisolone 40 mg/ml injectable solution | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 5 mg oral tablet, 48 tablet pack
n1=Mycose | n2=en:prednisolone 5 mg oral tablet, 48 tablet pack | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 5mg tablet
n1=Mycose | n2=en:prednisolone 5mg tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone 5mg/5ml syrup
n1=Mycose | n2=en:prednisolone 5mg/5ml syrup | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone acetate
n1=Mycose | n2=en:prednisolone acetate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone acetate 0.125% suspension
n1=Mycose | n2=en:prednisolone acetate 0.125% suspension | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone acetate 1% eye drops
n1=Mycose | n2=en:prednisolone acetate 1% eye drops | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone acetate 1% suspension
n1=Mycose | n2=en:prednisolone acetate 1% suspension | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone acetate 25mg/ml injection suspension 1ml ampule
n1=Mycose | n2=en:prednisolone acetate 25mg/ml injection suspension 1ml ampule | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone acetate 50mg/ml injection suspension 10ml vial
n1=Mycose | n2=en:prednisolone acetate 50mg/ml injection suspension 10ml vial | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone acetate pwdr
n1=Mycose | n2=en:prednisolone acetate pwdr | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone pwdr
n1=Mycose | n2=en:prednisolone pwdr | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone sodium phosphate
n1=Mycose | n2=en:prednisolone sodium phosphate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone sodium phosphate 0.5% single-use eye drops
n1=Mycose | n2=en:prednisolone sodium phosphate 0.5% single-use eye drops | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone sodium phosphate 1/8% solution
n1=Mycose | n2=en:prednisolone sodium phosphate 1/8% solution | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone sodium phosphate 20mg/ml injection solution 10ml vial
n1=Mycose | n2=en:prednisolone sodium phosphate 20mg/ml injection solution 10ml vial | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisolone tebutate
n1=Mycose | n2=en:prednisolone tebutate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone
n1=Mycose | n2=en:prednisone | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 1 mg delayed release oral tablet
n1=Mycose | n2=en:prednisone 1 mg delayed release oral tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 1 mg oral tablet
n1=Mycose | n2=en:prednisone 1 mg oral tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 1 mg/ml oral solution
n1=Mycose | n2=en:prednisone 1 mg/ml oral solution | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 10mg oral tablet and 10, 21 and 48 tablet packs
n1=Mycose | n2=en:prednisone 10mg oral tablet and 10, 21 and 48 tablet packs | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 2 mg delayed release oral tablet
n1=Mycose | n2=en:prednisone 2 mg delayed release oral tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 2.5mg tablet
n1=Mycose | n2=en:prednisone 2.5mg tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 20mg tablet
n1=Mycose | n2=en:prednisone 20mg tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 25 mg oral tablet
n1=Mycose | n2=en:prednisone 25 mg oral tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 5 mg delayed release oral tablet
n1=Mycose | n2=en:prednisone 5 mg delayed release oral tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 5 mg oral tablet
n1=Mycose | n2=en:prednisone 5 mg oral tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 5 mg/ml oral solution
n1=Mycose | n2=en:prednisone 5 mg/ml oral solution | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone 50mg tablet
n1=Mycose | n2=en:prednisone 50mg tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prednisone pwdr
n1=Mycose | n2=en:prednisone pwdr | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pregnancy complications, infectious
n1=Mycose | n2=en:pregnancy complications, infectious | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pregnancy immunology
n1=Mycose | n2=en:pregnancy immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:premature aging syndrome
n1=Mycose | n2=en:premature aging syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:premature alopecia
n1=Mycose | n2=en:premature alopecia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prematurely aged appearance
n1=Mycose | n2=en:prematurely aged appearance | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:presence of c3 nephritic factor autoantibody
n1=Mycose | n2=en:presence of c3 nephritic factor autoantibody | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:present but small tonsils
n1=Mycose | n2=en:present but small tonsils | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pressure sore
n1=Mycose | n2=en:pressure sore | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:primary combined immunodeficiency (1 patient)
n1=Mycose | n2=en:primary combined immunodeficiency (1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:primary dysfunction of b-lymphocyte isotype switching and memory b-cell generation
n1=Mycose | n2=en:primary dysfunction of b-lymphocyte isotype switching and memory b-cell generation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:primary immune deficiency disorder
n1=Mycose | n2=en:primary immune deficiency disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:primary infection nos
n1=Mycose | n2=en:primary infection nos | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:primary non-thrombocytopenic purpura
n1=Mycose | n2=en:primary non-thrombocytopenic purpura | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:primary pulmonary coccidioidomycosis
n1=Mycose | n2=en:primary pulmonary coccidioidomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:proctitis fungal
n1=Mycose | n2=en:proctitis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:progressive keratoderma tylodes
n1=Mycose | n2=en:progressive keratoderma tylodes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:properdin deficiency, x-linked
n1=Mycose | n2=en:properdin deficiency, x-linked | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prostatic coccidioidomycosis
n1=Mycose | n2=en:prostatic coccidioidomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prosthesis-related infection
n1=Mycose | n2=en:prosthesis-related infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:protozoal infection
n1=Mycose | n2=en:protozoal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:protozoal infestation of skin
n1=Mycose | n2=en:protozoal infestation of skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:prurigo
n1=Mycose | n2=en:prurigo | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pruritic disorder
n1=Mycose | n2=en:pruritic disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pruritus
n1=Mycose | n2=en:pruritus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pseudallescheria infections
n1=Mycose | n2=en:pseudallescheria infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pseudoepitheliomatous hyperplasia
n1=Mycose | n2=en:pseudoepitheliomatous hyperplasia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pseudomonas infections
n1=Mycose | n2=en:pseudomonas infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pseudomonas septicemia with skin involvement
n1=Mycose | n2=en:pseudomonas septicemia with skin involvement | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:psoriasis
n1=Mycose | n2=en:psoriasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:psychogenic pruritus
n1=Mycose | n2=en:psychogenic pruritus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:psychology qualifier
n1=Mycose | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:psychoneuroimmunology
n1=Mycose | n2=en:psychoneuroimmunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:puerperal infection
n1=Mycose | n2=en:puerperal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pulmonary blastomycosis
n1=Mycose | n2=en:pulmonary blastomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pulmonary mucormycosis
n1=Mycose | n2=en:pulmonary mucormycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pulmonary paracoccidioidomycosis
n1=Mycose | n2=en:pulmonary paracoccidioidomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pulmonary sporotrichosis
n1=Mycose | n2=en:pulmonary sporotrichosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pulmonary trichosporonosis
n1=Mycose | n2=en:pulmonary trichosporonosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pulmonary tuberculosis aggravated
n1=Mycose | n2=en:pulmonary tuberculosis aggravated | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pulmonary tuberculosis reactivated
n1=Mycose | n2=en:pulmonary tuberculosis reactivated | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:purulent drainage from external ear canal
n1=Mycose | n2=en:purulent drainage from external ear canal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:purulent enteritis
n1=Mycose | n2=en:purulent enteritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:purulent nasal discharge
n1=Mycose | n2=en:purulent nasal discharge | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:purulent nipple discharge
n1=Mycose | n2=en:purulent nipple discharge | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pyelonephritis
n1=Mycose | n2=en:pyelonephritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pyelonephritis fungal
n1=Mycose | n2=en:pyelonephritis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pyoderma
n1=Mycose | n2=en:pyoderma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pyogenic metastatic scleritis
n1=Mycose | n2=en:pyogenic metastatic scleritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pyometra
n1=Mycose | n2=en:pyometra | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pyonephrosis
n1=Mycose | n2=en:pyonephrosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pyothorax
n1=Mycose | n2=en:pyothorax | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pyrogenic infection
n1=Mycose | n2=en:pyrogenic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pythiosis
n1=Mycose | n2=en:pythiosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:pyuria
n1=Mycose | n2=en:pyuria | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:qualitative abnormality of granulocyte
n1=Mycose | n2=en:qualitative abnormality of granulocyte | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rabies
n1=Mycose | n2=en:rabies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:radiation damage
n1=Mycose | n2=en:radiation damage | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:radiotherapeutic
n1=Mycose | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reaction aggravation
n1=Mycose | n2=en:reaction aggravation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent bacterial and viral infections
n1=Mycose | n2=en:recurrent bacterial and viral infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent bacterial infection
n1=Mycose | n2=en:recurrent bacterial infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent bacterial skin infections
n1=Mycose | n2=en:recurrent bacterial skin infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent bacterial, viral, and fungal infections
n1=Mycose | n2=en:recurrent bacterial, viral, and fungal infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent candida infections
n1=Mycose | n2=en:recurrent candida infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent candidal infections
n1=Mycose | n2=en:recurrent candidal infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent cutaneous and systemic pyogenic infections
n1=Mycose | n2=en:recurrent cutaneous and systemic pyogenic infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent cutaneous mycoses
n1=Mycose | n2=en:recurrent cutaneous mycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent febrile illnesses
n1=Mycose | n2=en:recurrent febrile illnesses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent fevers
n1=Mycose | n2=en:recurrent fevers | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent fungal infections
n1=Mycose | n2=en:recurrent fungal infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections
n1=Mycose | n2=en:recurrent infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections (1 patient)
n1=Mycose | n2=en:recurrent infections (1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections (in severe cases)
n1=Mycose | n2=en:recurrent infections (in severe cases) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections (in some patients)
n1=Mycose | n2=en:recurrent infections (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections (increased susceptibility to mycobacterial infection after bcg immunization)
n1=Mycose | n2=en:recurrent infections (increased susceptibility to mycobacterial infection after bcg immunization) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections (pneumonia, sinusitis, fulminant varicella)
n1=Mycose | n2=en:recurrent infections (pneumonia, sinusitis, fulminant varicella) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections (pulmonary, skin, teeth)
n1=Mycose | n2=en:recurrent infections (pulmonary, skin, teeth) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections (sinusitis and bacterial pneumonia and meningitis)
n1=Mycose | n2=en:recurrent infections (sinusitis and bacterial pneumonia and meningitis) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections at variable sites (sinusitis, otitis media, facial cellulitis, adenitis, blepharitis, conjunctivitis, gastroenteritis)
n1=Mycose | n2=en:recurrent infections at variable sites (sinusitis, otitis media, facial cellulitis, adenitis, blepharitis, conjunctivitis, gastroenteritis) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections due to ciliary dysfunction
n1=Mycose | n2=en:recurrent infections due to ciliary dysfunction | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections in infancy and early childhood
n1=Mycose | n2=en:recurrent infections in infancy and early childhood | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections of mucosal surfaces
n1=Mycose | n2=en:recurrent infections of mucosal surfaces | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections, bacterial and fungal
n1=Mycose | n2=en:recurrent infections, bacterial and fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections, bacterial, viral, fungal, myobacterial
n1=Mycose | n2=en:recurrent infections, bacterial, viral, fungal, myobacterial | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections, particularly herpes viral
n1=Mycose | n2=en:recurrent infections, particularly herpes viral | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent infections, particularly to viruses and fungi
n1=Mycose | n2=en:recurrent infections, particularly to viruses and fungi | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent meningococcal disease
n1=Mycose | n2=en:recurrent meningococcal disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent mycobacterial disease (bcg and m. tuberculosis)
n1=Mycose | n2=en:recurrent mycobacterial disease (bcg and m. tuberculosis) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent neisserial infections
n1=Mycose | n2=en:recurrent neisserial infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent opportunistic infections
n1=Mycose | n2=en:recurrent opportunistic infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent respiratory infections
n1=Mycose | n2=en:recurrent respiratory infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent severe and invasive bacterial infections
n1=Mycose | n2=en:recurrent severe and invasive bacterial infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent severe infections
n1=Mycose | n2=en:recurrent severe infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent sinopulmonary infections
n1=Mycose | n2=en:recurrent sinopulmonary infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent skin and respiratory infections
n1=Mycose | n2=en:recurrent skin and respiratory infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent staphylococcal and gram-negative infections
n1=Mycose | n2=en:recurrent staphylococcal and gram-negative infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent staphylococcus aureus infections
n1=Mycose | n2=en:recurrent staphylococcus aureus infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent upper respiratory tract infection
n1=Mycose | n2=en:recurrent upper respiratory tract infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:recurrent viral infections
n1=Mycose | n2=en:recurrent viral infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced cd3 t-lymphocyte counts
n1=Mycose | n2=en:reduced cd3 t-lymphocyte counts | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced cd3+, cd4+, and cd8+ t-lymphocytes
n1=Mycose | n2=en:reduced cd3+, cd4+, and cd8+ t-lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced cd4 t-lymphocyte counts
n1=Mycose | n2=en:reduced cd4 t-lymphocyte counts | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced cd4+ t cells
n1=Mycose | n2=en:reduced cd4+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced cd4+/cd8+ ratio with cd8+ predominance
n1=Mycose | n2=en:reduced cd4+/cd8+ ratio with cd8+ predominance | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced delayed hypersensitivity
n1=Mycose | n2=en:reduced delayed hypersensitivity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced levels of cells with igm receptors
n1=Mycose | n2=en:reduced levels of cells with igm receptors | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced natural killer cell activity
n1=Mycose | n2=en:reduced natural killer cell activity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced natural killer cell cytotoxicity
n1=Mycose | n2=en:reduced natural killer cell cytotoxicity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced natural killer cell number
n1=Mycose | n2=en:reduced natural killer cell number | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced number of ct4+ t cells (in some patients)
n1=Mycose | n2=en:reduced number of ct4+ t cells (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced number of naive t cells (in some patients)
n1=Mycose | n2=en:reduced number of naive t cells (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced numbers of memory b cells
n1=Mycose | n2=en:reduced numbers of memory b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced production of interleukin 2 by mitogen stimulated blood lymphocytes
n1=Mycose | n2=en:reduced production of interleukin 2 by mitogen stimulated blood lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced t cell cytotoxicity
n1=Mycose | n2=en:reduced t cell cytotoxicity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduced/absent cd3+ t cells
n1=Mycose | n2=en:reduced/absent cd3+ t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reduction of mature b cells
n1=Mycose | n2=en:reduction of mature b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rehabilitation aspects
n1=Mycose | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:relative t-cell anergy
n1=Mycose | n2=en:relative t-cell anergy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:relatively increased number of natural killer cells
n1=Mycose | n2=en:relatively increased number of natural killer cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:remnant hyperlipidemia
n1=Mycose | n2=en:remnant hyperlipidemia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:renal abscess
n1=Mycose | n2=en:renal abscess | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:repeated invasive infections
n1=Mycose | n2=en:repeated invasive infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reproductive system infection
n1=Mycose | n2=en:reproductive system infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:reproductive tract infection
n1=Mycose | n2=en:reproductive tract infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:residual rag1 and rag2 activity
n1=Mycose | n2=en:residual rag1 and rag2 activity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:respiratory syncytial virus infection
n1=Mycose | n2=en:respiratory syncytial virus infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:respiratory tract infection fungal
n1=Mycose | n2=en:respiratory tract infection fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:respiratory tract infections
n1=Mycose | n2=en:respiratory tract infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rhinocerebral mucormycosis
n1=Mycose | n2=en:rhinocerebral mucormycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rhinosporidia infections
n1=Mycose | n2=en:rhinosporidia infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rhinosporidiosis
n1=Mycose | n2=en:rhinosporidiosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rickettsioses and other arthropod-borne diseases
n1=Mycose | n2=en:rickettsioses and other arthropod-borne diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rickettsiosis
n1=Mycose | n2=en:rickettsiosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rodent-borne hemorrhagic fever
n1=Mycose | n2=en:rodent-borne hemorrhagic fever | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:roentgenographic
n1=Mycose | n2=en:roentgenographic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rosacea
n1=Mycose | n2=en:rosacea | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rosacea hypertrophica
n1=Mycose | n2=en:rosacea hypertrophica | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rosacea, erythematotelangiectatic
n1=Mycose | n2=en:rosacea, erythematotelangiectatic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rosacea, phymatous
n1=Mycose | n2=en:rosacea, phymatous | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ross syndrome
n1=Mycose | n2=en:ross syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rotavirus infections
n1=Mycose | n2=en:rotavirus infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:rubella infection
n1=Mycose | n2=en:rubella infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:salmonella infections
n1=Mycose | n2=en:salmonella infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sarcoma
n1=Mycose | n2=en:sarcoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:scabies
n1=Mycose | n2=en:scabies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:scalp dermatoses
n1=Mycose | n2=en:scalp dermatoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:scalp infection
n1=Mycose | n2=en:scalp infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:scar
n1=Mycose | n2=en:scar | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:scar conditions and fibrosis of skin
n1=Mycose | n2=en:scar conditions and fibrosis of skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:scedosporium infection
n1=Mycose | n2=en:scedosporium infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:scleredema adultorum
n1=Mycose | n2=en:scleredema adultorum | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:scleroderma
n1=Mycose | n2=en:scleroderma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sclerosing osteomyelitis
n1=Mycose | n2=en:sclerosing osteomyelitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:seasonal allergic rhinitis
n1=Mycose | n2=en:seasonal allergic rhinitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sebaceous gland diseases
n1=Mycose | n2=en:sebaceous gland diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:seborrhea corporis
n1=Mycose | n2=en:seborrhea corporis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:secondary infections
n1=Mycose | n2=en:secondary infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:secondary respiratory infections
n1=Mycose | n2=en:secondary respiratory infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:selective iga immunodeficiency
n1=Mycose | n2=en:selective iga immunodeficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:self-inflicted skin lesions
n1=Mycose | n2=en:self-inflicted skin lesions | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sepsis
n1=Mycose | n2=en:sepsis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sepsis due to fungus
n1=Mycose | n2=en:sepsis due to fungus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:septic thrombophlebitis
n1=Mycose | n2=en:septic thrombophlebitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:septic toxemia
n1=Mycose | n2=en:septic toxemia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:septicemia
n1=Mycose | n2=en:septicemia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sequelae of infectious and parasitic diseases
n1=Mycose | n2=en:sequelae of infectious and parasitic diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:serratia marcescens infection
n1=Mycose | n2=en:serratia marcescens infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:serum autoantibodies
n1=Mycose | n2=en:serum autoantibodies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:serum circulating immune complexes contain galactose-deficient iga1
n1=Mycose | n2=en:serum circulating immune complexes contain galactose-deficient iga1 | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:serum complement decreased
n1=Mycose | n2=en:serum complement decreased | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:serum iga, igg, and ige severely deficient
n1=Mycose | n2=en:serum iga, igg, and ige severely deficient | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:serum igg autoantibodies to granulocyte/macrophage colony-stimulating factor (gm-csf, csf2, 138960)
n1=Mycose | n2=en:serum igg autoantibodies to granulocyte/macrophage colony-stimulating factor (gm-csf, csf2, 138960) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:serum immunoglobulins may be absent, normal, or increased
n1=Mycose | n2=en:serum immunoglobulins may be absent, normal, or increased | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:severe acute respiratory syndrome
n1=Mycose | n2=en:severe acute respiratory syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:severe asthma with fungal sensitisation
n1=Mycose | n2=en:severe asthma with fungal sensitisation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:severe b lymphocytopenia
n1=Mycose | n2=en:severe b lymphocytopenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:severe combined immunodeficiency
n1=Mycose | n2=en:severe combined immunodeficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:severe enteroviral infections
n1=Mycose | n2=en:severe enteroviral infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:severe viral infections
n1=Mycose | n2=en:severe viral infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:severely reduced proliferative response to mitogens, antigens, and alloantigens
n1=Mycose | n2=en:severely reduced proliferative response to mitogens, antigens, and alloantigens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:severely reduced response to candida and tetanus toxoid antigens
n1=Mycose | n2=en:severely reduced response to candida and tetanus toxoid antigens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:severely reduced response to mitogens
n1=Mycose | n2=en:severely reduced response to mitogens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sexually transmitted disorder
n1=Mycose | n2=en:sexually transmitted disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:shock
n1=Mycose | n2=en:shock | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sinusitis
n1=Mycose | n2=en:sinusitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:site-specific disorder of skin
n1=Mycose | n2=en:site-specific disorder of skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sjogren syndrome
n1=Mycose | n2=en:sjogren syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin
n1=Mycose | n2=en:skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin aging
n1=Mycose | n2=en:skin aging | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin and subcutaneous tissue disorders
n1=Mycose | n2=en:skin and subcutaneous tissue disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin anergy to recall antigens
n1=Mycose | n2=en:skin anergy to recall antigens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin atrophy
n1=Mycose | n2=en:skin atrophy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin atrophy adverse event
n1=Mycose | n2=en:skin atrophy adverse event | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin changes due to malnutrition
n1=Mycose | n2=en:skin changes due to malnutrition | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin disease attributable to corticosteroid therapy
n1=Mycose | n2=en:skin disease attributable to corticosteroid therapy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin disease, vesicular
n1=Mycose | n2=en:skin disease, vesicular | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin diseases, eczematous
n1=Mycose | n2=en:skin diseases, eczematous | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin diseases, genetic
n1=Mycose | n2=en:skin diseases, genetic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin diseases, metabolic
n1=Mycose | n2=en:skin diseases, metabolic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin diseases, papulosquamous
n1=Mycose | n2=en:skin diseases, papulosquamous | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin diseases, parasitic
n1=Mycose | n2=en:skin diseases, parasitic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin diseases, vesiculobullous
n1=Mycose | n2=en:skin diseases, vesiculobullous | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin disorder
n1=Mycose | n2=en:skin disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin disorder associated with aids
n1=Mycose | n2=en:skin disorder associated with aids | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin disorder due to phototherapy
n1=Mycose | n2=en:skin disorder due to phototherapy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin disorder due to physical agent and/or foreign substance
n1=Mycose | n2=en:skin disorder due to physical agent and/or foreign substance | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin disorders: severe generalized
n1=Mycose | n2=en:skin disorders: severe generalized | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin endocrine disorder
n1=Mycose | n2=en:skin endocrine disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin foreign body
n1=Mycose | n2=en:skin foreign body | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin graft disorder
n1=Mycose | n2=en:skin graft disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin histology
n1=Mycose | n2=en:skin histology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin hyperplasia
n1=Mycose | n2=en:skin hyperplasia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin infection
n1=Mycose | n2=en:skin infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin infection/inflammation
n1=Mycose | n2=en:skin infection/inflammation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin injury
n1=Mycose | n2=en:skin injury | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin irritation
n1=Mycose | n2=en:skin irritation | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin neoplasm
n1=Mycose | n2=en:skin neoplasm | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin pigmentation disorder
n1=Mycose | n2=en:skin pigmentation disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin rash
n1=Mycose | n2=en:skin rash | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin retraction
n1=Mycose | n2=en:skin retraction | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin scar
n1=Mycose | n2=en:skin scar | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin ulcer
n1=Mycose | n2=en:skin ulcer | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin vascular disorder
n1=Mycose | n2=en:skin vascular disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin vegetations
n1=Mycose | n2=en:skin vegetations | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:skin, hair and nails
n1=Mycose | n2=en:skin, hair and nails | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:slightly reduced neutrophil adherence
n1=Mycose | n2=en:slightly reduced neutrophil adherence | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:small lymph nodes
n1=Mycose | n2=en:small lymph nodes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:small lymph nodes, which lack paracortical regions
n1=Mycose | n2=en:small lymph nodes, which lack paracortical regions | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:small or absent thymus, which contains poorly formed hassal corpuscles
n1=Mycose | n2=en:small or absent thymus, which contains poorly formed hassal corpuscles | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:smallpox
n1=Mycose | n2=en:smallpox | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:soft tissue infection
n1=Mycose | n2=en:soft tissue infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:some patients may have autoantibodies to factor h, resulting in functional factor h deficiency
n1=Mycose | n2=en:some patients may have autoantibodies to factor h, resulting in functional factor h deficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:specific antibody production very poor
n1=Mycose | n2=en:specific antibody production very poor | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:spinal cord defect affecting skin
n1=Mycose | n2=en:spinal cord defect affecting skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:splenic infection fungal
n1=Mycose | n2=en:splenic infection fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:splinter of axilla, without major open wound, infected
n1=Mycose | n2=en:splinter of axilla, without major open wound, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:splinter of elbow, without major open wound, infected
n1=Mycose | n2=en:splinter of elbow, without major open wound, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:splinter of hand, without major open wound, infected
n1=Mycose | n2=en:splinter of hand, without major open wound, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:splinter of head, without major open wound, infected
n1=Mycose | n2=en:splinter of head, without major open wound, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:splinter of lower arm, without major open wound, infected
n1=Mycose | n2=en:splinter of lower arm, without major open wound, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:splinter of lower limb, without major open wound, infected
n1=Mycose | n2=en:splinter of lower limb, without major open wound, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:splinter of neck, without major open wound, infected
n1=Mycose | n2=en:splinter of neck, without major open wound, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:splinter of penis without major open wound, infected
n1=Mycose | n2=en:splinter of penis without major open wound, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:splinter of trunk without major open wound, infected
n1=Mycose | n2=en:splinter of trunk without major open wound, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sporothrix infections
n1=Mycose | n2=en:sporothrix infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sporotrichosis
n1=Mycose | n2=en:sporotrichosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sporotrichosis arthritis
n1=Mycose | n2=en:sporotrichosis arthritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:staphylococcal infection
n1=Mycose | n2=en:staphylococcal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:staphylococcus aureus infection
n1=Mycose | n2=en:staphylococcus aureus infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:streptococcal infection
n1=Mycose | n2=en:streptococcal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:subacute confusional state, of infective origin
n1=Mycose | n2=en:subacute confusional state, of infective origin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:subacute infectious disease
n1=Mycose | n2=en:subacute infectious disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:subclinical infection
n1=Mycose | n2=en:subclinical infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:subcutaneous emphysema resulting from a procedure
n1=Mycose | n2=en:subcutaneous emphysema resulting from a procedure | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:subcutaneous fat necrosis due to birth injury
n1=Mycose | n2=en:subcutaneous fat necrosis due to birth injury | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:subcutaneous pheohyphomycotic abscess and cyst
n1=Mycose | n2=en:subcutaneous pheohyphomycotic abscess and cyst | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:submammary monilia
n1=Mycose | n2=en:submammary monilia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sudden death
n1=Mycose | n2=en:sudden death | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sudden infant death syndrome
n1=Mycose | n2=en:sudden infant death syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:suicide attempt
n1=Mycose | n2=en:suicide attempt | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sun exposure
n1=Mycose | n2=en:sun exposure | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:superficial injuries involving multiple body regions
n1=Mycose | n2=en:superficial injuries involving multiple body regions | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:superficial injuries involving multiple regions of upper limb(s) with lower limb(s)
n1=Mycose | n2=en:superficial injuries involving multiple regions of upper limb(s) with lower limb(s) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:superficial injury of interscapular region with infection
n1=Mycose | n2=en:superficial injury of interscapular region with infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:superficial injury of lower limb, infected
n1=Mycose | n2=en:superficial injury of lower limb, infected | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:superficial injury of vulva with infection
n1=Mycose | n2=en:superficial injury of vulva with infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:superficial injury with infection
n1=Mycose | n2=en:superficial injury with infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:superinfection
n1=Mycose | n2=en:superinfection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:superinfection fungal
n1=Mycose | n2=en:superinfection fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:suppuration
n1=Mycose | n2=en:suppuration | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:suppurative arthritis
n1=Mycose | n2=en:suppurative arthritis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:suppurative inflammation of oral soft tissue
n1=Mycose | n2=en:suppurative inflammation of oral soft tissue | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:suppurative labyrinthitis
n1=Mycose | n2=en:suppurative labyrinthitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:suppurative phlebitis
n1=Mycose | n2=en:suppurative phlebitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:suppurative sinusitis with complications
n1=Mycose | n2=en:suppurative sinusitis with complications | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:surgical aspects
n1=Mycose | n2=en:surgical aspects | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:susceptibility to bacterial infections due to poor skin integrity
n1=Mycose | n2=en:susceptibility to bacterial infections due to poor skin integrity | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:susceptibility to chickenpox
n1=Mycose | n2=en:susceptibility to chickenpox | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:susceptibility to infection by mycobacterium leprae causing leprosy
n1=Mycose | n2=en:susceptibility to infection by mycobacterium leprae causing leprosy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:susceptibility to infection with human herpesvirus
n1=Mycose | n2=en:susceptibility to infection with human herpesvirus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:susceptibility to infections
n1=Mycose | n2=en:susceptibility to infections | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:susceptibility to mycobacterial disease
n1=Mycose | n2=en:susceptibility to mycobacterial disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:susceptible to vaccine-induced polio
n1=Mycose | n2=en:susceptible to vaccine-induced polio | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sweat
n1=Mycose | n2=en:sweat | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:sweat gland diseases
n1=Mycose | n2=en:sweat gland diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:swollen lymph node
n1=Mycose | n2=en:swollen lymph node | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:syphilis
n1=Mycose | n2=en:syphilis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:syphilis and other venereal diseases
n1=Mycose | n2=en:syphilis and other venereal diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:systemic diseases affecting skin
n1=Mycose | n2=en:systemic diseases affecting skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:systemic fungal infection affecting skin
n1=Mycose | n2=en:systemic fungal infection affecting skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:systemic inflammatory response (in some patients)
n1=Mycose | n2=en:systemic inflammatory response (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:systemic lupus erythematosis (in some patients)
n1=Mycose | n2=en:systemic lupus erythematosis (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:systemic lupus erythematosus
n1=Mycose | n2=en:systemic lupus erythematosus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:systemic mycosis
n1=Mycose | n2=en:systemic mycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:systemic scleroderma
n1=Mycose | n2=en:systemic scleroderma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:t cell defect, mild to severe
n1=Mycose | n2=en:t cell defect, mild to severe | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:t cells may show impaired proliferative response to tetanus toxoid
n1=Mycose | n2=en:t cells may show impaired proliferative response to tetanus toxoid | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:t regulatory cells show poor function
n1=Mycose | n2=en:t regulatory cells show poor function | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:t-cell dysfunction (1 patient)
n1=Mycose | n2=en:t-cell dysfunction (1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:t-cell dysfunction, variable (in some patients)
n1=Mycose | n2=en:t-cell dysfunction, variable (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:t-cell hyporesponsiveness (in some patients)
n1=Mycose | n2=en:t-cell hyporesponsiveness (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:t-cells show reduced cytotoxicity and reduced cytolytic granule exocytosis
n1=Mycose | n2=en:t-cells show reduced cytotoxicity and reduced cytolytic granule exocytosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:t-lymphocyte deficiency
n1=Mycose | n2=en:t-lymphocyte deficiency | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:t-lymphocytopenia
n1=Mycose | n2=en:t-lymphocytopenia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:taxonomic
n1=Mycose | n2=en:taxonomic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:technique
n1=Mycose | n2=en:technique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:terra firma-forme dermatosis
n1=Mycose | n2=en:terra firma-forme dermatosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tetanus
n1=Mycose | n2=en:tetanus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:therapeutic aspects
n1=Mycose | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:thick skin
n1=Mycose | n2=en:thick skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:thymic hypoplasia or aplasia
n1=Mycose | n2=en:thymic hypoplasia or aplasia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:thymoma
n1=Mycose | n2=en:thymoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:thymus hypoplasia (in some patients)
n1=Mycose | n2=en:thymus hypoplasia (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:thyroid hormone deficiency (1 patient)
n1=Mycose | n2=en:thyroid hormone deficiency (1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tick bite (disorder)
n1=Mycose | n2=en:tick bite (disorder) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tinea barbae and tinea capitis
n1=Mycose | n2=en:tinea barbae and tinea capitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tinea corporis (disorder)
n1=Mycose | n2=en:tinea corporis (disorder) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tinea cruris
n1=Mycose | n2=en:tinea cruris | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tinea imbricata
n1=Mycose | n2=en:tinea imbricata | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tinea infection
n1=Mycose | n2=en:tinea infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tinea manus
n1=Mycose | n2=en:tinea manus | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tinea pedis
n1=Mycose | n2=en:tinea pedis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tinea versicolor
n1=Mycose | n2=en:tinea versicolor | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tissue biopsy shows granulomas
n1=Mycose | n2=en:tissue biopsy shows granulomas | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tissue expander disorder
n1=Mycose | n2=en:tissue expander disorder | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tnf continuously elevated (in some patients)
n1=Mycose | n2=en:tnf continuously elevated (in some patients) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tongue fungal infection
n1=Mycose | n2=en:tongue fungal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tonsillar aspergillosis
n1=Mycose | n2=en:tonsillar aspergillosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tonsillitis fungal
n1=Mycose | n2=en:tonsillitis fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:torulopsis infection
n1=Mycose | n2=en:torulopsis infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:toxic megacolon due to clostridium difficile
n1=Mycose | n2=en:toxic megacolon due to clostridium difficile | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:toxoplasmosis
n1=Mycose | n2=en:toxoplasmosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:transepidermal elimination disorders
n1=Mycose | n2=en:transepidermal elimination disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:transient iga deficiency (1 patient)
n1=Mycose | n2=en:transient iga deficiency (1 patient) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:transplantation immunology
n1=Mycose | n2=en:transplantation immunology | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:traumatic petechiae
n1=Mycose | n2=en:traumatic petechiae | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:traumatic subcutaneous emphysema
n1=Mycose | n2=en:traumatic subcutaneous emphysema | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:traveler's health
n1=Mycose | n2=en:traveler's health | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone
n1=Mycose | n2=en:triamcinolone | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone 0.0025 mg/mg topical ointment
n1=Mycose | n2=en:triamcinolone 0.0025 mg/mg topical ointment | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone 0.01 mg/mg topical ointment
n1=Mycose | n2=en:triamcinolone 0.01 mg/mg topical ointment | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone 0.066 mg/ml topical spray
n1=Mycose | n2=en:triamcinolone 0.066 mg/ml topical spray | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone 1mg tablet
n1=Mycose | n2=en:triamcinolone 1mg tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone 2 mg oral tablet
n1=Mycose | n2=en:triamcinolone 2 mg oral tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone 4mg tablet
n1=Mycose | n2=en:triamcinolone 4mg tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone 8 mg oral tablet
n1=Mycose | n2=en:triamcinolone 8 mg oral tablet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide
n1=Mycose | n2=en:triamcinolone acetonide | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.00025 mg/mg topical ointment
n1=Mycose | n2=en:triamcinolone acetonide 0.00025 mg/mg topical ointment | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.0005 mg/mg topical ointment
n1=Mycose | n2=en:triamcinolone acetonide 0.0005 mg/mg topical ointment | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.001 mg/mg topical gel
n1=Mycose | n2=en:triamcinolone acetonide 0.001 mg/mg topical gel | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.005 mg/mg topical ointment
n1=Mycose | n2=en:triamcinolone acetonide 0.005 mg/mg topical ointment | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.1% cream
n1=Mycose | n2=en:triamcinolone acetonide 0.1% cream | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.1% ointment
n1=Mycose | n2=en:triamcinolone acetonide 0.1% ointment | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.1% oral paste
n1=Mycose | n2=en:triamcinolone acetonide 0.1% oral paste | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.1% topical lotion
n1=Mycose | n2=en:triamcinolone acetonide 0.1% topical lotion | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.147 mg/ml topical spray
n1=Mycose | n2=en:triamcinolone acetonide 0.147 mg/ml topical spray | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.25 mg/ml topical cream
n1=Mycose | n2=en:triamcinolone acetonide 0.25 mg/ml topical cream | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.25 mg/ml topical lotion
n1=Mycose | n2=en:triamcinolone acetonide 0.25 mg/ml topical lotion | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.5 mg/ml topical cream
n1=Mycose | n2=en:triamcinolone acetonide 0.5 mg/ml topical cream | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 0.5% cream
n1=Mycose | n2=en:triamcinolone acetonide 0.5% cream | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 10mg/ml injection suspension 5ml vial
n1=Mycose | n2=en:triamcinolone acetonide 10mg/ml injection suspension 5ml vial | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 3mg injection suspension ampule 1ml
n1=Mycose | n2=en:triamcinolone acetonide 3mg injection suspension ampule 1ml | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 40mg/1ml intra-articular/intramuscular inj
n1=Mycose | n2=en:triamcinolone acetonide 40mg/1ml intra-articular/intramuscular inj | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 50mcg nasal spray
n1=Mycose | n2=en:triamcinolone acetonide 50mcg nasal spray | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide 55 microgram aqueous nasal spray
n1=Mycose | n2=en:triamcinolone acetonide 55 microgram aqueous nasal spray | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone acetonide pwdr
n1=Mycose | n2=en:triamcinolone acetonide pwdr | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone diacetate
n1=Mycose | n2=en:triamcinolone diacetate | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone diacetate 0.4 mg/ml oral solution
n1=Mycose | n2=en:triamcinolone diacetate 0.4 mg/ml oral solution | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone diacetate 0.8 mg/ml oral solution
n1=Mycose | n2=en:triamcinolone diacetate 0.8 mg/ml oral solution | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone diacetate 10 mg/ml injectable suspension
n1=Mycose | n2=en:triamcinolone diacetate 10 mg/ml injectable suspension | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone diacetate 25mg/ml injection suspension ampule
n1=Mycose | n2=en:triamcinolone diacetate 25mg/ml injection suspension ampule | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone diacetate 40mg/ml suspension
n1=Mycose | n2=en:triamcinolone diacetate 40mg/ml suspension | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone hexacetonide
n1=Mycose | n2=en:triamcinolone hexacetonide | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone hexacetonide 20mg/ml injection suspension 5ml vial
n1=Mycose | n2=en:triamcinolone hexacetonide 20mg/ml injection suspension 5ml vial | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:triamcinolone hexacetonide 5mg/ml injection solution 5ml vial
n1=Mycose | n2=en:triamcinolone hexacetonide 5mg/ml injection solution 5ml vial | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:trichomonas infection
n1=Mycose | n2=en:trichomonas infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:trichomoniasis affecting skin
n1=Mycose | n2=en:trichomoniasis affecting skin | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:trichosporon infection
n1=Mycose | n2=en:trichosporon infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:trichosporonosis
n1=Mycose | n2=en:trichosporonosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tropical disease
n1=Mycose | n2=en:tropical disease | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tuberculoid leprosy
n1=Mycose | n2=en:tuberculoid leprosy | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tuberculosis
n1=Mycose | n2=en:tuberculosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tuberculosis aggravated
n1=Mycose | n2=en:tuberculosis aggravated | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tuberculous bronchopleural fistula
n1=Mycose | n2=en:tuberculous bronchopleural fistula | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tuberculous meningoencephalitis
n1=Mycose | n2=en:tuberculous meningoencephalitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:tumor lysis syndrome adverse event
n1=Mycose | n2=en:tumor lysis syndrome adverse event | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:ulcerative-necrotic
n1=Mycose | n2=en:ulcerative-necrotic | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:uncomplicated infection
n1=Mycose | n2=en:uncomplicated infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:undetectable igm and iga
n1=Mycose | n2=en:undetectable igm and iga | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:undetectable/absent peripheral lymph nodes
n1=Mycose | n2=en:undetectable/absent peripheral lymph nodes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:unevaluable reaction
n1=Mycose | n2=en:unevaluable reaction | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:unexpected therapeutic effect
n1=Mycose | n2=en:unexpected therapeutic effect | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:unspecified infection or infestation complicating pregnancy, childbirth, or the puerperium
n1=Mycose | n2=en:unspecified infection or infestation complicating pregnancy, childbirth, or the puerperium | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:unspecified infection or infestation of mother, antepartum condition or complication
n1=Mycose | n2=en:unspecified infection or infestation of mother, antepartum condition or complication | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:unspecified infection or infestation of mother, complicating pregnancy, childbirth, or the puerperiu
n1=Mycose | n2=en:unspecified infection or infestation of mother, complicating pregnancy, childbirth, or the puerperiu | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:unspecified infection or infestation of mother, delivered, with mention of postpartum complication
n1=Mycose | n2=en:unspecified infection or infestation of mother, delivered, with mention of postpartum complication | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:unspecified infection or infestation of mother, delivered, with or without mention of antepartum condition
n1=Mycose | n2=en:unspecified infection or infestation of mother, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:unspecified infection or infestation of mother, postpartum condition or complication
n1=Mycose | n2=en:unspecified infection or infestation of mother, postpartum condition or complication | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:unspecified infection or infestation of mother, unspecified as to episode of care or not applicable
n1=Mycose | n2=en:unspecified infection or infestation of mother, unspecified as to episode of care or not applicable | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:unspecified viral infection characterized by skin and mucous membrane lesions
n1=Mycose | n2=en:unspecified viral infection characterized by skin and mucous membrane lesions | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:upper respiratory fungal infection
n1=Mycose | n2=en:upper respiratory fungal infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:upregulation of alpha-interferon-stimulated genes
n1=Mycose | n2=en:upregulation of alpha-interferon-stimulated genes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:urethral wart
n1=Mycose | n2=en:urethral wart | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:urinary tract infection
n1=Mycose | n2=en:urinary tract infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:urinary tract infection fungal
n1=Mycose | n2=en:urinary tract infection fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:urogenital infection fungal
n1=Mycose | n2=en:urogenital infection fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:urticaria
n1=Mycose | n2=en:urticaria | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:use of ultrasonography
n1=Mycose | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:usually precipitated by viral infection (influenza a, influenza b, parainfluenza ii, and mycoplasma pneumoniae)
n1=Mycose | n2=en:usually precipitated by viral infection (influenza a, influenza b, parainfluenza ii, and mycoplasma pneumoniae) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:uveomeningoencephalitic syndrome
n1=Mycose | n2=en:uveomeningoencephalitic syndrome | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:vacuolated lymphocytes
n1=Mycose | n2=en:vacuolated lymphocytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:vaginal vault infection
n1=Mycose | n2=en:vaginal vault infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:variable (often increased) number of activated cd45ro+, dr+ circulating t cells
n1=Mycose | n2=en:variable (often increased) number of activated cd45ro+, dr+ circulating t cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:variable antibody response to vaccination
n1=Mycose | n2=en:variable antibody response to vaccination | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:variable autoimmune disorders
n1=Mycose | n2=en:variable autoimmune disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:variable deficit of tissue macrophages
n1=Mycose | n2=en:variable deficit of tissue macrophages | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:variable degree of t cell dysfunction
n1=Mycose | n2=en:variable degree of t cell dysfunction | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:variably decreased serum iga, igg, and igm
n1=Mycose | n2=en:variably decreased serum iga, igg, and igm | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:variably impaired t-cell proliferative responses
n1=Mycose | n2=en:variably impaired t-cell proliferative responses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:varicella zoster infection
n1=Mycose | n2=en:varicella zoster infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:vascular graft infection
n1=Mycose | n2=en:vascular graft infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:vascular hamartoma
n1=Mycose | n2=en:vascular hamartoma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:vasculitis
n1=Mycose | n2=en:vasculitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:verruca vulgaris
n1=Mycose | n2=en:verruca vulgaris | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:verrucous lesion
n1=Mycose | n2=en:verrucous lesion | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:very low b cells
n1=Mycose | n2=en:very low b cells | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:very low lymphocyte proliferation in response to mitogens and alloantigens
n1=Mycose | n2=en:very low lymphocyte proliferation in response to mitogens and alloantigens | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:vesiculo-bullous
n1=Mycose | n2=en:vesiculo-bullous | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:veterinary aspects
n1=Mycose | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:viral and prion infections of the central nervous system (a80-a89)
n1=Mycose | n2=en:viral and prion infections of the central nervous system (a80-a89) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:viral diseases generally accompanied by exanthem
n1=Mycose | n2=en:viral diseases generally accompanied by exanthem | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:viral hemorrhagic fever
n1=Mycose | n2=en:viral hemorrhagic fever | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:viral hepatitis
n1=Mycose | n2=en:viral hepatitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:viral infection
n1=Mycose | n2=en:viral infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:viral infectious disorders
n1=Mycose | n2=en:viral infectious disorders | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:viral meningoencephalitis
n1=Mycose | n2=en:viral meningoencephalitis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:viruses
n1=Mycose | n2=en:viruses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:vitamin a-responsive dermatosis
n1=Mycose | n2=en:vitamin a-responsive dermatosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:vitiligo
n1=Mycose | n2=en:vitiligo | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:vomiting - infective
n1=Mycose | n2=en:vomiting - infective | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:vulvovaginal candidiasis
n1=Mycose | n2=en:vulvovaginal candidiasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:vulvovaginal mycotic infection
n1=Mycose | n2=en:vulvovaginal mycotic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:waldenstrom hypergammaglobulinemic purpura
n1=Mycose | n2=en:waldenstrom hypergammaglobulinemic purpura | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:waterborne diseases
n1=Mycose | n2=en:waterborne diseases | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:west nile viral infection
n1=Mycose | n2=en:west nile viral infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:whitlow
n1=Mycose | n2=en:whitlow | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:whooping cough due to unspecified organism
n1=Mycose | n2=en:whooping cough due to unspecified organism | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:wound infection
n1=Mycose | n2=en:wound infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:wound infection fungal
n1=Mycose | n2=en:wound infection fungal | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:wounds and injuries
n1=Mycose | n2=en:wounds and injuries | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:xeroderma
n1=Mycose | n2=en:xeroderma | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:yeast infection
n1=Mycose | n2=en:yeast infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:zinc-responsive dermatosis
n1=Mycose | n2=en:zinc-responsive dermatosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:zoonotic bacterial infection
n1=Mycose | n2=en:zoonotic bacterial infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:zoonotic infection
n1=Mycose | n2=en:zoonotic infection | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
en:zygomycosis
n1=Mycose | n2=en:zygomycosis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
épidermomycose
n1=Mycose | n2=épidermomycose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
fusariose
n1=Mycose | n2=fusariose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
gale
(médecine)
n1=Mycose | n2=gale (médecine) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
herpès
n1=Mycose | n2=herpès | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
histoplasmose
n1=Mycose | n2=histoplasmose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infection à Chlamydia
n1=Mycose | n2=infection à Chlamydia | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infection à rickettsies
n1=Mycose | n2=infection à rickettsies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infection à spirochètes
n1=Mycose | n2=infection à spirochètes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infection bactérienne
n1=Mycose | n2=infection bactérienne | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infection méningococcique
n1=Mycose | n2=infection méningococcique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infection mycotique
n1=Mycose | n2=infection mycotique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infection par un champignon
n1=Mycose | n2=infection par un champignon | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infection
(contamination)
n1=Mycose | n2=infection (contamination) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infections à champignons
n1=Mycose | n2=infections à champignons | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infections bactériennes
n1=Mycose | n2=infections bactériennes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infections bactériennes et fongiques
n1=Mycose | n2=infections bactériennes et fongiques | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infections bactériennes et mycoses
n1=Mycose | n2=infections bactériennes et mycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
infections fongiques
n1=Mycose | n2=infections fongiques | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
levurose
n1=Mycose | n2=levurose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladie
n1=Mycose | n2=maladie | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladie causée par des bactéries
n1=Mycose | n2=maladie causée par des bactéries | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladie causée par une bactérie
n1=Mycose | n2=maladie causée par une bactérie | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladie de Beurmann
n1=Mycose | n2=maladie de Beurmann | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladie de la peau
n1=Mycose | n2=maladie de la peau | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladie de peau
n1=Mycose | n2=maladie de peau | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladie dermatologique
n1=Mycose | n2=maladie dermatologique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladie infectieuse bactérienne
n1=Mycose | n2=maladie infectieuse bactérienne | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladie
(médecine)
n1=Mycose | n2=maladie (médecine) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladies
n1=Mycose | n2=maladies | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladies bactériennes
n1=Mycose | n2=maladies bactériennes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladies causées par des bactéries
n1=Mycose | n2=maladies causées par des bactéries | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladies causées par une bactérie
n1=Mycose | n2=maladies causées par une bactérie | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladies infectieuses bactériennes
n1=Mycose | n2=maladies infectieuses bactériennes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
maladies infectieuses fongiques
n1=Mycose | n2=maladies infectieuses fongiques | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
médecine
n1=Mycose | n2=médecine | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
micromycètes
n1=Mycose | n2=micromycètes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
moisissure
n1=Mycose | n2=moisissure | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
muguet
n1=Mycose | n2=muguet | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycomycètes
n1=Mycose | n2=mycomycètes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycose cutanéo-muqueuse
n1=Mycose | n2=mycose cutanéo-muqueuse | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycose de l'ongle
n1=Mycose | n2=mycose de l'ongle | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycose de la peau glabre
n1=Mycose | n2=mycose de la peau glabre | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycose dermoépidermique chronique
n1=Mycose | n2=mycose dermoépidermique chronique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycose oculaire
n1=Mycose | n2=mycose oculaire | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycose sous-cutanée
n1=Mycose | n2=mycose sous-cutanée | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycose vaginale
n1=Mycose | n2=mycose vaginale | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycoses
n1=Mycose | n2=mycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycosique
n1=Mycose | n2=mycosique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycotique
n1=Mycose | n2=mycotique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
mycotoxicose
n1=Mycose | n2=mycotoxicose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
non précisée, bactériémie
n1=Mycose | n2=non précisée, bactériémie | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
onychomycose
n1=Mycose | n2=onychomycose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
orteils
n1=Mycose | n2=orteils | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
otomycose
n1=Mycose | n2=otomycose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
pityriasis
n1=Mycose | n2=pityriasis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
pityriasis rosé de Gibert
n1=Mycose | n2=pityriasis rosé de Gibert | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
pityriasis versicolor
n1=Mycose | n2=pityriasis versicolor | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
pneumocystose
n1=Mycose | n2=pneumocystose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
pneumonie à pneumocystis
n1=Mycose | n2=pneumonie à pneumocystis | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
processus pathologique
n1=Mycose | n2=processus pathologique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
saprophytes
n1=Mycose | n2=saprophytes | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
section e-4 mycoses
n1=Mycose | n2=section e-4 mycoses | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
septicémie fongique
n1=Mycose | n2=septicémie fongique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
sporotrichose
n1=Mycose | n2=sporotrichose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
technique
n1=Mycose | n2=technique | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
teigne
n1=Mycose | n2=teigne | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
teigne
(maladie)
n1=Mycose | n2=teigne (maladie) | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
tréhalose
n1=Mycose | n2=tréhalose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
trichophytie
n1=Mycose | n2=trichophytie | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
trouble bactérien infectieux
n1=Mycose | n2=trouble bactérien infectieux | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
troubles bactériens infectieux
n1=Mycose | n2=troubles bactériens infectieux | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
troubles infectieux fongiques
n1=Mycose | n2=troubles infectieux fongiques | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 15 / 0.5 ->
zygomycose
n1=Mycose | n2=zygomycose | rel=r_associated | relid=0 | w=15
- Mycose --
r_associated #0: 7 / 0.233 ->
dermatologie
n1=Mycose | n2=dermatologie | rel=r_associated | relid=0 | w=7
- Mycose --
r_associated #0: 6 / 0.2 ->
candida
n1=Mycose | n2=candida | rel=r_associated | relid=0 | w=6
- Mycose --
r_associated #0: 6 / 0.2 ->
humidité
n1=Mycose | n2=humidité | rel=r_associated | relid=0 | w=6
- Mycose --
r_associated #0: 6 / 0.2 ->
levure
n1=Mycose | n2=levure | rel=r_associated | relid=0 | w=6
- Mycose --
r_associated #0: 6 / 0.2 ->
mycose buccale
n1=Mycose | n2=mycose buccale | rel=r_associated | relid=0 | w=6
- Mycose --
r_associated #0: 6 / 0.2 ->
mycose des ongles
n1=Mycose | n2=mycose des ongles | rel=r_associated | relid=0 | w=6
- Mycose --
r_associated #0: 6 / 0.2 ->
mycose systémique
n1=Mycose | n2=mycose systémique | rel=r_associated | relid=0 | w=6
- Mycose --
r_associated #0: 5 / 0.167 ->
abcès
n1=Mycose | n2=abcès | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
affection de peau
n1=Mycose | n2=affection de peau | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
aleurie
n1=Mycose | n2=aleurie | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
aleuriospore
n1=Mycose | n2=aleuriospore | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
angiooedème
n1=Mycose | n2=angiooedème | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
aspergillose broncho-pulmonaire
n1=Mycose | n2=aspergillose broncho-pulmonaire | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
aspergillose broncho-pulmonaire allergique
n1=Mycose | n2=aspergillose broncho-pulmonaire allergique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
aspergillose bronchopulmonaire allergique
n1=Mycose | n2=aspergillose bronchopulmonaire allergique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
aspergillose bronchopulmonaire allergique (ABPA)
n1=Mycose | n2=aspergillose bronchopulmonaire allergique (ABPA) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
aspergillose pulmonaire
n1=Mycose | n2=aspergillose pulmonaire | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
aspergillose pulmonaire allergique
n1=Mycose | n2=aspergillose pulmonaire allergique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
aspergilloses bronchopulmonaires allergiques
n1=Mycose | n2=aspergilloses bronchopulmonaires allergiques | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Bactériémie
n1=Mycose | n2=Bactériémie | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Beurmann
n1=Mycose | n2=Beurmann | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
bursite poplitée
n1=Mycose | n2=bursite poplitée | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Candida albicans
n1=Mycose | n2=Candida albicans | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
candidiasis
n1=Mycose | n2=candidiasis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
candidose buccale
n1=Mycose | n2=candidose buccale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
céroïde lipofuscinose neuronale de type infantile tardive
n1=Mycose | n2=céroïde lipofuscinose neuronale de type infantile tardive | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
chat
(sexe de la femme)
n1=Mycose | n2=chat (sexe de la femme) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
chlamydiose
n1=Mycose | n2=chlamydiose | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
cholangiocarcinome
n1=Mycose | n2=cholangiocarcinome | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
cladosporiose
n1=Mycose | n2=cladosporiose | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
coccidioïdomycose
n1=Mycose | n2=coccidioïdomycose | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
d' Hérelle (phénomène de)
n1=Mycose | n2=d' Hérelle (phénomène de) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
dacryadénite
n1=Mycose | n2=dacryadénite | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
dacryoadénite
n1=Mycose | n2=dacryoadénite | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
dacryoadénite non précisée
n1=Mycose | n2=dacryoadénite non précisée | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
dacryocystite
n1=Mycose | n2=dacryocystite | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
dacryocystite non précisée
n1=Mycose | n2=dacryocystite non précisée | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
dacryocystites
n1=Mycose | n2=dacryocystites | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
dartre
n1=Mycose | n2=dartre | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
dermatomycose
n1=Mycose | n2=dermatomycose | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
dermatosis
n1=Mycose | n2=dermatosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
diplomyélie
n1=Mycose | n2=diplomyélie | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
doigts (arthrose des)
n1=Mycose | n2=doigts (arthrose des) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
doigts de pied
n1=Mycose | n2=doigts de pied | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
eczéma
n1=Mycose | n2=eczéma | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
élastome
n1=Mycose | n2=élastome | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
élimination des peaux mortes
n1=Mycose | n2=élimination des peaux mortes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
embranchement
n1=Mycose | n2=embranchement | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:allergic bronchopulmonary aspergillosis
n1=Mycose | n2=en:allergic bronchopulmonary aspergillosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:angioneurosis cutaneous
n1=Mycose | n2=en:angioneurosis cutaneous | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:aspergillomycosis
n1=Mycose | n2=en:aspergillomycosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:aspergillosis, allergic bronchopulmonary
n1=Mycose | n2=en:aspergillosis, allergic bronchopulmonary | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:athlete's foot
n1=Mycose | n2=en:athlete's foot | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:athletic foot
n1=Mycose | n2=en:athletic foot | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:avariosis
n1=Mycose | n2=en:avariosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:bacteraemia
n1=Mycose | n2=en:bacteraemia | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:bactieremia
n1=Mycose | n2=en:bactieremia | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:baker cyst
n1=Mycose | n2=en:baker cyst | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:Beurmann's disease
n1=Mycose | n2=en:Beurmann's disease | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:bile duct carcinoma
n1=Mycose | n2=en:bile duct carcinoma | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:blastodendriosis
n1=Mycose | n2=en:blastodendriosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:blue toe syndrome
n1=Mycose | n2=en:blue toe syndrome | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:bronchopneumonic aspergillosis
n1=Mycose | n2=en:bronchopneumonic aspergillosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:bronchopulmonary aspergillosis
n1=Mycose | n2=en:bronchopulmonary aspergillosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:Buschke's disease
n1=Mycose | n2=en:Buschke's disease | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:busse-buschke disease
n1=Mycose | n2=en:busse-buschke disease | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:candida
n1=Mycose | n2=en:candida | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:candida (fungus)
n1=Mycose | n2=en:candida (fungus) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:candida albicans
n1=Mycose | n2=en:candida albicans | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:Candida albicans
n1=Mycose | n2=en:Candida albicans | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:candidasis
n1=Mycose | n2=en:candidasis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:candidosis
n1=Mycose | n2=en:candidosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:certains assimilent au pityriasis versicolor
n1=Mycose | n2=en:certains assimilent au pityriasis versicolor | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:chlamydiosis
n1=Mycose | n2=en:chlamydiosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:chromophytosis
n1=Mycose | n2=en:chromophytosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:cladosporiosis
n1=Mycose | n2=en:cladosporiosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:cutaneous mycosis
n1=Mycose | n2=en:cutaneous mycosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:dacryoadenitis
n1=Mycose | n2=en:dacryoadenitis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:dacryocystitis
n1=Mycose | n2=en:dacryocystitis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:dermatomycosis
n1=Mycose | n2=en:dermatomycosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:dermatonosis
n1=Mycose | n2=en:dermatonosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:dermatopathy
n1=Mycose | n2=en:dermatopathy | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:dermatophytose
n1=Mycose | n2=en:dermatophytose | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:dermatosis
n1=Mycose | n2=en:dermatosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:digiti pedis
n1=Mycose | n2=en:digiti pedis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:elastoma
n1=Mycose | n2=en:elastoma | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:endomycosis
n1=Mycose | n2=en:endomycosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:epidermal disorder
n1=Mycose | n2=en:epidermal disorder | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:epidermomycosis
n1=Mycose | n2=en:epidermomycosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:epidermophytie
n1=Mycose | n2=en:epidermophytie | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:epidermophytosis of the foot
n1=Mycose | n2=en:epidermophytosis of the foot | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:eschar
n1=Mycose | n2=en:eschar | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:fungal septicaemia
n1=Mycose | n2=en:fungal septicaemia | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:fungi
n1=Mycose | n2=en:fungi | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:fungistatic
n1=Mycose | n2=en:fungistatic | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:giant swelling
n1=Mycose | n2=en:giant swelling | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:Gibert's pityriasis rosea
n1=Mycose | n2=en:Gibert's pityriasis rosea | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:gigans urticaria
n1=Mycose | n2=en:gigans urticaria | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:Gougerot-Sjögren's syndrome
n1=Mycose | n2=en:Gougerot-Sjögren's syndrome | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:herpes
n1=Mycose | n2=en:herpes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:herpes catarrhalis
n1=Mycose | n2=en:herpes catarrhalis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:herpes simplex
n1=Mycose | n2=en:herpes simplex | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:herpetic
n1=Mycose | n2=en:herpetic | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:intercurrent disease
n1=Mycose | n2=en:intercurrent disease | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:lues
n1=Mycose | n2=en:lues | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:meningococcal meningitis
n1=Mycose | n2=en:meningococcal meningitis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:mesenchymal hamartoma
n1=Mycose | n2=en:mesenchymal hamartoma | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:miconazole
n1=Mycose | n2=en:miconazole | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:microsporia
n1=Mycose | n2=en:microsporia | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:mycodermomycosis
n1=Mycose | n2=en:mycodermomycosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:mycosic
n1=Mycose | n2=en:mycosic | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:mycostatic
n1=Mycose | n2=en:mycostatic | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:orthopaedic support
n1=Mycose | n2=en:orthopaedic support | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:orthopedic support
n1=Mycose | n2=en:orthopedic support | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:pityriasis
n1=Mycose | n2=en:pityriasis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:pityriasis versicolor
n1=Mycose | n2=en:pityriasis versicolor | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:pneumocystis carinii pneumonia
n1=Mycose | n2=en:pneumocystis carinii pneumonia | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:pneumocystosis
n1=Mycose | n2=en:pneumocystosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:popliteal cyst
n1=Mycose | n2=en:popliteal cyst | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:psora
n1=Mycose | n2=en:psora | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:pulmonary aspergillosis
n1=Mycose | n2=en:pulmonary aspergillosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:Quincke's disease
n1=Mycose | n2=en:Quincke's disease | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:ringworm
n1=Mycose | n2=en:ringworm | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:ringworm of the nails
n1=Mycose | n2=en:ringworm of the nails | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:saccharomycosis
n1=Mycose | n2=en:saccharomycosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:Sjögren's syndrome
n1=Mycose | n2=en:Sjögren's syndrome | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:skin affliction
n1=Mycose | n2=en:skin affliction | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:skin disease
n1=Mycose | n2=en:skin disease | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:spondylitis
n1=Mycose | n2=en:spondylitis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:spondylosis
n1=Mycose | n2=en:spondylosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:superficial cutaneous mycosis
n1=Mycose | n2=en:superficial cutaneous mycosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:tendinitis
n1=Mycose | n2=en:tendinitis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:tendinosis
n1=Mycose | n2=en:tendinosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:thrush
n1=Mycose | n2=en:thrush | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:tinea capitis
n1=Mycose | n2=en:tinea capitis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:tinea flava
n1=Mycose | n2=en:tinea flava | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:tinea nodosa (inusité)
n1=Mycose | n2=en:tinea nodosa (inusité) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:tinea unguium
n1=Mycose | n2=en:tinea unguium | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:torulosis
n1=Mycose | n2=en:torulosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:triazole
n1=Mycose | n2=en:triazole | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:trichophytosis
n1=Mycose | n2=en:trichophytosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:trichosporosis
n1=Mycose | n2=en:trichosporosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:uterine corpus leiomyoma
n1=Mycose | n2=en:uterine corpus leiomyoma | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:uterine fibroids
n1=Mycose | n2=en:uterine fibroids | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:vaginal mycosis
n1=Mycose | n2=en:vaginal mycosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:vaginitis
n1=Mycose | n2=en:vaginitis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
en:vaginomycosis
n1=Mycose | n2=en:vaginomycosis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
encéphalopathie hypoglycémique
n1=Mycose | n2=encéphalopathie hypoglycémique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
épidermophytie
n1=Mycose | n2=épidermophytie | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
érythème noueux
n1=Mycose | n2=érythème noueux | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
eschare
n1=Mycose | n2=eschare | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
excroissance
n1=Mycose | n2=excroissance | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
fibrome de l'utérus
n1=Mycose | n2=fibrome de l'utérus | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
fibrome utérin
n1=Mycose | n2=fibrome utérin | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
fibromes utérins
n1=Mycose | n2=fibromes utérins | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
fibromyome de l'utérus
n1=Mycose | n2=fibromyome de l'utérus | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
fibromyome utérin
n1=Mycose | n2=fibromyome utérin | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
fongémie
n1=Mycose | n2=fongémie | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
fongémies
n1=Mycose | n2=fongémies | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
fracture du col fémoral
n1=Mycose | n2=fracture du col fémoral | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Fungi
n1=Mycose | n2=Fungi | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
gale
n1=Mycose | n2=gale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
géotrichose
n1=Mycose | n2=géotrichose | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
géotrichoses
n1=Mycose | n2=géotrichoses | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
grains de Fordyce du pénis
n1=Mycose | n2=grains de Fordyce du pénis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
grippe porcine
n1=Mycose | n2=grippe porcine | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
hamartome mésenchymateux
n1=Mycose | n2=hamartome mésenchymateux | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
hépatite C
n1=Mycose | n2=hépatite C | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
hépatite C
(maladie)
n1=Mycose | n2=hépatite C (maladie) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
herpes
n1=Mycose | n2=herpes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
herpès labial
n1=Mycose | n2=herpès labial | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
herpétique
n1=Mycose | n2=herpétique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
hidrosadénite
n1=Mycose | n2=hidrosadénite | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
hordéole
n1=Mycose | n2=hordéole | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
hypertrophie chronique de la glande lacrymale
n1=Mycose | n2=hypertrophie chronique de la glande lacrymale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
hypoalbuminémie
n1=Mycose | n2=hypoalbuminémie | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
infection à chlamydia
n1=Mycose | n2=infection à chlamydia | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
infection à cladosporium trichoides
n1=Mycose | n2=infection à cladosporium trichoides | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
infection à fusarium
n1=Mycose | n2=infection à fusarium | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
infection intracrânienne
n1=Mycose | n2=infection intracrânienne | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
infection mycosique systémique
n1=Mycose | n2=infection mycosique systémique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
infection sexuellement transmissible
n1=Mycose | n2=infection sexuellement transmissible | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
IST
(infection sexuellement transmissible)
n1=Mycose | n2=IST (infection sexuellement transmissible) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
kératose
n1=Mycose | n2=kératose | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
kyste de Baker
n1=Mycose | n2=kyste de Baker | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
kyste poplité
n1=Mycose | n2=kyste poplité | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
kyste synovial de l'espace poplité
n1=Mycose | n2=kyste synovial de l'espace poplité | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
kyste synovial poplité
n1=Mycose | n2=kyste synovial poplité | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
leiomyome
n1=Mycose | n2=leiomyome | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
léiomyome
n1=Mycose | n2=léiomyome | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
léiomyome de l'utérus
n1=Mycose | n2=léiomyome de l'utérus | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
léiomyome de l'utérus non précisé
n1=Mycose | n2=léiomyome de l'utérus non précisé | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
léiomyome utérin
n1=Mycose | n2=léiomyome utérin | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
léiomyomes
n1=Mycose | n2=léiomyomes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
lésion cutanée
n1=Mycose | n2=lésion cutanée | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
lésion de la peau
n1=Mycose | n2=lésion de la peau | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
lichen scléreux vulvaire
n1=Mycose | n2=lichen scléreux vulvaire | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Lièvres
n1=Mycose | n2=Lièvres | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
lymphoedème non filarien
n1=Mycose | n2=lymphoedème non filarien | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie de Chicago
n1=Mycose | n2=maladie de Chicago | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie de Ménétrier
n1=Mycose | n2=maladie de Ménétrier | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie de Pierce
n1=Mycose | n2=maladie de Pierce | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie de Sanfilippo
n1=Mycose | n2=maladie de Sanfilippo | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie fongique
n1=Mycose | n2=maladie fongique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie infantile
n1=Mycose | n2=maladie infantile | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie infectieuse de l'appareil digestif
n1=Mycose | n2=maladie infectieuse de l'appareil digestif | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie infectieuse sexuellement transmissible
n1=Mycose | n2=maladie infectieuse sexuellement transmissible | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie infectieuse transmise sexuellement
n1=Mycose | n2=maladie infectieuse transmise sexuellement | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie inflammatoire
n1=Mycose | n2=maladie inflammatoire | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie intercurrente
n1=Mycose | n2=maladie intercurrente | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie sexuellement transmissible
n1=Mycose | n2=maladie sexuellement transmissible | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
maladie transmissible sexuellement
n1=Mycose | n2=maladie transmissible sexuellement | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Maladies
n1=Mycose | n2=Maladies | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
malformation lymphatique
n1=Mycose | n2=malformation lymphatique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
méningite à méningocoque
n1=Mycose | n2=méningite à méningocoque | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
méningite à méningocoques
n1=Mycose | n2=méningite à méningocoques | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
méningite méningococcique
n1=Mycose | n2=méningite méningococcique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
miconazole
n1=Mycose | n2=miconazole | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
microsporie
n1=Mycose | n2=microsporie | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
moisissures
n1=Mycose | n2=moisissures | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
MST
(maladie sexuellement transmissible)
n1=Mycose | n2=MST (maladie sexuellement transmissible) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mts
n1=Mycose | n2=mts | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mucopolysaccharidose de Hurler
n1=Mycose | n2=mucopolysaccharidose de Hurler | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Mucorales
n1=Mycose | n2=Mucorales | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mucormycose sinusienne
n1=Mycose | n2=mucormycose sinusienne | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
muguet
(candidose)
n1=Mycose | n2=muguet (candidose) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycétome
n1=Mycose | n2=mycétome | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose à champignons dimorphes
n1=Mycose | n2=mycose à champignons dimorphes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose à champignons filamenteux
n1=Mycose | n2=mycose à champignons filamenteux | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose à champignons unicellulaires
n1=Mycose | n2=mycose à champignons unicellulaires | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose à leptothrix
n1=Mycose | n2=mycose à leptothrix | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose à moisissures
n1=Mycose | n2=mycose à moisissures | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose acquise
n1=Mycose | n2=mycose acquise | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose auto-immune
n1=Mycose | n2=mycose auto-immune | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose bénigne
n1=Mycose | n2=mycose bénigne | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose chez l'homme
n1=Mycose | n2=mycose chez l'homme | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose chez la femme
n1=Mycose | n2=mycose chez la femme | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose congénitale
n1=Mycose | n2=mycose congénitale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose contagieuse
n1=Mycose | n2=mycose contagieuse | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose curable
n1=Mycose | n2=mycose curable | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose cutanée superficielle
n1=Mycose | n2=mycose cutanée superficielle | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose cutanéo-dermatologique
n1=Mycose | n2=mycose cutanéo-dermatologique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose cutanéo-dermique
n1=Mycose | n2=mycose cutanéo-dermique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose cutanéo-profonde
n1=Mycose | n2=mycose cutanéo-profonde | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose cutanéo-sous-cutanée
n1=Mycose | n2=mycose cutanéo-sous-cutanée | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose cutanéo-superficielle
n1=Mycose | n2=mycose cutanéo-superficielle | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose de l'anus
n1=Mycose | n2=mycose de l'anus | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose de l'oesophage
n1=Mycose | n2=mycose de l'oesophage | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose de la moustache
n1=Mycose | n2=mycose de la moustache | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose de la peau lisse
n1=Mycose | n2=mycose de la peau lisse | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose de la peau pileuse
n1=Mycose | n2=mycose de la peau pileuse | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose de la peau velue
n1=Mycose | n2=mycose de la peau velue | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des follicules pileux
n1=Mycose | n2=mycose des follicules pileux | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des glandes sébacées
n1=Mycose | n2=mycose des glandes sébacées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des glandes sudoripares
n1=Mycose | n2=mycose des glandes sudoripares | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des glandes sudoripares apocrines
n1=Mycose | n2=mycose des glandes sudoripares apocrines | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des glandes sudoripares eccrines
n1=Mycose | n2=mycose des glandes sudoripares eccrines | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des grands plis
n1=Mycose | n2=mycose des grands plis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des membres
n1=Mycose | n2=mycose des membres | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes circulatoires
n1=Mycose | n2=mycose des organes circulatoires | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes de communication
n1=Mycose | n2=mycose des organes de communication | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes de défense
n1=Mycose | n2=mycose des organes de défense | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes de locomotion
n1=Mycose | n2=mycose des organes de locomotion | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes de nutrition
n1=Mycose | n2=mycose des organes de nutrition | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes de perception
n1=Mycose | n2=mycose des organes de perception | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes de régulation
n1=Mycose | n2=mycose des organes de régulation | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes de relation
n1=Mycose | n2=mycose des organes de relation | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes de reproduction
n1=Mycose | n2=mycose des organes de reproduction | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes digestifs
n1=Mycose | n2=mycose des organes digestifs | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes endocriniens
n1=Mycose | n2=mycose des organes endocriniens | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes excitateurs
n1=Mycose | n2=mycose des organes excitateurs | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes excréteurs
n1=Mycose | n2=mycose des organes excréteurs | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes génitaux externes
n1=Mycose | n2=mycose des organes génitaux externes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes immunitaires
n1=Mycose | n2=mycose des organes immunitaires | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes lymphatiques
n1=Mycose | n2=mycose des organes lymphatiques | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes moteurs
n1=Mycose | n2=mycose des organes moteurs | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes reproducteurs
n1=Mycose | n2=mycose des organes reproducteurs | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes respiratoires
n1=Mycose | n2=mycose des organes respiratoires | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes sécréteurs
n1=Mycose | n2=mycose des organes sécréteurs | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes sédatifs
n1=Mycose | n2=mycose des organes sédatifs | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes sensoriels
n1=Mycose | n2=mycose des organes sensoriels | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des organes urinaires
n1=Mycose | n2=mycose des organes urinaires | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des parties intimes
n1=Mycose | n2=mycose des parties intimes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des petits plis
n1=Mycose | n2=mycose des petits plis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones brûlantes
n1=Mycose | n2=mycose des zones brûlantes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones cachées
n1=Mycose | n2=mycose des zones cachées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones corporelles
n1=Mycose | n2=mycose des zones corporelles | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones couvertes
n1=Mycose | n2=mycose des zones couvertes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones crevassées
n1=Mycose | n2=mycose des zones crevassées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones croûteuses
n1=Mycose | n2=mycose des zones croûteuses | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones cutanées
n1=Mycose | n2=mycose des zones cutanées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones de chaleur
n1=Mycose | n2=mycose des zones de chaleur | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones de contact
n1=Mycose | n2=mycose des zones de contact | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones de frottement
n1=Mycose | n2=mycose des zones de frottement | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones de macération
n1=Mycose | n2=mycose des zones de macération | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones de transpiration
n1=Mycose | n2=mycose des zones de transpiration | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones découvertes
n1=Mycose | n2=mycose des zones découvertes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones dermiques
n1=Mycose | n2=mycose des zones dermiques | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones douloureuses
n1=Mycose | n2=mycose des zones douloureuses | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones enflammées
n1=Mycose | n2=mycose des zones enflammées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones enflées
n1=Mycose | n2=mycose des zones enflées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones épidermiques
n1=Mycose | n2=mycose des zones épidermiques | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones étendues
n1=Mycose | n2=mycose des zones étendues | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones exposées
n1=Mycose | n2=mycose des zones exposées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones externes
n1=Mycose | n2=mycose des zones externes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones fragiles
n1=Mycose | n2=mycose des zones fragiles | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones gonflées
n1=Mycose | n2=mycose des zones gonflées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones humides
n1=Mycose | n2=mycose des zones humides | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones infectées
n1=Mycose | n2=mycose des zones infectées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones inflammées
n1=Mycose | n2=mycose des zones inflammées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones internes
n1=Mycose | n2=mycose des zones internes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones intimes
n1=Mycose | n2=mycose des zones intimes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones irritées
n1=Mycose | n2=mycose des zones irritées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones localisées
n1=Mycose | n2=mycose des zones localisées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones persistantes
n1=Mycose | n2=mycose des zones persistantes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones profondes
n1=Mycose | n2=mycose des zones profondes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones protégées
n1=Mycose | n2=mycose des zones protégées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones prurigineuses
n1=Mycose | n2=mycose des zones prurigineuses | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones récidivantes
n1=Mycose | n2=mycose des zones récidivantes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones récurrentes
n1=Mycose | n2=mycose des zones récurrentes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones réfractaires
n1=Mycose | n2=mycose des zones réfractaires | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones réinfectées
n1=Mycose | n2=mycose des zones réinfectées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones résistantes
n1=Mycose | n2=mycose des zones résistantes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones rouges
n1=Mycose | n2=mycose des zones rouges | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones sèches
n1=Mycose | n2=mycose des zones sèches | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones sensibles
n1=Mycose | n2=mycose des zones sensibles | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones sous-cutanées
n1=Mycose | n2=mycose des zones sous-cutanées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones squameuses
n1=Mycose | n2=mycose des zones squameuses | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones suintantes
n1=Mycose | n2=mycose des zones suintantes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones superficielles
n1=Mycose | n2=mycose des zones superficielles | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surallergisées
n1=Mycose | n2=mycose des zones surallergisées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surattaquées
n1=Mycose | n2=mycose des zones surattaquées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surdéfendues
n1=Mycose | n2=mycose des zones surdéfendues | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surdépilées
n1=Mycose | n2=mycose des zones surdépilées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surépaissies
n1=Mycose | n2=mycose des zones surépaissies | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surépilées
n1=Mycose | n2=mycose des zones surépilées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surfragilisées
n1=Mycose | n2=mycose des zones surfragilisées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surimmunisées
n1=Mycose | n2=mycose des zones surimmunisées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surinfectées
n1=Mycose | n2=mycose des zones surinfectées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surinfiltrées
n1=Mycose | n2=mycose des zones surinfiltrées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surinflammées
n1=Mycose | n2=mycose des zones surinflammées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surirritées
n1=Mycose | n2=mycose des zones surirritées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surprotégées
n1=Mycose | n2=mycose des zones surprotégées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones surtraumatisées
n1=Mycose | n2=mycose des zones surtraumatisées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones ulcérées
n1=Mycose | n2=mycose des zones ulcérées | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose des zones visibles
n1=Mycose | n2=mycose des zones visibles | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose digestive invasive
n1=Mycose | n2=mycose digestive invasive | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose digestive non invasive
n1=Mycose | n2=mycose digestive non invasive | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose disséminée
n1=Mycose | n2=mycose disséminée | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose du pénis
n1=Mycose | n2=mycose du pénis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose du système nerveux
n1=Mycose | n2=mycose du système nerveux | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose du tronc
n1=Mycose | n2=mycose du tronc | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose du vagin
n1=Mycose | n2=mycose du vagin | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose endogène
n1=Mycose | n2=mycose endogène | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose exogène
n1=Mycose | n2=mycose exogène | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose iatrogène
n1=Mycose | n2=mycose iatrogène | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose incurable
n1=Mycose | n2=mycose incurable | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose infectieuse
n1=Mycose | n2=mycose infectieuse | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose intertrigineuse
n1=Mycose | n2=mycose intertrigineuse | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose intestinale
n1=Mycose | n2=mycose intestinale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose irréversible
n1=Mycose | n2=mycose irréversible | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose locale
n1=Mycose | n2=mycose locale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose localisée
n1=Mycose | n2=mycose localisée | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose maligne
n1=Mycose | n2=mycose maligne | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose masculine
n1=Mycose | n2=mycose masculine | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose non contagieuse
n1=Mycose | n2=mycose non contagieuse | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose non infectieuse
n1=Mycose | n2=mycose non infectieuse | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste antibiotiques
n1=Mycose | n2=mycose opportuniste antibiotiques | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste buccale
n1=Mycose | n2=mycose opportuniste buccale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste candida albicans
n1=Mycose | n2=mycose opportuniste candida albicans | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste chronique
n1=Mycose | n2=mycose opportuniste chronique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste corticoïdes
n1=Mycose | n2=mycose opportuniste corticoïdes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste cutanée
n1=Mycose | n2=mycose opportuniste cutanée | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste diabète
n1=Mycose | n2=mycose opportuniste diabète | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste facteurs de risque
n1=Mycose | n2=mycose opportuniste facteurs de risque | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste généralisée
n1=Mycose | n2=mycose opportuniste généralisée | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste grossesse
n1=Mycose | n2=mycose opportuniste grossesse | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste hygiène
n1=Mycose | n2=mycose opportuniste hygiène | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste immunodéprimé
n1=Mycose | n2=mycose opportuniste immunodéprimé | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste infection fongique
n1=Mycose | n2=mycose opportuniste infection fongique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste invasive
n1=Mycose | n2=mycose opportuniste invasive | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste levures
n1=Mycose | n2=mycose opportuniste levures | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste localisée
n1=Mycose | n2=mycose opportuniste localisée | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste maladie auto-immune
n1=Mycose | n2=mycose opportuniste maladie auto-immune | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste nosocomiale
n1=Mycose | n2=mycose opportuniste nosocomiale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste prévention
n1=Mycose | n2=mycose opportuniste prévention | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste profonde
n1=Mycose | n2=mycose opportuniste profonde | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste prolifération
n1=Mycose | n2=mycose opportuniste prolifération | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste pulmonaire
n1=Mycose | n2=mycose opportuniste pulmonaire | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste récurrente
n1=Mycose | n2=mycose opportuniste récurrente | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste résistante
n1=Mycose | n2=mycose opportuniste résistante | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste sévère
n1=Mycose | n2=mycose opportuniste sévère | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste stress
n1=Mycose | n2=mycose opportuniste stress | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste superficielle
n1=Mycose | n2=mycose opportuniste superficielle | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste systémique
n1=Mycose | n2=mycose opportuniste systémique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste traitement
n1=Mycose | n2=mycose opportuniste traitement | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste transplanté
n1=Mycose | n2=mycose opportuniste transplanté | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste vaginale
n1=Mycose | n2=mycose opportuniste vaginale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose opportuniste VIH
n1=Mycose | n2=mycose opportuniste VIH | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose péri-anale
n1=Mycose | n2=mycose péri-anale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose péritonéale
n1=Mycose | n2=mycose péritonéale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose primitive
n1=Mycose | n2=mycose primitive | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose pulmonaire non invasive
n1=Mycose | n2=mycose pulmonaire non invasive | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose réactive
n1=Mycose | n2=mycose réactive | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose résistante
n1=Mycose | n2=mycose résistante | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose réversible
n1=Mycose | n2=mycose réversible | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose sanguine
n1=Mycose | n2=mycose sanguine | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose systémique non invasive
n1=Mycose | n2=mycose systémique non invasive | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose unguéale
n1=Mycose | n2=mycose unguéale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale bicarbonate de soude
n1=Mycose | n2=mycose vaginale bicarbonate de soude | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale causes
n1=Mycose | n2=mycose vaginale causes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale grossesse
n1=Mycose | n2=mycose vaginale grossesse | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale huiles essentielles
n1=Mycose | n2=mycose vaginale huiles essentielles | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale prévention
n1=Mycose | n2=mycose vaginale prévention | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale récidivante
n1=Mycose | n2=mycose vaginale récidivante | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale remède naturel
n1=Mycose | n2=mycose vaginale remède naturel | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale symptômes
n1=Mycose | n2=mycose vaginale symptômes | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement
n1=Mycose | n2=mycose vaginale traitement | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement antibiotique
n1=Mycose | n2=mycose vaginale traitement antibiotique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement bicarbonate de soude
n1=Mycose | n2=mycose vaginale traitement bicarbonate de soude | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement crème
n1=Mycose | n2=mycose vaginale traitement crème | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement grossesse
n1=Mycose | n2=mycose vaginale traitement grossesse | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement homéopathique
n1=Mycose | n2=mycose vaginale traitement homéopathique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement huiles essentielles
n1=Mycose | n2=mycose vaginale traitement huiles essentielles | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement local
n1=Mycose | n2=mycose vaginale traitement local | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement maison
n1=Mycose | n2=mycose vaginale traitement maison | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement naturel
n1=Mycose | n2=mycose vaginale traitement naturel | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement naturel efficace
n1=Mycose | n2=mycose vaginale traitement naturel efficace | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement oral
n1=Mycose | n2=mycose vaginale traitement oral | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement partenaire
n1=Mycose | n2=mycose vaginale traitement partenaire | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement pharmacie
n1=Mycose | n2=mycose vaginale traitement pharmacie | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement rapide
n1=Mycose | n2=mycose vaginale traitement rapide | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
mycose vaginale traitement sans ordonnance
n1=Mycose | n2=mycose vaginale traitement sans ordonnance | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Mycoses
n1=Mycose | n2=Mycoses | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
myome utérin
n1=Mycose | n2=myome utérin | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
myopathie de Duchenne
n1=Mycose | n2=myopathie de Duchenne | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
non précisé, léiomyome de l'utérus
n1=Mycose | n2=non précisé, léiomyome de l'utérus | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
non précisée, dacryoadénite
n1=Mycose | n2=non précisée, dacryoadénite | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
non précisée, dacryocystite
n1=Mycose | n2=non précisée, dacryocystite | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
non précisée, maladie vénérienne
n1=Mycose | n2=non précisée, maladie vénérienne | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
oedème angioneurotique
n1=Mycose | n2=oedème angioneurotique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
oedème de Quincke
n1=Mycose | n2=oedème de Quincke | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
onyxis dermatophytique
n1=Mycose | n2=onyxis dermatophytique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
orteil bleu (syndrome de l')
n1=Mycose | n2=orteil bleu (syndrome de l') | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
orteil en col de cygne
n1=Mycose | n2=orteil en col de cygne | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
orteil en griffe
n1=Mycose | n2=orteil en griffe | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
orteil en marteau
n1=Mycose | n2=orteil en marteau | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
orthèse
n1=Mycose | n2=orthèse | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
orthèse active
n1=Mycose | n2=orthèse active | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
orthèse plantaire
n1=Mycose | n2=orthèse plantaire | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
orthèse profilée
n1=Mycose | n2=orthèse profilée | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
orthobiologie
n1=Mycose | n2=orthobiologie | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Orthobunyavirus
n1=Mycose | n2=Orthobunyavirus | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
orthocéphale
n1=Mycose | n2=orthocéphale | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
orthodiagraphie
n1=Mycose | n2=orthodiagraphie | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
paradontose
n1=Mycose | n2=paradontose | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
pathologie dermatologique
n1=Mycose | n2=pathologie dermatologique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
pédicures-podologues
n1=Mycose | n2=pédicures-podologues | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
perlèche candidosique
n1=Mycose | n2=perlèche candidosique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
piedra
n1=Mycose | n2=piedra | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Pitt-Rogers-Danks (syndrome de)
n1=Mycose | n2=Pitt-Rogers-Danks (syndrome de) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Pityriasis rosé de Gibert
n1=Mycose | n2=Pityriasis rosé de Gibert | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
pityriasis rosé de gibert
n1=Mycose | n2=pityriasis rosé de gibert | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
Pityriasis versicolor
n1=Mycose | n2=Pityriasis versicolor | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
plante des pieds
n1=Mycose | n2=plante des pieds | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
pneumocystose pulmonaire
n1=Mycose | n2=pneumocystose pulmonaire | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
pneumonie à pneumocystis carinii
n1=Mycose | n2=pneumonie à pneumocystis carinii | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
pneumonie à Pneumocystis Carinii
n1=Mycose | n2=pneumonie à Pneumocystis Carinii | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
pneumonie interstitielle à cellules plasmatiques
n1=Mycose | n2=pneumonie interstitielle à cellules plasmatiques | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
pneumopathie à pneumocystis
n1=Mycose | n2=pneumopathie à pneumocystis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
pneumopathie à pneumocystis carinii
n1=Mycose | n2=pneumopathie à pneumocystis carinii | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
psoriasis
n1=Mycose | n2=psoriasis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
roséole
n1=Mycose | n2=roséole | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
septicémie mycosique
n1=Mycose | n2=septicémie mycosique | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
siphilis
n1=Mycose | n2=siphilis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
spondylite
n1=Mycose | n2=spondylite | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
sur le corps
n1=Mycose | n2=sur le corps | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
syndrome de Gougerot-Sjögren
n1=Mycose | n2=syndrome de Gougerot-Sjögren | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
syndrome des yeux de chat
n1=Mycose | n2=syndrome des yeux de chat | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
syndrome du cimeterre
n1=Mycose | n2=syndrome du cimeterre | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
syphilis
n1=Mycose | n2=syphilis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
teigne de l'ongle
n1=Mycose | n2=teigne de l'ongle | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
tendinite
n1=Mycose | n2=tendinite | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
tendinites
n1=Mycose | n2=tendinites | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
tendinose
n1=Mycose | n2=tendinose | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
tinea capitis
n1=Mycose | n2=tinea capitis | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
tinea flava
n1=Mycose | n2=tinea flava | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
tinea imbricata
n1=Mycose | n2=tinea imbricata | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
tinea versicolor
n1=Mycose | n2=tinea versicolor | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
tokelau
n1=Mycose | n2=tokelau | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
tokelau
(mycose)
n1=Mycose | n2=tokelau (mycose) | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
triazole
n1=Mycose | n2=triazole | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
trombidiose
n1=Mycose | n2=trombidiose | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
trou maculaire
n1=Mycose | n2=trou maculaire | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
tumeur de Krukenberg
n1=Mycose | n2=tumeur de Krukenberg | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
utérus fibromateux
n1=Mycose | n2=utérus fibromateux | rel=r_associated | relid=0 | w=5
- Mycose --
r_associated #0: 5 / 0.167 ->
vaginite
n1=Mycose | n2=vaginite | rel=r_associated | relid=0 | w=5
| ≈ 19 relations entrantes
- Plante ---
r_associated #0: 29 -->
Mycose
n1=Plante | n2=Mycose | rel=r_associated | relid=0 | w=29
- Mycose buccale ---
r_associated #0: 26 -->
Mycose
n1=Mycose buccale | n2=Mycose | rel=r_associated | relid=0 | w=26
- Mycose des ongles ---
r_associated #0: 26 -->
Mycose
n1=Mycose des ongles | n2=Mycose | rel=r_associated | relid=0 | w=26
- Mycose invasive ---
r_associated #0: 26 -->
Mycose
n1=Mycose invasive | n2=Mycose | rel=r_associated | relid=0 | w=26
- Mycose systémique ---
r_associated #0: 26 -->
Mycose
n1=Mycose systémique | n2=Mycose | rel=r_associated | relid=0 | w=26
- Mycose vaginale ---
r_associated #0: 26 -->
Mycose
n1=Mycose vaginale | n2=Mycose | rel=r_associated | relid=0 | w=26
- piment ---
r_associated #0: 26 -->
Mycose
n1=piment | n2=Mycose | rel=r_associated | relid=0 | w=26
- Fungi ---
r_associated #0: 25 -->
Mycose
n1=Fungi | n2=Mycose | rel=r_associated | relid=0 | w=25
- Mycose opportuniste ---
r_associated #0: 25 -->
Mycose
n1=Mycose opportuniste | n2=Mycose | rel=r_associated | relid=0 | w=25
- embranchement ---
r_associated #0: 22 -->
Mycose
n1=embranchement | n2=Mycose | rel=r_associated | relid=0 | w=22
- fungi ---
r_associated #0: 10 -->
Mycose
n1=fungi | n2=Mycose | rel=r_associated | relid=0 | w=10
- mycose buccale ---
r_associated #0: 5 -->
Mycose
n1=mycose buccale | n2=Mycose | rel=r_associated | relid=0 | w=5
- mycose des ongles ---
r_associated #0: 5 -->
Mycose
n1=mycose des ongles | n2=Mycose | rel=r_associated | relid=0 | w=5
- mycose invasive ---
r_associated #0: 5 -->
Mycose
n1=mycose invasive | n2=Mycose | rel=r_associated | relid=0 | w=5
- mycose opportuniste ---
r_associated #0: 5 -->
Mycose
n1=mycose opportuniste | n2=Mycose | rel=r_associated | relid=0 | w=5
- mycose systémique ---
r_associated #0: 5 -->
Mycose
n1=mycose systémique | n2=Mycose | rel=r_associated | relid=0 | w=5
- mycose vaginale ---
r_associated #0: 5 -->
Mycose
n1=mycose vaginale | n2=Mycose | rel=r_associated | relid=0 | w=5
- Mycose cutanée ---
r_associated #0: 4 -->
Mycose
n1=Mycose cutanée | n2=Mycose | rel=r_associated | relid=0 | w=4
- Mycose cutanée
(maladie professionnelle) ---
r_associated #0: 2 -->
Mycose
n1=Mycose cutanée (maladie professionnelle) | n2=Mycose | rel=r_associated | relid=0 | w=2
|